<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=gb2312">
<meta name=Generator content="Microsoft Word 14 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:ËÎÌå;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:ºÚÌå;
	panose-1:2 1 6 9 6 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 2 5 9 0 0 0 0 0 0;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:2 4 5 3 5 2 3 3 2 2;}
@font-face
	{font-family:Latha;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Raavi;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Shruti;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Tunga;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:3 8 6 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@ËÎÌå";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
	{color:#0054A6;
	text-decoration:none none;}
a:visited, span.MsoHyperlinkFollowed
	{color:#0054A6;
	text-decoration:none none;}
p
	{margin-right:0cm;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.1, li.1, div.1
	{mso-style-name:Ò³Ã¼1;
	margin-right:0cm;
	margin-left:0cm;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.navigation, li.navigation, div.navigation
	{mso-style-name:navigation;
	margin-right:0cm;
	margin-left:0cm;
	border:none;
	padding:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.tocgroup, li.tocgroup, div.tocgroup
	{mso-style-name:tocgroup;
	margin-right:0cm;
	margin-left:0cm;
	line-height:12.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
p.headline, li.headline, div.headline
	{mso-style-name:headline;
	margin-right:0cm;
	margin-left:0cm;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	color:#0054A6;
	text-decoration:underline;}
p.group, li.group, div.group
	{mso-style-name:group;
	margin-right:0cm;
	margin-left:0cm;
	font-size:10.5pt;
	font-family:"Times New Roman","serif";}
p.10, li.10, div.10
	{mso-style-name:Ò³½Å1;
	margin-right:0cm;
	margin-left:0cm;
	text-align:center;
	font-size:7.5pt;
	font-family:"Times New Roman","serif";}
p.publication, li.publication, div.publication
	{mso-style-name:publication;
	margin-right:0cm;
	margin-left:0cm;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	color:#666666;}
p.linespace, li.linespace, div.linespace
	{mso-style-name:linespace;
	margin-right:0cm;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.top, li.top, div.top
	{mso-style-name:top;
	margin-right:0cm;
	margin-left:0cm;
	text-align:right;
	font-size:7.5pt;
	font-family:"Times New Roman","serif";}
p.infodesk, li.infodesk, div.infodesk
	{mso-style-name:infodesk;
	margin-right:0cm;
	margin-left:0cm;
	text-align:center;
	font-size:8.0pt;
	font-family:"Arial","sans-serif";}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
.MsoChpDefault
	{font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
.MsoPapDefault
	{margin-bottom:10.0pt;
	line-height:115%;}
 /* Page Definitions */
 @page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.WordSection1
	{page:WordSection1;}
-->
</style>

</head>

<body lang=ZH-CN link="#0054A6" vlink="#0054A6">

<div class=WordSection1>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ff840166-adf2-40bd-aef0-c8c07be4a98a.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SRL
gives preventive tips on International Day of Action for Women¡¯s Health</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Urges early diagnosis to resolve several health ailmentsSRL
Diagnostics released a four zone specific study report highlighting heath
disorders afflicting women in India. The national study declared major diseases
such as anaemia, cardiovascular dis...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 4:56:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ad71b96b-0181-489e-9094-e1a2833a259a.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Circulating
25-hydroxyvitamin D and survival in women with ovarian cancer [Cancer]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Vitamin D status might be associated with cancer
survival. Survival after ovarian cancer is poor, but the association with
vitamin D has rarely been examined.Objective: We evaluated the association
between serum 25-hydroxyvitamin D [25(O...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 12:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d983519a-832b-4cbc-bf00-910f712fe82d.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bayer
to Highlight Latest Oncology Research at ASCO 2015 Abstracts: 5034, TPS5082,
5063, TPS1104, 3558, 3560, 6015, TPS5080</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Bayer HealthCare Pharmaceuticals Inc.
announced today the Company's line-up of oncology research to be presented in a
scientific forum at the 51st Annual Meeting of the American Society of Clinical
Oncology (ASCO), May 29 ¨C June 2, in...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c90842d7-1d78-4009-a3d3-2d1de78b5266.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amgen
Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Amgen&nbsp;(NASDAQ: AMGN) today announced
that data at the 51st Annual Meeting of the American Society of Clinical
Oncology (ASCO) will showcase the Company's continued efforts across both
pipeline and marketed products, including key resu...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bb62be05-9c33-4fb2-892a-a8dd16831b7d.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AACE
Pioneers Obesity Medicine Treatment Across All Specialties</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The American Association of Clinical Endocrinologists (AACE)</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AACE announces a new obesity medicine treatment module and
toolkit at its 24th Annual Scientific and Clinical Congress.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-gdo5></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/838c4409-c35f-44c7-a69d-06ce8755a9a4.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dicerna
Announces Expansion of Ongoing DCR-MYC Phase 1 Study to Evaluate Safety and
Efficacy in Patients with Advanced Pancreatic Neuroendocrine Tumors (PNETs)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Dicerna Pharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Dicerna today announced it is expanding its ongoing Phase 1
study of DCR-MYC in solid tumors, multiple myeloma, or lymphoma to include a
cohort of patients with pancreatic neuroendocrine tumors.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/92dc909e-a2ea-4618-b8d5-d1055f907369.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celgene
Announces Presentations of Investigational Studies in Solid Tumor and Blood
Cancers at ASCO 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Celgene Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Celgene Corporation (NASDAQ:CELG) today announced more than 55
presentations reporting on investigational studies in blood and solid tumor
cancers will be presented during the 51st American Society of Clinical Oncology
meeting in Chicago, Ill. from ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bdb81138-b6bc-4c2c-bc46-1d96b2c90dba.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Janssen
to Showcase Data from Five Compounds Including Daratumumab and IMBRUVICA at the
2015 American Society of Clinical Oncology (ASCO) Annual Meeting - Note: This
release corresponds to ASCO abstracts LBA8512, 8587, 8590, TPS8609, TPS8608,
LBA7005, 7012, TPS8599, TPS8601, 7024, TPS7095, TPS7096, 5005, 5047, 5053,
5014, 5028, TPS5071, TPS5084, 10503, 6537, TPS5606</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Janssen Research &amp; Development, LLC
(Janssen) announced that data from five oncology treatments across the
portfolio, including marketed and investigational compounds, will be presented
at the American Society of Clinical Oncology (AS...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/46ddec55-b906-4e60-9db1-443e3b71ba3b.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>O¡¯Connor
Hospital Recognized for Outstanding Quality</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Daughters of Charity Health System</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>O¡¯Connor Hospital was recognized with an ¡°A¡± grade in the Spring
2015 Hospital Safety Score by the Leapfrog Group, the highest available rating
for patient safety in the nation. The hospital also received an ¡°A¡± rating in
Fall 2014.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 3:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ce498c73-a71d-4166-80da-d60bbe66258a.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Contrast
Auto-injectors Gain Momentum in Western Europe Market participants have begun
to bundle their products with imaging systems to expand sales, finds Frost
&amp; Sullivan</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- The use of auto-injectors to ensure controlled
and efficient contrast delivery for quick and accurate imaging modality
diagnosis is gathering momentum in Western Europe. To exploit the market
upswing, auto-injector and imaging modalit...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:58:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/aeca37f4-216f-41af-85be-7ef07ae8429e.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Data
on Long-Term Safety and Effectiveness of Hysingla&reg; ER (hydrocodone bitartrate)
Extended-Release Tablets CII Presented at American Pain Society Scientific
Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Purdue Pharma today presented data from a
long-term (76 week) safety and efficacy study of Hysingla ER, a once-daily,
single-entity hydrocodone bitartrate tablet formulated with abuse-deterrent
properties. Results of this and two othe...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7b89dc59-1700-413b-98f7-093525ce8c89.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Older
patients receive less evidence-based cardiac care than younger patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>People in their 80s and 90s are more likely to develop acute
coronary syndrome than their younger counterparts. Despite this, they receive less
therapy and fewer diagnostic procedures. A doctoral thesis at Sahlgrenska
Academy has explored the topic.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/264d4d41-7554-42a5-9e05-966be56fac82.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>iRhythm
Expands Leadership Team with Appointment of Derrick Sung, Ph.D. as Executive
Vice President of Global Strategy and Corporate Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;iRhythm Technologies, Inc.,&nbsp;a leading
digital healthcare solutions company focusing on the advancement of cardiac
care, announced today the appointment of Derrick Sung, Ph.D. to the executive
management team as executive vice presiden...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-hw3t></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1cafa141-5564-4563-9e9c-a412a4c67e60.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rosetta
Genomics Launches Two Assays for Bladder Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rosetta Genomics Ltd.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and
provider of microRNA-based molecular and other diagnostics, announces that the
Company will commercially introduce two FGFR3 gene mutation assays; one for
diagnostic monitoring using urin...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/46e6ce72-e458-4d0d-a576-61d1d129ea15.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Commonwealth
Laboratories, Inc. Announces Launch of IBSchek(TM), a New, Simple Blood Test to
Quickly and Reliably Diagnose Irritable Bowel Syndrome (IBS)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Marketwired - Medical and Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New Diagnostic Test for IBS Can Reduce Frustration, Time and
Cost Associated With the Current Practice of Diagnosis by Exclusion Used for an
Estimated 40 Million IBS Sufferers</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f8ebedeb-89d7-4ddb-96ae-9e5412c55a90.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
APPROVES FIRST ASEPTICALLY SPRAY DRIED BIOLOGIC</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ Nova Laboratories has welcomed the FDA¡¯s approval of Raplixa
from ¡­ commercial supply.&nbsp; The US Food and Drug Administration has
approved the Raplixa fibrin ¡­ , M.D., director of the FDA¡¯s Center for
Biologics Evaluation ¡­ manufacturing option will...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7cbe5c0e-a683-4059-82b8-9bc7a3f315d5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celiac
Disease Markedly Underdiagnosed in Adults, Say Danish Researchers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Press Release</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Dateline City:UPPSALA, SwedenStudy using celiac disease antibody
tests suggests that reliance on classic symptoms alone to diagnose patients may
be inadequateUPPSALA, Sweden--(BUSINESS WIRE)--Celiac disease (CD), which
produces unpleasant symptoms a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/62081ecb-9f0a-497b-9cb8-856c0ddde32c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Business
Highlights from the Healthcare Space: Complementary Research on Amphastar
Pharma, Can-Fite BioPharma, Nanosphere, Immune Pharmaceuticals and Actinium
Pharma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --Can-Fite BioPharma Ltd. announced on May 11,
2015, that it has received clearance from the European Medicines Agency to
commence dosing patients in Europe in its global Phase II trial for CF102 in
the treatment of hepatocellular carcin...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/07488843-a4e1-4d9c-a99a-9e8f246729dd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Strand
Life Sciences to Highlight Clinical Utility Data for StrandAdvantage at 2015
ASCO Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d0e753ff-0b7e-458e-9307-e49ba444cb33.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OncoCyte
Corporation Completes Equity Financing Round</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc. (NYSE MKT:BTX) and its subsidiary OncoCyte
Corporation today announced that OncoCyte has received a new round of financing
to fund further development and commercialization activities for its cancer
diagnostic products. With completion...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bc0e7649-77a6-4af8-93e4-4a988f7e69ad.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>World-renowned
Clinical Expert in Urological Oncology Joins Metamark Team</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Metamark</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Metamark, a privately-held company dedicated to providing
comprehensive solutions for advanced urological care, announced today that
Jerome P. Richie, M.D. will join Metamark¡¯s executive leadership team as Chief
Medical Officer, effective July 1, 20...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f4dbbf9e-9027-4fa9-9fd6-07920b1f3339.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Reports 2015 First Quarter Results 42 percent growth in customer base
year-over-year, and 31 percent increase in year-over-year revenues</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Great Basin Scientific, Inc. (NASDAQ:
GBSN), a molecular diagnostic testing company,&nbsp;today reported earnings
results for the quarter ended March 31, 2015. Revenue for the quarter was
$458,730,&nbsp;which represented a 31 percent increase i...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ee48dfec-50b5-4e42-8c20-5fbadd335bd1.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Astellas
Announces New Data in Advanced Prostate and Breast Cancers, Acute Myeloid
Leukemia, and Lung and Renal Cancers To Be Presented at 2015 ASCO Annual
Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Astellas today announced several abstracts
across multiple cancers that will be presented at the 2015 American Society of
Clinical Oncology (ASCO) Annual Meeting on May 29-June 2 in Chicago. </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 7:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5104f71a-08ad-45ad-a0fa-89209785e53c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agenus
Announces Oral Presentation at ASCO Highlighting Improved Survival with
Prophage Immunotherapy in Brain Cancer Compared to Historical Controls</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agenus Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agenus Inc. (NASDAQ:AGEN), an immunology company developing
innovative treatments for cancers and other diseases, today announced that data
on continuing survival from a Phase 2 study of its Prophage vaccine in
glioblastoma multiforme (GBM) has been...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/49e6ddc7-1414-4cf5-8077-b109fb2ab1e6.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Australian Prostate Cancer Diagnostic Technology to Feature at International
Urology Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SYDNEY, May 14, 2015 /PRNewswire/ -- A new prostate cancer
diagnostic test developed by Australian scientists will be featured at a
prestigious international oncology conference next week. The MiCheck&#8482;
technology, developed by scientists at Minomic ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5efc89a4-9a96-4a36-afac-af4af847f33d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sage
Preps For Final Test As Epilepsy Drug Holds Up in Small Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ben Fidler The patient numbers keep growing for Sage
Therapeutics, but, at least for now, the story is the same¡ªits experimental
epilepsy drug remains promising. Now comes the hard part: testing it in a big,
randomized, placebo-controlled trial.Camb...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/058fc7f5-a7b9-42a2-876c-4ba57f1dfba5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Medtronic
Receives FDA Approval, CE Mark For Cryoballoon to Treat Atrial Fibrillation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ Catheter has received U.S. Food and Drug Administration (FDA)
approval for the treatment ¡­ clinical reports, in support of FDA premarket
approval. 4 Packer D ¡­</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/711cefe5-94eb-401a-8bdb-51e1bb5f81d5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Australian Prostate Cancer Diagnostic Technology to Feature at International
Urology Conference Full data from 300 patient pilot study to be presented at
prestigious American Urology Association Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- A new prostate cancer diagnostic test developed
by Australian scientists will be featured at a prestigious international oncology
conference next week.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/35d53901-fca2-45d4-bc2c-f806bb556d67.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>/R
E P E A T -- Montreal Heart Institute and AstraZeneca to screen 80,000 samples
for cardiovascular and diabetes genetic traits/</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -&nbsp;The Montreal Heart Institute (MHI) today
announced a collaboration with AstraZeneca, to search the genomes of up to
80,000 patients for genes associated with cardiovascular diseases and diabetes,
their complications and treatment outco...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bb394426-2d5c-4a58-ba60-429f22b546e4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
test could spot sepsis early and may be diagnosed in less than an hour&nbsp;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Articles | Mail Online</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Scientists have discovered that sepsis leaves 11 tell-tale signs
in the blood. The discovery raises hope of a simple blood test that rapidly
picks up the illness, saving some of the 40,000 lives lost every year.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:57:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4ca5374f-c5ac-44a3-88ca-bf5da8607a2e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TB
Alliance Launches &quot;Nix-TB&quot; Clinical Trial to Test New XDR-TB
Treatment First clinical trial to test a new all-oral regimen for extensively
drug-resistant TB; Nix-TB is a critical step in the development of a universal
treatment for all types of TB</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- TB Alliance and its partners
announced the start of a clinical trial of a new regimen to treat extensively
drug-resistant tuberculosis (XDR-TB.) It is the first study to test an all-oral
drug regimen, comprised of drugs wit...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2d8fcf75-c7e8-4c54-86ca-057814aa2ef3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Drugmaker
dives into personalized medicine for asthma, heart disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healthcare Packaging: News, trends and analysis of
pharmaceuticals, biologics, medical devices, and nutraceuticals</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The company will be working on a diagnostic test that would work
with an experimental asthma drug, as well as working with scientists on genes
relating to heart disease.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:48:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2df36a79-d14c-41f6-907f-39dff78f800c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
nod for drugs crucial for Lupin, Dr Reddy¡¯s Laboratories</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Economic Times</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Lupin posted its worst quarterly performance with a drop in
growth in key markets like US and Japan, resulting in flat revenues and a
300-bps drop in operating margin.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:45:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b0c90d6d-23b2-4c57-b49e-087258965ef9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
ibrutinib (IMBRUVICA&reg;) Data to be Showcased at American Society of Clinical
Oncology (ASCO) Annual Meeting IMBRUVICA Combination Data in Chronic
Lymphocytic Leukemia to be Featured in Official ASCO Press Program</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Pharmacyclics, Inc. (NASDAQ: PCYC)
announced today that ibrutinib (IMBRUVICA&reg;) single-agent and combination data
will be featured in seven oral and poster sessions at the 51st American Society
of Clinical Oncology (ASCO) Annual Meetin...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:22:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/53f3cc6a-3e05-4f1e-ac33-f8b0e95e382d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clinical
Utility of Trovagene's Urine-Based Liquid Biopsy Platform to Be Highlighted at
the American Society of Clinical Oncology Meeting Precision Cancer Monitoring
technology offers advantages over tissue biopsy and demonstrates ability to
monitor tumor dynamics in lung, pancreatic, and colon cancers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Trovagene, Inc. (NASDAQ: TROV), a developer
of cell-free molecular diagnostics, announced today that clinical data from
four studies utilizing its Precision Cancer MonitoringSM platform will be
presented at the 2015 American Society o...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a81902d1-ab22-4c53-8660-185bca0bf547.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clovis
Oncology Announces Data Presentations at 2015 ASCO Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Clovis Oncology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Clovis Oncology Announces Data Presentations at 2015 ASCO Annual
Meeting</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ee372b6c-7427-43fa-9e0d-32357235d10b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genentech¡¯s
Investigational Immunotherapy MPDL3280A Doubled the Likelihood of Survival
Compared with Chemotherapy in People with a Specific Type of Lung Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genentech</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
RHHBY), today announced interim results from a global, randomized Phase II
study (POPLAR) in people with previously treated non-small cell lung cancer
(NSCLC). The study showed the investi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7b16fc39-78c1-4fe9-9c34-6ca444eeddfb.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Invitae
and Collaborators to Present New Data at the 2015 American Society of Clinical
Oncology Annual Meeting Focusing on the Clinical Utility of Multi-Gene Panel
Tests for Hereditary Breast and Ovarian Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Invitae Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Invitae Corporation(NYSE:NVTA), a genetic information company,
announced that new data will be presented during the 51st American Society of
Clinical Oncology (ASCO) Annual Meeting. The presentation, ¡°Clinical Impact of
Multi-Gene Panel Testing for ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/40a14ebb-0a4f-461d-b149-ec56aa0aa614.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AstraZeneca
to Update on Progress with Immuno-Oncology Pipeline and Combination Treatments
at ASCO 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AstraZeneca</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AstraZeneca and MedImmune, the Company¡¯s global biologics
research and development arm, will demonstrate rapid progress with their
combination-focused oncology pipeline at the American Society of Clinical
Oncology (ASCO) Annual Meeting, May 29-June ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/33bfb043-5c5c-4ede-8525-19a8ae3b0f57.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genentech¡¯s
Investigational Medicine Alectinib Shrank Tumors in Nearly Half of People With
Specific Type of Lung Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genentech</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
RHHBY), today announced positive results from two pivotal studies (NP28673 and
NP28761) that showed alectinib, its oral investigational anaplastic lymphoma
kinase (ALK) inhibitor, shrank t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/716bdf3a-9ca9-406b-8221-7ccce3109c7e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WHO
Approves Cepheid Ebola Assay for Use in Affected Countries</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4439ecc5-2b3a-4225-982b-309a84632cec.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Scientists
find genetic signature enabling early, accurate sepsis diagnosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Investigators at the Stanford University School of Medicine have
identified a pattern of gene activity that could help scientists create a blood
test for quickly and accurately detecting whether patients are experiencing a
deadly immune-system panic...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:53:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ca44b04c-74d5-4b05-9789-293698263e17.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>National
study finds lower depression, better mental health during the Great Recession</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Men and women in the U.S. had lower odds of depression diagnoses
and better mental health during the Great Recession of 2007-09 compared to
pre-recession according to a University of Maryland (UMD) study published in
the journal PLOS ONE. Post-reces...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:53:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0664ada3-4534-4d62-a37e-8fecfd612abf.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Stanford
Team Discovers Diagnostic Gene Set for Sepsis; Aims to Develop Clinical Assay</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:48:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a129d4bf-68ee-49f3-9063-883462625c06.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CAP
and ADASP Offer New Guideline to Improve Laboratory Testing Leading pathology
organizations provide recommendations for systematic and timely secondary
reviews of surgical pathology cases, leading to more accurate diagnoses and
improved patient care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- Today, the College of American
Pathologists (CAP) and the Association of Directors of Anatomic and Surgical
Pathology (ADASP) announced the joint release of a new evidence-based guideline
to provide recommendations for seco...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/78563180-14eb-4518-8dcd-369e527843d8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fulfilling
Our Energy Future¡¯s Potential: 5 Key Challenges</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Daniel Schwartz I believe that 2035 is a crucial year for the
global energy economy. Over the next 20 years, Citibank forecasts a global
investment of roughly $10 trillion in new electricity generation infrastructure
and $7 trillion in new distribut...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 1:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8f4fe55d-6009-4247-bd98-b9aad7b2b7b6.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Optimism
over faster diagnosis of neglected Chagas disease: MSF</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Reuters: Health News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BOGOTA (Thomson Reuters Foundation) - Researchers are optimistic
a rapid test for Chagas disease will be approved early next year,
revolutionizing diagnosis and ensuring earlier treatment for a disease
affecting seven million people, mainly in Latin...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 1:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/353f28c4-f5c8-4039-a121-8fad34aabf31.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Optimism
over faster diagnosis of neglected Chagas disease - MSF - TRFN</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Reuters: Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BOGOTA, May 13 (Thomson Reuters Foundation) - Researchers are
optimistic a rapid test for Chagas disease will be approved early next year,
revolutionising diagnosis and ensuring earlier treatment for a disease
affecting seven million people, mainly ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:57:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cd8f7e8f-f9c6-4af7-b374-bb6ccda994da.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Silicon
Valley Comes to Oxford to Discuss How Humans Can Win Against Machines in the
Workplace of the Future</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:53:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2785dec4-024e-4faa-a170-eeb9572dd607.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>COPAN
is Proud to Announce FDA Clearance for FecalSwab&#8482; to Standardize and Simplify
Enteric Culture and Molecular Diagnostics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- COPAN, an innovative company focused on bringing
breakthrough products to Microbiology preanalytics around the world, announced
that it has obtained FDA clearance for its new FecalSwab&#8482;.&nbsp; </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 11:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/89f2c2fb-2a39-4e37-a088-040a67916bbb.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tekscan
Launches New Website</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tekscan, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tekscan has launched their new website and complete rebrand of
both the company and individual divisions. Each division emerged with a unique
identity that utilizes an updated color palette, design scheme, new product
photography, and messaging ¨C al...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 11:44:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/00c199bb-ce10-4998-bf99-5402ed201d89.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Gelesis,
PureTech¡¯s Weight-Loss Hopeful, Postpones IPO</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ben Fidler Gelesis gobbled up some cash from private investors
just a few months ago. But it looks like public investors don¡¯t have the same
type of appetite for the Boston startup¡¯s hydrogel weight-loss pills.According
to research firm Renaissance ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3f02c4a7-1708-4918-9dc8-0352ec0e5f49.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Wisconsin
Roundup: Marquette, NorthStar, Forte Research, &amp; More</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Jeff Engel Here¡¯s a smattering of the latest news from
Wisconsin¡¯s innovation and technology community:¡ªMadison-based NorthStar
Medical Radioisotopes said it completed its first large-scale test run of
producing molybdenum-99 (Mo-99), the parent iso...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a78550ff-5740-48e2-b368-c0533bcbdd4a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>San
Antonio Chamber of Commerce and Denim Group Celebrate One Year Anniversary of
Providing Unique MBA-Style Cybersecurity Boot Camp for Veterans</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Denim Group</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Marking its one year anniversary, the San Antonio, TX
Cybersecurity Boot Camp is designed to assist talented veterans in navigating
the challenges of entrepreneurship to start their own businesses.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ce9d555c-d30d-42cf-91b9-7675803e026d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Accutest
Recently Completed its 22nd Successful FDA Inspection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>MUMBAI, May 13, 2015 /PRNewswire/ -- During the
period&nbsp;April 6th to 8th 2015, Accutest successfully completed its 22nd
USFDA inspection without receiving any form 483. Accutest is a leading global
independent CRO with a track record of more than 2,2...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3ac4f11d-7fbc-43b1-ae87-cde0fcc9104c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We¡¯re Catching up on Vertex, AstraZeneca and More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Krisanne Johnson for The Wall Street JournalHello, everyone, and
how are you this fine, sunny morning? The middle of the week has arrived, as
you may know, so why not celebrate with a delicious cup of stimulation? After
all, you made is this far, wh...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/66f83425-e2d6-4738-b0d3-c8909f7c5f1e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Chiropractic
Care of Minnesota, Inc. Launches ChiroCare Centers of Excellence</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Chiropractic Care of Minnesota, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Chiropractic Care of Minnesota, Inc. (CCMI), a nonprofit that
offers the largest independent network of credentialed chiropractors and
licensed acupuncturists in the Upper Midwest, today announces the launch of its
distinguished ChiroCare Centers of...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5825ea91-9192-416f-a601-6a6b0ad50636.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rosetta
Genomics Receives Additional U.S. Patent Protection for the Cancer Origin Test&#8482;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rosetta Genomics Ltd.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and
provider of microRNA-based molecular and other diagnostics, announces that the
Company has received a Notice of Allowance from the United States Patent and
Trademark Office for U.S. paten...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-ssah></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/971324b0-b1c7-4e7d-b723-8433ef0a2a8c.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We¡¯re Catching up on Pfizer, Antibiotics and Lots
More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rise and shine, everyone, another busy day is on the way. This
morning is getting off to a fabulous start, though, as a delightfully warm sun
is enveloping the subdued Pharmalot campus, where the officials mascots are
snoozing and the short people a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2a6055d2-a8e5-4a42-bb46-d3bff1ad41a9.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Corporation Announces Resignation of an Independent Director</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HONG KONG, May 14, 2015 /PRNewswire/ -- China Cord Blood
Corporation (NYSE: CO) (&quot;CCBC&quot; or the &quot;Company&quot;), China's
leading provider of cord blood collection, laboratory testing, hematopoietic
stem cell processing and stem cell storage services, toda...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/da770d47-b15a-4b1f-9eb9-0f9f86219320.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>D-Pharm
Receives Final Report for Its Phase 2 Clinical Study of THR-18 in Acute Stroke
Patients Treated With tPA THR-18 reduces intracranial hemorrhage and brain
edema, and enhances recovery in acute ischemic stroke patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/81ca6955-f903-4371-a361-4f85fd2810d7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epic
Sciences to Present at UBS Global Healthcare Conference Epic's circulating
tumor cell liquid biopsy provides comprehensive, real-time information that
could help guide precision cancer treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Epic Sciences, Inc. (&quot;Epic&quot;), a
private biotech company that designs and develops diagnostics to personalize
and advance the treatment and management of cancer, announced today that
Michael Rodriguez, chief financial officer, will pre...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fa40d1b9-9da5-4a53-96db-c3d754d72ffa.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SLIPS
Technologies Expands Team</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SLIPS Technologies</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SLIPS Technologies, Inc. has expanded its team to include
additional business development and scientific expertise in order to meet
growing demand for industrial and medical applications.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dc60fa8a-25f9-4799-aae0-a59c2a809525.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ARIAD
Announces Data Presentations at the 2015 ASCO Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ARIAD Pharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
clinical data on Iclusig&reg; (ponatinib) and brigatinib (AP26113), its
investigational anaplastic lymphoma kinase inhibitor, will be presented at the
Annual Meeting of the American Society...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 7:38:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/11ce0816-b2f5-491f-96c3-64501bf48e08.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Discovery
Labs Announces Results of Phase 2a Clinical Trial of AEROSURF&reg; Encouraging
safety and physiological data suggest that aerosolized KL4 surfactant can be
delivered to the lung of premature infants with respiratory distress syndrome</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Discovery Laboratories, Inc. (NASDAQ:
DSCO), a specialty biotechnology company focused on developing aerosolized KL4
surfactant therapies for respiratory diseases, today reported top line data
from its recently completed AEROSURF&reg; pha...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 7:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/601501a9-df85-466c-ae58-4d0e63537fe3.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Inside
The MIT's Labs In Singapore, Where Researchers Develop New Methods For Early
Cancer Detection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Forbes Real Time</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Researchers are working on a &quot;blood test&quot; that could
replace the more invasive biopsy, and open also the doors to personalized
treatments of the disease.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/acfa2304-0456-4d9e-934a-558773100af4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerulean
Announces CRLX101 Poster Presentations at the 2015 American Society for
Clinical Oncology (ASCO) Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cerulean Pharma Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cerulean announced that four abstracts on its lead candidate,
CRLX101, are included in the 2015 American Society of Clinical Oncology (ASCO)
Annual Meeting held in Chicago from May 29 through June 2.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/186c7c10-3332-41cd-8a79-71b704c76c35.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Why
the joint family system is the best to bring up children</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Nation News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>On 15th May, International Day of Families is celebrated
throughout the world to raise awareness through workshops, seminars,
exhibitions and organized discussions about the importance and the role of
family in society. The family is a universal soc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 5:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/900ddf8b-3fcb-435c-8bf6-e61e0a0d0906.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Imaging
MR-Conditional Implants to Spot Adverse Reactions Fast</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>GE Healthcare The Pulse</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Magnetic Resonance Imaging (MRI) has become a cornerstone of
modern radiology. Without the radiation associated with X-ray and CT scans,
physicians can use it to see any part of the body, from any angle. Some MRI
techniques are so advanced that a fu...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 5:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/33e1d619-dfbf-4bd2-b43c-14b4f928a91a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
age of genome editing could lead to cure for sickle cell anemia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UNSW Australia researchers have shown that changing just a
single letter of the DNA of human red blood cells in the laboratory increases
their production of oxygen-carrying haemoglobin - a world-first advance that
could lead to a cure for sickle cel...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 5:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6db914db-fbbf-442e-87b9-55bcb6e5b9af.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Handshake
strength 'could predict' heart attack risk</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UK headlines</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New research suggests the strength of a person's hand-grip could
predict the risk of heart attacks and strokes - and is a stronger predictor of
death than blood pressure checks.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 2:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/48a9a013-ff13-4260-ab01-3b6aa51f94e1.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Thymic
Low Affinity/Avidity Interaction Selects Natural Th1 Cells [IMMUNE SYSTEM
DEVELOPMENT]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Identification of intrathymic eomesodermin+ (Eomes+) CD4 T cells
creates a novel idea that there is more than one way for the generation of
innate CD4 T cells. Promyelocytic leukemia zinc finger protein+ T cells and
natural Th17 cells are known to b...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 12:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/72fd6e84-ff40-426d-b628-5a87069a0db0.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genetic
Vaccines To Potentiate the Effective CD103+ Dendritic Cell-Mediated
Cross-Priming of Antitumor Immunity [IMMUNOTHERAPY AND VACCINES]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The development of effective cancer vaccines remains an urgent,
but as yet unmet, clinical need. This deficiency is in part due to an
incomplete understanding of how to best invoke dendritic cells (DC) that are crucial
for the induction of tumor-spe...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 12:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1252f269-0745-4973-bef7-e93eed08662a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Smiths
Medical to Sponsor US and Global Symposiums, Exhibitor Theater Presentations at
Upcoming Conferences</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Smiths Medical</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Upcoming Conferences in Louisville, KY; Hong Kong and Nashville,
TN will feature independent biofilm research presented by Marcia Ryder, PhD,
MS, RN.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6c147f3c-e93c-4356-a498-74443fdd9330.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biochemical
auto analyser installed at Siddha institute</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>It tests blood parameters, liver markers with single sample</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:54:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c77bb225-d332-4da4-ad58-eb3a4bb1908b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dan
Ryan Awarded 2015 Hearthstone BUILDER Humanitarian Award</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Hearthstone and Hanley Wood's BUILDER
Magazine, together with Kohler Company, the founding Sponsor, honored the first
recipient of the Humanitarian Award sixteen years ago.&nbsp; It is an award
bestowed upon a builder who has demonstrated ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/28368412-ca80-4061-af93-363149ae92a7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
issues draft guidance on blood donations from MSM</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com HEMATOLOGY ONCOLOGY RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The FDA has formally recommended a proposal to allow men who
have sex with men to donate blood, provided that their most recent sexual
contact was at least 1 year ago. ¡°Since September 1985, FDA has recommended
that blood establishments indefinitely...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fcccbd25-9295-45e8-b639-2eef8e65ad9b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Children¡¯s
Hospital Los Angeles Researchers Find How the Tumor Microenvironment
Contributes to Drug-Resistant Neuroblastoma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Children's Hospital Los Angeles</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Researchers at Children¡¯s Hospital Los Angeles have made an
important step toward finding a target in the fight against drug-resistant
neuroblastoma (NBL), the most common solid malignancy found, outside of the
skull, in children.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/39b83b2a-aca9-449d-a172-6dc0cfbbc821.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Diagnostic
Tests for Biologic Asthma Therapy Under Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7d492d63-7b14-4e28-8348-c785acb7c234.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Milwaukee
Emergency Center for Animals blood bank filling up in Greenfield</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a547ccb4-e95d-4e0f-87b3-20f341ea5986.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
bank shut down in Kalikapur as blood was not screened for HIV</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3866ef8c-2762-44a1-9101-a142f7e1a44d.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dominion
Diagnostics Named One of Rhode Island's 2015 Best Places To Work by Providence
Business News</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Dominion Diagnostics, a leading national
provider of drug testing, medication monitoring, and clinical support services,
has been named one of Rhode Island's Best Places to Work.&nbsp; Dominion
Diagnostics will be honored among other winne...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8e9af59c-35ed-4a50-8d02-8e7621434af7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sangamo
BioSciences Announces Joint Steering Committee Decision To Consolidate ZFP
Therapeutic&reg; Strategy For Hemoglobinopathies Development Decision Leverages
Recent Data with New ZFN-mediated Genome Editing Approach for Both Sickle Cell
Disease and Beta-Thalassemia Programs</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Sangamo BioSciences, Inc. (NASDAQ: SGMO)
announced that it will consolidate development paths for the zinc finger
nuclease (ZFN)-mediated genome editing programs targeting beta-thalassemia and
sickle cell disease (SCD). This decision ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8492329f-e101-46ff-ad72-548a923f591e.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
blood test quickly reveals severity of radiation injury</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A novel blood test could greatly improve triage of victims of
radiation accidents by rapidly predicting who will survive, who will die, and
who should receive immediate medical countermeasures, according to scientists
at Dana-Farber Cancer Institute.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:53:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/85dcaff8-22b9-4c44-9630-9df8ef0b42b4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>First
patient enrolled in dabigatran study comparing anticoagulation strategies
during AF ablation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Boehringer Ingelheim</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The first patient with atrial fibrillation (AF) has been
enrolled in the global RE-CIRCUIT&#8482; study.4 The study assesses the safety and
efficacy of uninterrupted anticoagulation with dabigatran etexilate (Pradaxa&reg;)
during ablation procedures compared ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 1:26:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/57fedbba-6830-4f17-b3ae-4d75211f93c1.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cybersecurity
and the artificial pancreas¡ªwhat are the risks?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>An artificial pancreas, designed for blood glucose control in
diabetes, is controlled by software that runs on mobile computing platforms
such as laptops, tablets, and smartphones, and operates over wireless networks
under local or remote medical su...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fb6a098d-a9ee-4f21-a57c-7182a2ec0d70.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Durham's
BioCryst takes big step, moves new drug into human testing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Raleigh Business News - Local Raleigh News | The Triangle
Business Journal</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Durham drug developer BioCryst Pharmaceuticals (Nasdaq: BCRX)
will test an experimental treatment for hereditary angioedema (HAE) in humans
for the first time. In drug development, this is a big step. Companies that
think they have a new disease tre...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e9f62e06-3b25-4bf1-a8e5-40d74ba30022.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dear
Prudence: Help! I¡¯ve been bitten by a bat and also charged with soliciting a
prostitute</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>National Post - Top Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Emily Yoffe, aka Dear Prudence, is online weekly to chat live
with readers. An edited transcript of the chat is below. (Send questions to
Prudence at&nbsp;prudence@slate.com.)Emily Yoffe: Good afternoon, everyone. I
look forward to your questions.Q. A Re...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:49:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/91e59047-4f15-489c-8bad-1829d06ca036.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Guidance that Dare Not Speak Its Name</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Eye on FDA</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>In December 2014, Commissioner Hamburg announced a proposed change
in the FDA¡¯s long-standing policy regarding blood donations from gay men ¨C See
¡°FDA Commissioner Margaret A. Hamburg¡¯s statement on FDA¡¯s Blood Donor Deferral
Policy for Men Who Have...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:46:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c2fb5d8b-d33a-46b9-b3a4-304eac39c3da.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HealthPartners
review confirms effectiveness of cognitive behavioral therapy to treat chronic
insomnia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HealthPartners</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HealthPartners Sleep Health Center adds to research that
cognitive behavior therapy for insomnia is effective at treating chronic
insomnia without medication.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a349dfea-08b9-4ed0-b8e9-dd5fbee44f4b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Phelps
Memorial Hospital Center Leads the Way, Introduces Telehealth</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Phelps Memorial Hospital Center</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Since the passage of the Affordable Care Act,the emphasis on
healthcare in the U.S. has shifted towards the importance of preventive care as
a way of improving the health of the population and avoiding costly
hospitalizations. Now, Phelps Memorial H...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 11:59:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c2c2be22-7c4b-4301-8d7e-818735218d44.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CBER-Regulated
Products: Shortages and Discontinuations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>What's New: Vaccines, Blood &amp; Biologics RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A CBER-regulated product shortage occurs when a CBER-regulated
product is not commercially available in sufficient quantity to meet the
demand.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 11:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dfb2ccfd-5f5d-41ad-9449-cd2c950b8742.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WALNUTS
can slow bowel cancer growth by 'reducing blood supply to tumours'</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Articles | Mail Online</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A handful of walnuts a day caused more omega-3 fatty acids to
congregate in bowel cancer cells. The more omega-3, the smaller the tumours,
researchers from Harvard Medical School found.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 11:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0ab18e04-d5ec-43cb-a682-fb88b3abf361.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
propose to lift ban on blood donation for gay, bisexual men</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA and Over The Counter News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ past 12 months. Yesterday, the FDA issued a draft guidance ¡­
in commercial sex work or non-prescription injection drug use would remain ¡­
some organizations are against the FDA's draft guidelines ¡­ the FDA's draft
guidelines for the policy. The FD...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 11:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f5ccbc1a-f697-442e-9d0d-e4c2fffb02a4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novel
biomarkers may provide guide to personalized hepatitis C therapy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A simple blood test can be used to predict which chronic
hepatitis C patients will respond to interferon-based therapy, according to a
report in the May issue of Cellular and Molecular Gastroenterology and
Hepatology, the basic science journal of th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fad33055-ce63-4c96-9846-adb98ded7ee6.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nurse
in Italy Tests Positive for Ebola; Was in Sierra Leone</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Drug Discovery &amp; Development All</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Italy's health ministry said a nurse who came to Italy from
Sierra Leone last week has tested positive for the Ebola virus.The ministry
said a blood sample was sent to Rome for testing Tuesday from Sardinia, where
the nurse had arrived on May 8.The ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1abf9a65-0ce5-44ae-9dd7-fe2655308bb5.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Christopher's
Crew comes through</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/64bbcde5-8ae0-4b69-90aa-5708a5860753.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ablative
Solutions Announces CE Mark of the Peregrine System&#8482; Infusion Catheter
Transcatheter Perivascular Alcohol Denervation for the Treatment of
Uncontrolled Hypertension</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Ablative Solutions, Inc. (ASI), a
venture-backed, privately-held clinical stage company headquartered in
Kalamazoo, MI, with offices in Menlo Park, CA, today announced that it has
received the CE Certificate of Conformity allowing ASI...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:14:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/51fe5404-69d5-4da4-a719-bf8794608c2f.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Competition,
Innovation Driving Blood Testing Market; $56.6 Billion Projected in 2019</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRWeb - Daily News Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>According to the new report from BCC Research, the blood testing
market totaled $49.5 billion in 2013 and nearly $50 billion in 2014. This
market is expected to reach $56.6 billion in 2019, with a compound annual
growth rate (CAGR) of 2.6%.(PRWeb Ma...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:55:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e1ed4724-b582-4525-b618-a648ae160a7a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Men
Who Exercise May Delay High Cholesterol, University of South Carolina Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioSpace.com Featured News and Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Men who get plenty of aerobic exercise may delay the onset of
age-related high cholesterol, potentially lowering their risk for heart
disease, a new study suggests.Researchers followed thousands of men over
several decades, periodically drawing bloo...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-mtex></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bc1a6162-dc0d-459f-961f-696d49ca522c.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rail
Project Loses $3Million to Blood Bank of Hawaii</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 1:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ba07e119-66c1-48cc-84f7-e532c3165fff.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rail
project budget loses $3M to Blood Bank of Hawaii move</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3a12360d-ac33-4ff5-9826-2efa20054cc9.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Turned
Away for Being Transgender, Seattle Woman Sues Blood Bank</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c31c353a-c1ce-48c3-9f2a-c798e376aaa9.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Community
Blood Bank offers chance to win tickets to see Kenny Chesney</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7a48a32a-ec3a-47cb-a2e9-0c155d00c650.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Inside
the Amtrak disaster: Passengers thrown across train, furniture ripped from
floor in crash that killed at least six</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>National Post - Top Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AP Photo/Joseph KaczmarekEmergency personnel help a passenger at
the scene of a train wreck, Tuesday, May 12, 2015, in Philadelphia where an Amtrak
train headed to New York City derailed and crashed.PHILADELPHIA ¡ª Daylight
revealed mangled train car...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-kp3e></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9326f2d0-6023-445e-85e1-99601db5fbc6.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Gabass
file appeal for submission of no case&nbsp;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>citifmonline</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>An Accra Circuit Court on Wednesday adjourned to May 18 to
enable the defence council of Dr Sulley Ali Gabass, medical practitioner,
accused of sodomising, a 16-year-old Senior High School student to move a
motion.The defence counsel had filed a mot...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 3:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9f403e61-5e3a-4f1d-9376-1f70e183926c.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Variations
in liver cancer attributable to hepatitis virus variations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Significant clinical variations exist among patients with the
most common type of liver cancer called hepatocellular carcinoma (HCC),
depending on the viral cause of the disease -hepatitis B virus (HBV) or
hepatitis C virus (HCV). These differences ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 7:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5de8892d-0a9f-473b-a250-f49482f97c07.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clinical
Utility of Trovagene's Urine-Based Liquid Biopsy Platform to Be Highlighted at
the American Society of Clinical Oncology Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SAN DIEGO, May 13, 2015 /PRNewswire/ --&nbsp;Trovagene, Inc.
(NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today
that clinical data from four studies utilizing its Precision Cancer
MonitoringSM platform will be presented at th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:50:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a6b4cf54-2bc1-4472-9831-9af02305d5f3.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aethlon
Medical Announces Health Canada Approval of Ebola Treatment Protocol</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Aethlon Medical, Inc. (OTCQB:AEMD), the
pioneer in developing targeted therapeutic devices to address infectious
diseases and cancer, today disclosed that&nbsp;the Medical Devices Bureau of
Health Canada has approved a clinical study proto...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-dujz></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f689a032-8bd1-4e52-ac33-40d444e32edd.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Clinical Studies Affirm That Patient-Reported Outcomes Can Improve Quality,
Reduce Costs of Care for High-Cost, Complex Diseases The role of the patient -
and user-friendly technology at the point-of-care - are becoming increasingly
important to industry's transition to value-based care, says chief medical
officer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- To improve the quality and reduce the costs of
treatment provided to patients with complex diseases, a new series of studies
being unveiled this week suggests we should start by talking to patients
themselves.A series of new clinical ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-hujn></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2a13f7de-aa32-4d81-ab7e-e72789165eff.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Reports 2015 First Quarter Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SALT LAKE CITY, May 14, 2015 /PRNewswire/ --&nbsp;Great Basin
Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostic testing
company,&nbsp;today reported earnings results for the quarter ended March 31,
2015. Revenue for the quarter was $458,730,&nbsp;which repre...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 8:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f9741eeb-5fd3-4058-a524-d27c3ea73c18.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Caris
Life Sciences Announces Presentation of Comprehensive Tumor Profiling Research
at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting Research
Demonstrates Clinical Utility of Caris Molecular Intelligence and Advances
Molecular Understanding of Cancer to Enable the Delivery of Precision Medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Caris Life Sciences&reg;, a leading biotechnology
company focused on fulfilling the promise of precision medicine, today
announces the acceptance of 22 clinical studies by the American Society of
Clinical Oncology (ASCO) for presentation ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bb675518-fee8-4696-ab4f-1e8d8fcfcbad.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics major shareholder Acquires $5111484.00 in Stock (HTGM)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 14, 2015 4:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e53e2db1-661a-4479-96c7-6b4b763b8853.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Transgenomic
to Hold First Quarter Financial Results Conference Call on May 14, 2015 at
5:00PM EDT</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Transgenomic, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Transgenomic, Inc. (NASDAQ:TBIO), today announced that the
company will hold its First Quarter 2015 Financial Results and Business Update
Conference Call on Thursday, May 14, 2015 at 5:00 PM EDT. The company will
present an overview of financial res...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/52d92c13-b7c8-42e3-ac42-0ec7c6ed21ae.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>COPAN
Is Proud To Announce FDA Clearance For FecalSwab To Standardize And Simplify
Enteric Culture And Molecular Diagnostics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>DeviceSpace.com Breaking News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>MURRIETA, Calif., May 13, 2015 /PRNewswire/ -- COPAN, an
innovative company focused on bringing breakthrough products to Microbiology
preanalytics around the world, announced that it has obtained FDA clearance for
its new FecalSwab.FecalSwab compris...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 1:49:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b860b659-2057-4774-8c89-c49854f0db02.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fluoresentric,
Inc. to Launch XCR Dx Subsidiary</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluoresentric, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluoresentric, Inc. to launch XCR Dx subsidiary; company
finalizes new instrument business unit plan to cut medical lab costs, speed
test results.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a4cb853b-4ff7-4aa4-b0ea-13b234e21bc2.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Unique
Maternal Blood DNA Markers During Pregnancy Linked To Early Autism Diagnosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Forbes Real Time</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The interrelationships and interaction of environment, genes,
and parental age have all been linked to autism spectrum disorders (ASD).
Epigenetic marks--molecular tags on DNA that tell genes when to ¡°turn on¡± or
off¡ªare also influenced by the inter...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 11:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4e6b7763-65ac-46ff-9af4-7d4fd6b31bca.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fresh
off $250M investment from Roche, Foundation Medicine testing volume up 67%</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceDiagnostics News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Foundation Medicine provided additional detail about Roche's
multimillion-dollar investment in the cancer-focused molecular diagnostic
company during its Q1 2015 earnings call.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 10:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/28018064-9a9c-4542-b7ff-fafcaabb43d3.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Researchers
find some rare diseases are caused by the destruction of functional boundaries
within DNA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Recent investigations have shown that our genome and those of
other mammals is partitioned into large functional units called topologically
associated domains, or TADs for short. TADs are very long DNA sections
containing one or more genes and their...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 9:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/50115488-f270-4bf5-9510-5bb41903753f.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Taking
Action with Skin Cancer on the Rise</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- (Family Features) With the return of warmer
weather and longer days, it's good to remember that temperatures aren't the
only thing on the rise. Skin cancer rates continue to increase and cause more
deaths each year, with one in five A...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/55c6dd82-93e2-40b5-8724-5a6df09c326d.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Insmed
Announces Upcoming Data Presentations at the American Thoracic Society 2015
International Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Insmed Incorporated</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical
company focused on developing orphan treatments for rare pulmonary diseases,
today reported that three ARIKAYCE&#8482; abstracts and three INS1009 abstracts will
be presented at the American Th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1037afb1-389b-4790-aad1-185609371527.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>St.
Jude Medical Expands Portfolio of MRI-Compatible Devices to High Voltage in
Europe</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>St. Jude Medical, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>St. Jude Medical expands portfolio of MRI-compatible devices to
high voltage in Europe.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dd008d5a-3536-45ae-bea9-68cd5e86e8a3.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Inflammatory
myopathy with anti-signal recognition particle antibodies: case series of 100
patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Orphanet Journal of Rare Diseases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Anti-signal recognition particle (SRP) antibodies
are used as serological markers of necrotizing myopathy, which is characterized
by many necrotic and regenerative muscle fibers without or with minimal
inflammatory cell infiltration. The...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d23c33aa-20b3-4ecf-9027-25c0cf959db4.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agilent
Technologies Presents Thought Leader Award to Lipidomics Expert Dr. Jules
Griffin</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agilent Technologies Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agilent Technologies Inc. (NYSE:&nbsp;A) today announced that
Dr. Jules Griffin has received an Agilent Thought Leader Award in recognition
of his work in lipidomics.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c2817617-65fa-446b-adab-2b4f23630569.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sorin
and Cyberonics Announce Executive Leadership Team for the New Company upon
Close of Merger</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Sorin Group</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Sorin, S.p.A and Cyberonics, Inc. announce Executive Leadership
Team for the new company effective at the close of the proposed merger.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b75ff70c-c4e3-4df2-b916-70bc6f141a2b.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sorin
And Cyberonics Announce Executive Leadership Team For The New Company Upon
Close Of Merger</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Sorin S.p.A., (MTA; Reuters Code: SORN.MI
&quot;Sorin&quot;), a global medical device company and a leader in the
treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX,
&quot;Cyberonics&quot;), a medical device company with core expert...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/31f2bf93-5bc0-4e2b-aad5-02938ea9b7c0.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
approves Roche's cancer diagnostic as a guide to use of Amgen, Lilly meds</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceDiagnostics News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The FDA approved Roche's diagnostic for the&nbsp;KRAS&nbsp;mutation
in metastatic colorectal cancer patients, saying it needed to identify those
without the mutation, for whom treatment with Eli
Lilly's&nbsp;Erbitux&nbsp;or&nbsp;Amgen's&nbsp;Vectibix&nbsp;may be effective.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ce53e265-4bc7-44dd-9158-80d8ff7f05b5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bristol-Myers
Squibb to Present Data at 2015 American Society of Clinical Oncology (ASCO)
Annual Meeting that Demonstrate the Promise of its Broad Immuno-Oncology
Portfolio Across Solid Tumors and Blood Cancers Including Multiple Myeloma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bristol-Myers Squibb Company</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bristol-Myers Squibb to Present Data at 2015 American Society of
Clinical Oncology (ASCO) Annual Meeting that Demonstrate the Promise of its
Broad Immuno-Oncology Portfolio</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6572061c-83c3-4efd-b3ce-f19895d6ca0f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Strand
Life Sciences Introduces Scientific Advisory Board Company Is Focused on U.S.
Roll-Out of StrandAdvantage, Company's Pan-Cancer Genomic Profiling Service</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Strand Life Sciences, a global genomic
profiling company that uses next-generation sequencing technology to empower
cancer care, today announced the appointment of its scientific advisory board.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b207ce6f-5034-4192-9425-446f96075563.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Selecta
Takes Nanotech to Gene Therapy, Celiac With New Deals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ben Fidler Selecta Biosciences looks to have found two new
potential niches for its nanoparticle technology.The Watertown, MA-based
company is announcing two deals this morning. First, Selecta said that Sanofi
has chosen to license a potential immun...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 7:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0a0d61f1-4b79-4c1a-9696-2206de1508d2.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Foundation
Medicine's Comprehensive Genomic Profile Informs Therapeutic Choices and Leads
to Promising Outcomes in Pediatric Patients With Gliomas</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Foundation Medicine, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Foundation Medicine, Inc. (NASDAQ:FMI) today announced new data
demonstrating that its comprehensive genomic profiling assay, FoundationOne&reg;,
identified a high frequency of clinically relevant genomic alterations in
pediatric gliomas that informed t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a4527372-6f90-405f-946d-2f1c02602b3d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LitePoint
President Brad Robbins to Speak at IoT World Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>LitePoint</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>LitePoint, a leading provider of wireless test solutions,
announced that President Brad Robbins will be leading a session on product
development at the Internet of Things World Conference in San Francisco on May
13. Billed as the world¡¯s largest and...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9df658ad-4b45-44e5-89d8-cade9ae1d3fa.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MRI¡ªprostate
cancer screening for the future?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A screening method that combines a traditional PSA test with an
MRI detects a significantly greater number of prostate cancer cases and
improves diagnostic accuracy. The study was conducted as part of the largest
international research project on pr...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/63b68618-658f-458d-bd59-b66e0b3e0317.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AstraZeneca
makes a move into precision medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmafile - News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AstraZeneca has signalled its intention to ramp up the use of
personalised medicine strategies to find new candidate drugs and match patients
to treatment ¨C after striking major deals in the growing field.It is developing
a diagnostic test to identi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 5:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/936e32be-62a3-4287-896f-5607f6ec5d0a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Montreal
Heart Institute and AstraZeneca to screen 80,000 samples for cardiovascular and
diabetes genetic traits</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -&nbsp;The Montreal Heart Institute (MHI) today
announced a collaboration with AstraZeneca, to search the genomes of up to 80,000
patients for genes associated with cardiovascular diseases and diabetes, their
complications and treatment outco...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/891d46e1-f2de-46df-9672-0e1de33db31e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Orexigen
Therapeutics Provides Statement on Termination of the Light Study and Updates
on Contrave Collaboration with Takeda Pharmaceuticals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Orexigen Therapeutics, Inc. (Nasdaq: OREX)
today issued the following statement regarding the termination of the Light
Study a cardiovascular (CV) outcomes trial that compared the obesity drug
Contrave&reg;&nbsp;(naltrexone HCI and bupropion H...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:19:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/527fe250-6b79-4a14-a139-c5f7bec37c6b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Veracyte
Announces Publication of Study Showcasing Development of Percepta&#8482; Bronchial
Genomic Classifier -- Article Published Online in BMC Medical Genomics --</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Veracyte, Inc. (NASDAQ: VCYT), a molecular
diagnostics company pioneering the field of molecular cytology, today announced
the online publication of a study on the derivation of the company's Percepta
Bronchial Genomic Classifier, whi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 5:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6f4a7449-769a-4935-947d-7966d48261ad.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>/C
O R R E C T I O N -- Diagnostic BioSystems/</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Diagnostic BioSystems, an innovator of
immunohistochemistry (IHC) solutions in the life science research and anatomic
pathology markets, announced it has completed its growth capital financing with
BroadOak Capital Partners, a life sc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 5:25:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4a3f52c4-5d3f-4f0f-b878-382aa229afa5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vaccines,
Small Peptides, aptamers and Immunotherapy [9]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Leaders in Pharmaceutical Business Intelligence</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Vaccines, Small Peptides, aptamers and Immunotherapy [9] Larry
H. Bernstein, MD, FCAP, Writer, Curator </span><span lang=EN-US><a
href="http://pharmaceuticalintelligence.com/2015/05/12/lhbern/Vaccines,_Small_Peptides,_"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>http://pharmaceuticalintelligence.com/2015/05/12/lhbern/Vaccines,_Small_Peptides,_</span></a></span><span
lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'> aptamers_and_Immunotherapy_[9] Vaccines, Small Peptides,
aptame...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2d22fd14-73c9-480f-92de-018721a84284.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Personalized
Screening Test for Ovarian Cancer Shows Encouraging Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Drug Discovery &amp; Development All</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Results from The UK Collaborative Trial of Ovarian Cancer
Screening could usher in a new era of cancer screenings, according to research
and consulting firm GlobalData¡¯s in Vitro Diagnostics Analyst Dr. Andrew S.
Thompson.Scientists from the Univers...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/89071aae-140a-43ee-8216-77a1edd4c157.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Blood Test for Fibromyalgia Moves a Step Closer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Drug Discovery &amp; Development All</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New research by our scientists could lead to a blood test to
diagnose fibromyalgia.Fibromyalgia is common pain syndrome causing widespread
muscle and bone pain, as well as fatigue and disturbed sleep. It has no obvious
physical cause, is poorly unde...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:46:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a18d9d03-6827-4bce-80a5-6c204a03daee.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Food
and Drug Administration Advisory Panel Voted 12 to 1 to Recommend Approval of
ORKAMBI&#8482; (lumacaftor/ivacaftor) to Treat People with Cystic Fibrosis Ages 12
and Older Who Have Two Copies of the F508del Mutation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Vertex Pharmaceuticals Incorporated</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that the&nbsp;U.S. Food and Drug Administration¡¯s (FDA)
Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 12 to 1 to recommend
that the FDA approve ORKAMBITM (lumacaftor/ivacaftor)...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b7e9b1f9-e74f-49c3-8e42-7e7737853a1f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Opexa
Therapeutics Reports First Quarter 2015 Financial Results and Provides
Corporate Update</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Opexa Therapeutics, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Opexa Therapeutics, Inc. reports First Quarter 2015 Financial
Results</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e6d5d37c-a5e3-4d0e-a5a2-1908f7928277.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tokai
Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health
Care Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tokai Pharmaceuticals</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a clinical-stage
biopharmaceutical company focused on developing novel therapies for prostate
cancer and other hormonally driven diseases, today announced that management
will provide a company overview at...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b1eeb9ed-5453-46c2-aa0b-8f8b7ac16f4e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PDI
Reports 20% First Quarter 2015 Revenue Growth -- Strong Commercial Services Q1 Top
Line Performance with Solid Pipeline</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;PDI, Inc.&nbsp;(Nasdaq: PDII) today
reported financial and operational results for the first quarter
ended&nbsp;March 31, 2015.&nbsp;Investors can also access a webcast of the live
conference call by linking through the investor relations section of...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1dba9d47-fc4f-46f6-8b21-bf0c99db64ea.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Panel Backs Vertex¡¯s Two-Drug Combo For Cystic Fibrosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ben Fidler An FDA advisory panel this afternoon recommended
approval of a new combination treatment for cystic fibrosis from Vertex
Pharmaceuticals, potentially paving the way for billions of dollars in future
sales if the agency ultimately approves...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c5355321-2657-4cac-9238-df02672b8f0a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Invitae
Announces First Quarter 2015 Financial Results and Highlights</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Invitae Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Invitae Corporation(NYSE: NVTA) today reported financial and
operating results for the first quarter ended March 31, 2015. Highlights for
the quarter include:</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fc718654-2319-444a-820f-3bc100427a72.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
proposes 1-yr abstinence for gay, bisexual men to donate blood</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA and Over The Counter News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ the Food and Drug Administration (FDA), the agency spells out
its ¡­ American Medical Association, praised the FDA for ¡°taking a step in ¡­ ,
Sweden and United Kingdom, the FDA said. In the new draft ¡­ , non-prescription
injection drug use, or had a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 2:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a5e05e9a-da7a-4121-9685-19c580d53dc8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Digital
Clamp Meter Measures Current Flow in Electrical Systems and Equipment Megger's
DCM1500 measures AC and DC current up to 1500 A</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NORRISTOWN, Pa., May 12,&nbsp;2015 /PRNewswire/ -- Megger now
offers a digital clamp meter used to measure current flow in electrical systems
and equipment during installation, maintenance and monitoring. The DCM1500 can
measure AC and DC current up to 1,...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 2:24:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1b56b422-bc66-41f6-b8e3-a96715a1f1fe.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Medtronic
announces FDA approval of its 3rd-gen Cryoablation Catheter</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceMedicalDevices News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medtronic announced concurrent FDA and CE-mark approval of the
latest generation of its stroke-fighting Arctic Front Advance ST Cryoablation
Catheter. The device features a shorter tip designed to help physicians
visualize the procedure in real-time...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 1:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4fdd334e-9678-43af-b035-d864a0f6eeac.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epigenomics
AG Announces Q1 2015 Financial Results and Reports on Operational Highlights</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Epigenomics AG Ad hoc Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Berlin (Germany) and Germantown, MD (U.S.A.) - Epigenomics AG
(Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer
molecular diagnostics company today announced its financial res...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 1:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2a183bf8-e258-4f37-afbc-df5087eea1f3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Medtronic
Receives FDA Approval and CE Mark for Arctic Front Advance&reg; ST Cryoballoon to
Treat Atrial Fibrillation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharma News from PharmiWeb.com</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medtronic Receives FDA Approval and CE Mark for Arctic Front
Advance&reg; ST Cryoballoon to Treat Atrial FibrillationThir...Medtronic plc</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:48:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6060362d-aa42-44fb-b021-e4b3df48b139.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>100
drivers get to test Toyota's wacky three-wheeler</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>USATODAY - Tech Top Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ten of the strange electric three-wheelers will be put into the
hands of drivers in Japan. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/63ff5275-c156-40d8-8647-d385aea7f1aa.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Medtronic
Wins FDA Nod and CE Mark for Arctic Front Advance ST Cryoballoon</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>DeviceSpace.com Breaking News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medtronic Receives FDA Approval and CE Mark for Arctic Front
Advance ST Cryoballoon to Treat Atrial FibrillationThird-Generation Cryoballoon
Designed to Allow Enhanced Positioning and Help Improve Capture of Real-Time
Data with Achieve Mapping Cathe...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/360bdd98-45a2-4ff2-b883-0b93a5d4830c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
OKs Roche's mutation test for colorectal cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDLI SmartBrief</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The FDA approved the cobas KRAS Mutation Test developed by Roche
Holding for use in metastatic colorectal cancer patients wit&nbsp;-More-&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6e570f42-a215-4a56-b9f5-230c1463f558.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clinical
Study Results Suggest ZipLine&reg; Medical¡¯s Non-invasive Zip&reg; Surgical Skin
Closure Device Has Faster Closure Time than Sutures and Less Patient Pain</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ZipLine Medical, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Company will introduce Zip&reg; to cardiac electrophysiolgists at
annual meeting of the Heart Rhythm Society (HRS) in Boston, May 13-16</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4dee1431-190f-4820-858a-558b68f94888.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Schulman
IRB to House Review Board and Operational Support at RTP Office</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Schulman Associates IRB, Inc., the
industry-leading central IRB in customer service and technology, has announced
board expertise and operational support to be based at its new office on
Laboratory Drive in Research Triangle Park, Dur...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/938c36f9-0780-4656-b133-620619d204ff.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Juventas
Therapeutics Adds $13.5 Million In New Financing And Expands Board Of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Juventas Therapeutics, Inc., a clinical-stage
biotechnology company focused on developing non-viral gene therapies to treat
advanced cardiovascular diseases, today announced that the company has secured
$13.5 million in financing. Gre...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 9:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/75080a64-7a7c-4756-889a-5fb8718f88b3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Frost
&amp; Sullivan Applauds Blue Belt Technologies for Establishing the Industry
Standard for Image-Guided Orthopedic Surgery with its Navio&reg; Surgical System
Navio&reg;'s user-friendly design and advanced guiding systems have improved
surgical outcomes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Based on its recent analysis of the
orthopedic surgery market, Frost &amp; Sullivan recognizes Blue Belt
Technologies, Inc. with the 2014 Global Frost &amp; Sullivan Award for Enabling
Technology Leadership. Blue Belt Technologies' Navio&reg; sys...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3b41fcb3-cb0d-471f-83e7-27dcf5340127.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Swift
setback: A preclinical success in hep B is followed by safety woes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceBiotechResearch News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A few weeks ago, TetraLogic Pharmaceuticals touted a preclinical
program demonstrating that its drug birinapant could play a major role in
swiftly erasing hepatitis B. Soon after, the Malvern, PA-based biotech
announced that it had struck a deal to ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/96cb6130-63b5-480e-9520-5f8bcd85cf25.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Calling
All Dog Owners: Profess Your Love For Your Precious Pup With The &quot;I HEART
My Dog&quot; Program From Merial, The Maker Of HEARTGARD&reg; Plus
(ivermectin/pyrantel), To Support Canine Companions For Independence Merial,
the Maker of HEARTGARD Plus, will Sponsor $1 - up to $150,000 - to Canine
Companions for Independence for Every Dog Love Letter Submitted or Social
Action Taken; Actor Scott Foley and His Dog, Frankie, Join the Effort</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;From wet noses to wagging tails and long
walks together ¨C dogs give their owners countless reasons to love them. Merial,
the maker of HEARTGARD&reg; Plus (ivermectin/pyrantel), is asking dog lovers to use
social media to tell the world wh...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c9b4ae6c-1c19-4465-ae0f-e34705299a6e.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Public
Statement from EuroVacc Foundation and IDT Biologika, Switzerland, Germany, May
13, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genevensis Healthcare Communication</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Volunteers in HIV vaccine clinical trials in Switzerland and the
US are being asked to return for medical follow-up. On May 4, 2015 clinical
trial material of a candidate HIV vaccine (NYVAC-HIV-PT1) used in two phase I
clinical studies in 2012-2013 ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/86b6babd-8c3b-412f-9a62-b92d1ddeca47.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Japanese
HIV/aids diagnostics market report, research, trends, size and forecast 2015
just published</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 4:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cd7e1dd2-8aac-4b93-9bd7-dc1512b9328b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AstraZeneca
and Abbott to develop companion diagnostic tests for tralokinumab in severe
asthma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Latest press releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AstraZeneca today announced that it has entered an agreement
with Abbott, a global healthcare company, to develop companion diagnostic tests
to identify patients with severe asthma who are most likely to benefit from the
investigational biological t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/95813418-b2c9-4b21-b9f7-35fa9ad01180.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>EMA
Grants Kiadis Pharma's Lead Product ATIR&#8482; ATMP Certificate for Quality and
Non-Clinical Data</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AMSTERDAM, May 13, 2015 /PRNewswire/ -- Kiadis Pharma
B.V.&nbsp;&nbsp;(&quot;Kiadis Pharma&quot;&nbsp;or&nbsp;&quot;the
Company&quot;), a clinical stage biopharmaceutical company developing
innovative immunotherapy treatments, today announces that its lead product
ATIR&#8482; for blood cancers ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 2:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7b5a7b4d-585d-4976-a186-ee40fa481770.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Suspected
Connecticut serial killer identified</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Breaking news from newstimes.com</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Law enforcement sources confirm that Howell, a former
Wethersfield landscaper, now serving a 15-year prison sentence for the death of
a young woman in 2003, is suspected of being the serial killer responsible for
the death of at least eight women --...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 12:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9ac0a184-f2f9-4bc4-a6ae-7b2b499fc602.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>'Pigeon's
blood' ruby fetches world record price of &pound;19m</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>News - Latest breaking UK news</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rare coloured stone becomes most expensive jewel that is not a
diamond, as pearl necklace also reaches historic price at auction in Geneva</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:49:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/97e079c0-cf8c-41a2-a858-0dd92e1c6cdf.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>GORE&reg;
EXCLUDER&reg; Iliac Branch Endoprosthesis is First Dedicated System of Its Kind
Registered in Australia and New Zealand</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>W. L. Gore &amp; Associates</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The GORE&reg; EXCLUDER&reg; Iliac Branch Endoprosthesis intended for
endovascular treatment of common iliac artery or aortoiliac aneurysms has been
included on the Australian Register of Therapeutic Goods.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/13fc58b0-e43c-4774-81b9-04353364dc25.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmasmart
exclusively recognized by American Society of Hypertension in new clinical
guide</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Latest News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Michael JohnsenPharmaSmart was recognized as uniquely qualified
among kiosks for use in the diagnosis and treatment of hypertension.read more</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 5:51:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b4922d64-5b84-4b9a-9bab-61d0ba4ab300.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Women
Are Not Just Carriers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Hemophilia Federation of America</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Jennifer and her father Gary during a book signing of,&nbsp;Vial
023: A Father¡¯s Pursuit of JusticeWhile some women experience bleeding symptoms
monthly or even more frequently, other women may go years before bleeding
issues are recognized, making a dia...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a2a2ac9c-73ba-4249-acfb-fd56a31e9d2c.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Key to Stopping Sarcomas' Spread</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Drug Discovery &amp; Development All</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>When sarcomas become large enough and outgrow their blood
supply, they become vulnerable to hypoxia ¡ª a lack of oxygen. That adaptation
not only enables them to survive the stress of low oxygen ¡ª it also enables
them to withstand cancer drugs.Read m...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:46:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d07895e0-88df-4a79-9b0b-e9b16e447992.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Newly
Published Cosmetic Safety Study by Dr. Rod J. Rohrich Supports Protocol for
Hypertension Management During Facelift Surgery</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRWeb - Daily News Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A retrospective review of 1,089 of Dr. Rohrich¡¯s Dallas facelift
patients confirms the importance of blood pressure management before, during,
and after facial surgery to avoid incidences of postoperative hematomas and
suggests an effective algorith...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bdab7525-cda6-4b47-bbd3-e52960430eda.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>UPDATE
1-Baxter buys cancer drugs from Italian drugmaker for $900 mln</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Reuters: Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12 (Reuters) - Baxter International Inc said it agreed to
buy two drugs to treat a rare form of blood cancer from Italian drugmaker
Sigma-Tau Finanziaria SpA for $900 million, before expenses.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:55:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f0ed2b73-79a3-46bb-ad86-580ac6ba74c0.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Glimmer
of hope in cancer fight: ¡®Liquid biopsies¡¯ are transforming treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>National Post - Top Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A new type of blood test is starting to transform cancer
treatment, sparing some patients the surgical and needle biopsies long needed
to guide their care. The tests, called liquid biopsies, capture cancer cells or
DNA that tumours shed into the blo...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/789db548-27ea-49bb-9ee3-3459909733c4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Baxter
buys cancer drugs from Italian drugmaker for $900 mln</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Reuters: Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12 (Reuters) - Baxter International Inc said it agreed to
buy Italian drugmaker Sigma-Tau Finanziaria SpA's portfolio of drugs to treat
rare forms of blood cancer for $900 million, before expenses.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/805c94e1-5dee-4393-b661-5acd6d12c2d0.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
American College of Phlebology Debuts Free Online Vein Assessment Tool
Education is key in identifying vein disorders</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Approximately 25 million people are affected
with venous disease in the United States. The American College of Phlebology
(ACP) has released a unique online vein self-assessment resource free to the
general public to help people under...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0f2c7137-d9cc-4018-b520-8c00afc514b1.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Baxter
BioScience to Expand Global Oncology Footprint with Acquisition of Oncaspar&reg;
Portfolio for Leukemia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Baxter International Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Baxter BioScience announced plans to acquire the Oncaspar
product line from Sigma Tau.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a5e5f3f5-2df3-48ed-a490-bdd186c6e8f6.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Red
Cross Helping in 8 Midwest States In Wake of 135 Possible Tornadoes Providing
Shelter, Food, Relief Supplies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- The American Red Cross is helping
people in eight Midwest states after as many as 135 possible tornadoes moved
through the region over the last several days.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 2:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/20769a62-b9ab-4aea-a058-8671ce3ef8c7.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Food Bank of Northern Nevada Receives Anthem Blue Cross and Blue Shield in
Nevada Grant to Deliver Nutritious Meals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Anthem Blue Cross and Blue Shield in Nevada</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Anthem Blue Cross and Blue Shield announces $25,000 grant to
Food Bank of Northern Nevada to fund mobile food pantry</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 1:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/979a2c4e-56f9-4e54-baef-3e9a0f7666ae.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vivione
Biosciences Finalizes Agreement With University of Rochester for Exclusive
Worldwide Rights to Novel Infectious Disease-Related Biomarker</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Marketwired - Medical and Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>DALLAS, TX--(Marketwired - May 13, 2015) - Vivione Biosciences
Inc. (&quot;Vivione&quot;) (TSX VENTURE: VBI), announced today the execution of
an Option Agreement with the University of Rochester to gain exclusive
worldwide rights to a novel biomarker for inf...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d2968cdf-187c-4c47-9f5f-77eea307c9f5.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioTime¡¯s
Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From
Israel¡¯s Office of the Chief Scientist</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure
Neurosciences Ltd. (Cell Cure) today announced that Cell Cure has been awarded
a grant for 2015 of 6.24 million shekels (approximately $1.61 million) from
Israel¡¯s Office of the Chief Scient...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/211d84be-1b3e-4b6d-b19b-00c9725d22df.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>European
Market for Infectious Disease Molecular Diagnostics Analysed by
VPGMarketResearch.com in New Study Available at MarketPublishers.com</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRWeb - Daily News Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New report ¡°2015 European Infectious Disease Molecular
Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies,
Competitive Landscape¡± prepared by VPGMarketResearch.com is now available at
MarketPublishers.com.(PRWeb May 12, 20...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 11:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3d309cdb-6543-4443-8528-fdbb22814302.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Diabetes
increases risk for HCC in adults with HBV</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Taiwanese patients with chronic hepatitis B virus infection and
newly diagnosed diabetes had an increased risk for hepatocellular carcinoma
over time, according to study findings.¡°In 2012, diabetes resulted in 1.5
million deaths and it became the [e...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f0728236-17bf-4369-bc79-c30478e829c2.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Top
Virologists of the Global Virus Network (GVN) Meet in China to Address Threats</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Global Virus Network (GVN)</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Global Virus Network (GVN) in partnership with Beijing
University of Technology, a GVN Center of Excellence, will host its 7th meeting
of top virologists May 16-19, 2015 in Beijing, China.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6c6ea545-e624-45b7-b3d3-1e1333d3eda5.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Latest
research report on Spanish HIV/aids diagnostics market 2015 published by
leading ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 10:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9a0e65a5-bc9e-4ab0-970c-e6f5de0559d7.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Soon-Shiong
reels in $100M for cancer genomics unit</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceDiagnostics News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Billionaire Patrick Soon-Shiong roped in $100 million for his
NantBioscience unit, a subsidiary which includes molecular diagnostics venture
NantOmics and an immuno-oncology-focused operation, NantCell.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/14b07c2d-768f-4f83-a636-09aa8d16f00e.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genomics
of Young Lung Cancer and INHERIT Studies Accepted for Presentation at ASCO</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bonnie J. Addario Lung Cancer Foundation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Addario Lung Cancer Medical Institute research studies funded by
Bonnie J. Addario Lung Cancer Foundation chosen for presentation at the May
2015 American Society of Clinical Oncology Annual Meeting</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a3b900cd-ae04-4274-bed5-6cd1226ed5e9.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Report:
Aligent's Cartagenia Deal Evidence of Trend Towards Computer Power in Labs</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Kalorama says Agilent's recent acquisition of a
diagnostic software company is evidence of a trend towards more powerful
information systems in laboratories that will drive the LIS(laboratory
information systems) market to towards gro...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 13, 2015 7:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5775ebd2-983f-4cce-a8fe-adbcda7f65b9.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tfap2a
and 2b act downstream of Ptf1a to promote amacrine cell differentiation during
retinogenesis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Molecular Brain</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Retinogenesis is a precisely controlled developmental process
during which different types of neurons and glial cells are generated under the
influence of intrinsic and extrinsic factors. Three transcription factors,
Foxn4, ROR¦Â1 and their downstrea...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a0b913da-551d-4f99-a8d6-395a1a224e6d.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sex
differences in the corpus callosum in preschool-aged children with autism
spectrum disorder</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Molecular Autism</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Abnormalities in the corpus callosum have been
reported in individuals with autism spectrum disorder (ASD), but few studies
have evaluated young children. Sex differences in callosal organization and
diffusion characteristics have also n...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/185da8de-820c-451f-b954-d53cd72dfc3c.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
female protective effect in autism spectrum disorder is not mediated by a single
genetic locus</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Molecular Autism</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: A 4:1 male to female sex bias has consistently been
observed in autism spectrum disorder (ASD). Epidemiological and genetic studies
suggest a female protective effect (FPE) may account for part of this bias; however,
the mechanism of suc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e57303fd-94cb-44b4-9db8-a816abbb3439.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Veracyte
Announces Publication of Study Showcasing Development of Percepta&#8482; Bronchial
Genomic Classifier</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SOUTH SAN FRANCISCO, Calif., May 12, 2015 /PRNewswire/
--&nbsp;Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company
pioneering the field of molecular cytology, today announced the online
publication of a study on the derivation of the company's...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 5:50:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bf7ed1bc-3502-48e3-adee-1fcc0c22b14e.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dyax
Corp. Appoints Dr. Abbie Celniker to Board of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Dyax Corp.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Dyax Corp. (NASDAQ: DYAX), a biopharmaceutical company focused
on the development and commercialization of novel biotherapeutics for unmet
medical needs, today announced the appointment of Abbie Celniker, Ph.D., to its
Board of Directors.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6e400734-fb9f-4cbd-a42c-f4f72e9f25f5.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Indiana
Organizations Conduct Large Study to Assess PGx Testing Impact in Community
Setting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 1:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f7a4684c-577a-4b4b-9fc4-8995dcea3a5e.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OPKO
Announces First Quarter Operating and Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>OPKO Health, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>OPKO Health, Inc. (NYSE:OPK), a multi-national biopharmaceutical
and diagnostics company, today reported operating and financial results for its
first quarter ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/39736530-691b-4528-ba78-4bb3554b9637.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pennsylvania
Bio Announces Chairman-Elect and New Board Members</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pennsylvania Bio</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pennsylvania Bio, the statewide trade association representing
the commonwealth¡¯s life sciences industry, announced today the appointment of
Marc S. Malandro, PhD, CLP, RTTP as chairman-elect of the association. Dr.
Malandro is the Founding Director...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 1:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/12047273-b415-4fa4-aa19-06f25bea4b33.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Repurposed
anti-cholesterol drug could improve treatment-resistant anemias</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Each year, between 25 and 35 children in the United States and
Canada are diagnosed with an inherited bone marrow failure syndrome called
Diamond Blackfan anemia (DBA), according to the US Centers for Disease Control
and Prevention. Although rare, t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 11:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/91a3d4a7-d32a-4517-b64a-44f0d9a62ce1.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epitope
Diagnostics Launches a Novel 25-OH Vitamin D ELISA Kit</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR.com Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Epitope Diagnostics, Inc. has added a new ELISA kit to their
product line to detect the total amount of 25-OH vitamin D2 and D3 in serum or
plasma sample. This is a monoclonal antibody-based ELISA with a unique vitamin
D releasing buffer for easy an...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/23e4fa81-f907-4475-9e53-df95e16d2e4d.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>VolitionRx
Announces First Quarter 2015 Financial Results and Business Update</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), a life
sciences company focused on developing blood-based diagnostic tests for a broad
range of cancer types and other conditions, today announced financial results
for the first quarter ended Marc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a46eda5e-7ff1-48ad-98e0-8f3a28d8daef.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CSL
Behring Proudly Supports HAE Day with Global Partnerships, Donations and
Hereditary Angioedema A...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CSL Behring News Release Archive</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Third annual awareness day shines a light on rare, potentially
life-threatening condition</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cd82612d-80bd-4702-84fe-111db5fd6187.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MicroBiome
Therapeutics Receives Positive Response From FDA For Use Of Expedited
Regulatory Pathway For Diabetes Drug NM505 --FDA Greenlights 505(B)(2)
Regulatory Route for MBT's Microbiome Modulator-Metformin Combination That
Significantly Improves GI Tolerability and Blood Glucose Control Compared to
Metformin Alone--</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;MicroBiome TherapeuticsTM LLC, (MBT) today
reported that the U.S. Food &amp; Drug Administration (FDA) has responded
positively to the company's pre-IND request to use the 505(b)(2) abbreviated
regulatory pathway for development of lead p...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/feaa1b32-f096-4398-82be-b7221d809807.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioTrinity
2015 Highlights Resurgence in Life Sciences Funding and Examines Key Industry
Themes and Challenges</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --OBN is the Membership organisation supporting and
bringing together the UK's emerging life sciences companies, corporate partners
and investors. Our 380-plus Member companies are located across the Golden
Triangle and beyond to Notting...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/22eb06a0-de74-4e5f-8adb-b6f0a245c42e.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardiac
Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients
With Breast Cancer [Breast Cancer]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PurposePatients treated with adjuvant trastuzumab require
adequate cardiac monitoring. We describe the patterns of cardiac monitoring and
evaluate factors associated with adequate monitoring in a large
population-based study of older patients with b...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8262e814-f4a2-4b03-9eef-5034c009d771.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amarin
v. FDA and Public Meeting On Off-Label Promotion Signal An Important Year For
Clarity Around Scientific Exchange and the First Amendment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Policy and Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>2015 could prove to be a significant year for how the Food and
Drug Administration approaches drug companies¡¯ off-label speech. FDA has
stressed that they are in the process of attempting to ¡°harmonize¡± their
promotional guidances with the First Ame...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 11:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/69c96235-8a48-443f-8384-2f01b3a35c97.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bioventus
Names General Counsel Jeanne Forneris to Lead Strategy for the Company, Adds
Thomas Umbel to Lead Business Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bioventus</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bioventus&reg;, a leader in orthobiologic solutions, today announced
changes to its executive leadership team. Jeanne Forneris has been named Vice
President of Strategy and General Counsel. Forneris has been a member of the
Bioventus executive team sinc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/320596df-bc9e-4729-b85e-f52b0beea1ba.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Preventice
Solutions launches BodyGuardian&reg; with BodyGuardian Remote Patient Monitoring
System in the United States Advanced, wireless remote patient monitoring system
to be available in Q3, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Preventice Solutions announced today that
BodyGuardian Heart Remote Patient Monitoring System and PatientCare platform
will be commercially available in Q3, 2015. Testing with the BodyGuardian
Remote Monitoring System is underway nati...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6ee4888c-bf8d-4879-a9c4-2aa8f4250c62.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Chiasma
Announces New Data for Investigational Octreotide Capsules to be Presented at
ECE 2015 Studies show acromegaly patients face significant burdens with
available treatment options</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ --Chiasma, Inc., a U.S. privately held
biopharma company developing octreotide capsules for the orphan condition
acromegaly, today announced that two abstracts evaluating patients with
acromegaly will be presented at the 17th ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:20:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/39a3b2ea-e731-4c08-a7ad-c85ccbd9b32b.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Angionetics
Presents At 2015 Annual Marcum MicroCap Conference On Business And Generx&reg;
Clinical Development Activities</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Angionetics Inc., a majority-owned subsidiary of
Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), announced
today that it will be a featured presenter at the 4th Annual 2015 Marcum
MicroCap Conference on Wednesday, May...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dadd3db5-d718-47be-84e3-c6a2c8648ef8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We¡¯re Catching up on Mylan, Teva and Much More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ReutersGood morning, folks, and how are you today? Busy, no
doubt. Here on the Pharmalot campus, we are maintaining the usual hectic pace
as we hustle one of the short people out the door for the ride to the local
schoolhouse, brew a few needed cups...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:56:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2a298749-56e1-45c9-924a-55d11a997326.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LabCorp
is Scheduled to Present at the UBS Global Healthcare Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Laboratory Corporation of America(R) Holdings</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Laboratory Corporation of America&reg; Holdings (LabCorp&reg;) (NYSE:
LH) today announced it will participate at the UBS Global Healthcare
Conference. LabCorp¡¯s presentation is planned for Tuesday, May 19, 2015 at 8:00
AM (ET).</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b006b1bb-dec2-4300-89c3-bfdc21cfb68e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Data
on Rosetta Genomics' Novel Thyroid Nodule Classification Assay to be Presented
at the ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/376196fb-f154-4154-95f4-abebd76c8f36.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Takeda
Pharmaceuticals and Orexigen Therapeutics Announce Termination of the
Cardiovascular Outcomes Study (Light Study) of the Obesity Drug Contrave&reg;
(naltrexone HCl and bupropion HCl)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Takeda Pharmaceutical Company Limited and
its wholly-owned subsidiary, Takeda Development Center Americas, Inc. (Takeda)
and Orexigen Therapeutics, Inc. (Nasdaq: OREX) (Orexigen) have accepted the
recommendation of the Executive Steer...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/278b25c8-4620-4af4-a808-6f42600788e1.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Data
on Rosetta Genomics¡¯ Novel Thyroid Nodule Classification Assay to be Presented
at the American Association of Clinical Endocrinologists 24th Annual Scientific
and Clinical Congress</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rosetta Genomics Ltd.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and
provider of microRNA-based molecular and other diagnostics, announces that data
on the Company¡¯s novel, microRNA-based assay for accurate thyroid nodule
classification will be presented at...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f96cde6e-f635-4fc1-8d06-6bddbd133e1c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AbbVie's
Commitment to Gastroenterology and Hepatology Showcased at Digestive Disease
Week&reg; (DDW) 2015 - Abstracts presented further evaluate the safety, efficacy of
HUMIRA&reg; (adalimumab) in moderate to severe Crohn's disease, pediatric Crohn's
disease and ulcerative colitis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;AbbVie (NYSE: ABBV) announced that 18
abstracts in its gastroenterology and hepatology programs will be presented at
Digestive Disease Week&reg; (DDW) 2015, May 16 ¨C 19, in Washington, D.C. The
abstracts feature results from studies furth...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/662ca423-3732-4fcc-9430-bec6520b8d14.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>United
Healthcare Approves Coverage for Biodesix¡¯ VeriStrat Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Biodesix, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Biodesix today announced that its VeriStrat test received a
positive coverage decision from United Healthcare, one of the largest
commercial insurance company in the US.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/259ce62a-c07b-4132-84d3-8f4cde3b0115.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CellNetix
Adopts N-of-One TrialMatch&#8482;, Based on N-of-One¡¯s Leading Clinical
Interpretation Evidence for NGS Tests</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>N-of-One, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>N-of-One announced that CellNetix Pathology and Laboratories has
adopted N-of-One¡¯s new clinical trial matching solution, TrialMatch&#8482;, as well
as N-of-One clinical interpretation evidence services.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3d087122-84a4-436b-8509-83818b40e45e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>K.
Peter Hirth, PhD, Joins Iconic Therapeutics as Board Member and Senior
Scientific Advisor</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Iconic Therapeutics, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>iconic add bod member and sr sci advisor</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/471b3332-dae8-4fe9-b7e7-b1899369d4dd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Datar
Genetics and AHERF announce collaboration to validate liquid biopsy for brain
tumours</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Collaboration study to validate and demonstrate clinical utility
of Exosome-based diagnostics for providing individualised treatment decisions
to Glioblastoma (GBM) patientsDatar Genetics (Datar) has announced a strategic
collaboration with Apollo H...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f694c5d0-f256-408b-a613-6e7f9b38f5b7.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Navidea
Reports First Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek&reg;
Revenue Guidance</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Navidea Biopharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Navidea Biopharmaceuticals announced financial results for the
first quarter of 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/83e325f7-0207-4faa-85bf-2bfe90b83be0.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
malaria test could lead to global eradication of the disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>One of the biggest difficulties faced by worldwide programs
aimed at eliminating malaria is that the tests they use are not sensitive
enough to detect all people who have the disease and need treatment. A study
appearing online today in Clinical Che...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7136a101-f646-40bb-a7c1-398561d336d9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioLight
Announces Closing of Upsized US$6.6 Million Private Placement</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4ade7378-68ff-49d6-9c28-5a7e2ba9145b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
research could lead to a blood test for common pain syndrome fibromyalgia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New UK research could lead to a blood test to diagnose the
common pain condition, fibromyalgia.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ff9fbbee-e117-4891-83a4-b4d439fcdc15.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Talking
Cure? For Cancer Immunotherapy, Still Many Rivers to Cross</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Alex Lash Cancer is a humbling thing: Our own cells gone bad,
killing us from the inside, and so often able to rebound from attack or avoid
it entirely. There has been progress fighting some types of cancers, but in no
way equal to the resources (or...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 6:59:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/117618c5-5864-4abd-978e-8c33e76a1649.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Risk
of Prostate Cancer as High as Breast Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NEW YORK, May 12, 2015 /PRNewswire/ --&nbsp;World renowned
robotic prostate cancer surgeon, Dr. David Samadi, evaluates the parallels
between Prostate cancer and Breast cancer.&nbsp;Prostate cancer is just as
common in men as breast cancer is in women with ov...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 6:58:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d8b32e8a-7eed-4c84-98f7-6d7e91737575.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tokai
Pharmaceuticals Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tokai Pharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), a clinical-stage
biopharmaceutical company focused on developing novel therapies for prostate
cancer and other hormonally driven diseases, today reported company highlights
and financial results for the fir...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 6:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9546efd0-5b16-494a-8e1c-e7ab9bd8285b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TAYO
Targets Prime Properties for Cannabis Industry¡¯s Support Sector</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Taylor Consulting, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>TAYO Targets Prime Properties for Cannabis Industry¡¯s Support
Sector</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 5:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f863f83d-8c71-4d93-ada0-cb9df120f454.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
Receives FDA Approval For Colorectal Cancer Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ announced that the U.S. Food and Drug Administration (FDA) has
approved the cobas ¡­ the most comprehensive companion diagnostic FDA approved
portfolio for oncology in ¡­</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 3:55:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/85a24a04-eef8-46dc-9c6a-75ecc24bb6cd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aerocrine
Sales Grow to Record Levels Again for 1st Quarter, NIOX VERO Launch in the US
Off to A Strong Start</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Aerocrine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Regulatory News:</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 2:21:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5c210d41-5d74-4eb7-a697-d13ae33fda2e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MediSapiens
d¨¦veloppe rapidement son activit¨¦ dans les domaines de la m¨¦decine de pr¨¦cision
et du diagnostic g¨¦nomique</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CAMBRIDGE, Massachusetts, May 12, 2015 /PRNewswire/ -- Le
d¨¦veloppeur finlandais d'applications de bioinformatique&nbsp;MediSapiens
Ltd&nbsp;&nbsp;¨¦largit le champ de ses activit¨¦s ¨¤ la conception de solutions
de bioinformatique destin¨¦es ¨¤ la m¨¦decine...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 2:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8c3c4f2e-160b-4e98-9dd3-eadc60fee3d3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mainstay
Medical ¨C Interim Management Statement</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Mainstay Medical Intl. PLC</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1ee3ed35-d91e-4b66-a8ac-b8261da784fc.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>US
FDA approves Roche's cobas KRAS mutation test for diagnostic use</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2318ec06-8399-4045-aa75-c33dcef6fa2c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Risk
Algorithm Using Serial Biomarker Measurements Doubles the Number of
Screen-Detected Cancers Compared With a Single-Threshold Rule in the United
Kingdom Collaborative Trial of Ovarian Cancer Screening [Gynecologic Cancer]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PurposeCancer screening strategies have commonly adopted
single-biomarker thresholds to identify abnormality. We investigated the impact
of serial biomarker change interpreted through a risk algorithm on cancer
detection rates.Patients and MethodsIn...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7deddd99-533d-4c04-a5e2-b2346982a842.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Simpson's
Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger
Adults With Acute Myeloid Leukemia [Hematologic Malignancy]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PurposeTo evaluate the impact of DNMT3A mutations on outcome in
younger patients with cytogenetic intermediate-risk acute myeloid
leukemia.Patients and MethodsDiagnostic samples from 914 patients (97% &lt; 60
years old) were screened for mutations in D...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b923e340-93a8-41bb-ab13-03e27a7e0a2f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>United
States Molecular Diagnostics Market &amp; Test Volume ¨C Application Segment
Analysis (2010 ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e70b399b-1f63-4407-98e0-8f29d1923b25.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Project
Data Sphere tops first-year target</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Daily Extra</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Data-sharing consortium Project Data Sphere LLC said on Monday
that it accrued comparator-arm clinical trial data from 26,000 patient lives,
which surpassed the first-year target of 25,000 lives the not-for-profit set
when the CEO Roundtable on Canc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dc9713a8-d805-4349-a7f9-9bb52187ae2a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Myriad
Ramps Up Sample Prep Automation as it Moves Hereditary Cancer Testing to MyRisk
NGS Panel</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:46:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8ac871ba-eb6c-4ce9-bedf-ab652cc87cdd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>United
States (USA)-Molecular Diagnostics Market, Test Volume Forecast &amp; Companies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>LONDON, May 11, 2015 /PRNewswire/ -- Molecular diagnostics is a
rapidly¨Cadvancing area of research and medicine, with newtechnologies and
applications being added continuously. Molecular diagnostics is the promising
area which can transform disease ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 6:51:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/effab75b-1b85-46b5-98a1-c14112973bac.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies' immunoSEQ&reg; Assay Provides Groundbreaking Insight into T-Cell
Fate ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 5:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/872dec86-4093-4521-bd13-8d4347c7b41a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Approves Roche KRAS Mutation Test for Metastatic Colorectal Cancer Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 5:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ce0f354e-bfcc-4a34-b596-2192c078c9d5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies' immunoSEQ&reg; Assay Provides Groundbreaking Insight into T-Cell
Fate, Significantly Advancing Understanding of Adaptive Immunity Study led by
Thomas S. Kupper, MD published in Nature Medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Adaptive Biotechnologies, the leader in
next generation sequencing (NGS) to profile T- and B-cell receptors,
demonstrated in today's issue of Nature Medicine the ability of the immunoSEQ&reg;
Assay to interrogate cell fate in naturally oc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 5:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/49c171d9-f01a-467c-af11-7ab03518936f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Performs GMP and Pre-Approval Inspections of Impax's Hayward Facility</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HAYWARD, Calif., May 11, 2015 /PRNewswire/ --&nbsp;Impax
Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug
Administration (FDA) performed a three week inspection of the Company's
Hayward, California manufacturing facility. Thi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:50:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f719a201-7445-40a8-8445-ff301209545d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Halozyme
Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Halozyme Therapeutics Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>- Revenues increase 56 percent to $18.7 million, loss narrows to
$15.1 million -- Royalty revenue increases 70 percent from the fourth quarter
-- Interim results of Halozyme's randomized Phase 2 study in pancreatic cancer
to be presented at the annu...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b81b89d3-1cad-4f15-8ead-396b2afb1346.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Navidea
Secures $60 Million Loan with CRG; Funding to Support Lymphoseek&reg;
Commercialization and Advancement of Development Pipeline</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Navidea Biopharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Navidea entered into a term loan with CRG which provides for an
initial funding of $50 million which will be used to retire debt and provide a
net amount of $18 M in capital to Navidea.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fb8315b3-3945-4ddf-9574-2500944e6806.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dana-Farber
and Boston Children's Hospital opens Phase I trial of immunotherapy for
children with relapsed or treatment-resistant leukemia Trial studies
breakthrough method for turning patients' immune system against their cancer
cells</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- Dana-Farber/Boston Children's Cancer
and Blood Disorders Center has joined a clinical trial of immunotherapy for
children with relapsed or treatment-resistant acute lymphoblastic leukemia
(ALL). Led by Memorial Sloan Ketter...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7edf5efd-ae48-43e3-a49a-c97cba0d7a9f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vermillion
Reports First Quarter 2015 Financial Results and Provides Business Update
Conference Call at 4:30 p.m. ET Today</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Vermillion, Inc. (NASDAQ: VRML), a
bio-analytical solutions company focused on gynecologic disease, reported financial
results for the first quarter ended March 31, 2015 and provided a business
update. Forward-Looking StatementsThis p...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7d4baf49-1c9d-4840-af80-ac54cc48ca91.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ImmunoCellular
Therapeutics Announces First Quarter 2015 Financial Results Phase 3
Registration Trial for ICT-107 to Initiate in Second Half of 2015; Financial
Results Conference Call to be Held on May 12, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
(&quot;ImmunoCellular&quot;) (NYSE MKT: IMUC) today announced financial results
for the first quarter 2015.&nbsp; </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4a0b5f82-18cc-4372-94da-08cfe8c77527.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ignyta
Announces First Quarter 2015 Company Highlights and Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ignyta, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ignyta, Inc. (Nasdaq: RXDX),&nbsp;a precision oncology biotechnology
company, today announced company highlights and financial results for the first
quarter ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c3357f84-6ade-4799-b434-d7006020f1ee.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lilly
and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Eli Lilly and Company (NYSE:LLY) and
BioNTech AG today announced they have entered into a research collaboration to
discover novel cancer immunotherapies. The companies will seek to use the power
of the body's own immune system to att...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 3:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/41953dd5-fb40-472c-bb14-6a3139691f15.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
approves cobas KRAS Mutation Test for metastatic colorectal cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com HEMATOLOGY ONCOLOGY RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Roche today announced that it was granted FDA approval for the
cobas KRAS Mutation Test, a diagnostic test used to help determine appropriate
therapy options for patients with metastatic colorectal cancer, according to a
press release.The cobas KRAS...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 2:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/119ff406-b490-4c50-a6c7-e10225c03134.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Chembio
Diagnostics' (CEMI) CEO John Sperzel on Q1 2015 Results - Earnings Call
Transcript ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 1:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/85c081cf-6ef5-4582-8623-ede211603628.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ask
an Expert - Diagnostics testing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 1:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0c5805a4-8bf7-40fc-a098-56549844fff0.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OSE
Pharma to Partner Tedopi&reg; with RAFA Laboratories for Long Term Licensing and
Distribution Agreement in Israel</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --It will look to enrol 500 patients with
invasive/metastatic non-small cell lung cancer (NSCLC), expressing the HLA-A2
receptor. Tedopi&reg; will be used as a second line treatment for patients for whom
first line treatments (such as chemot...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 12:44:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6f4a7449-769a-4935-947d-7966d48261ad.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Diagnostic
BioSystems Raises Growth Capital and Expands Facility and Management Team to
Support Continued Growth Innovator in immunohistochemistry pursues growth
opportunities and strategic partnerships</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Diagnostic BioSystems, an innovator of
immunohistochemistry (IHC) solutions in the life science research and anatomic
pathology markets, announced it has completed its growth capital financing with
BroadOak Capital Partners, a life sc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 12:24:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c9cc16e1-65c9-4847-ba2f-7b9736c0657a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fast
Company Names Veracyte CEO, Bonnie Anderson, to Its &quot;100 Most Creative
People in Business 2015&quot; List</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a molecular
diagnostic company pioneering the field of molecular cytology, announced that
company President and CEO Bonnie H. Anderson has been selected to Fast
Company's &quot;100 Most Creative People in Bus...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 12:08:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e12dcc5e-195b-41fc-b84d-57357f8e6d51.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Five
things for pharma marketers to know: Monday, May 11</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Latest articles from Medical Marketing and Media Channel</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Mylan weighs Teva takeover; GSK and UNC launch research center
and drug company; FDA approves Roche colorectal cancer drug diagnostic</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 11:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a5257cf8-8df8-49de-8e34-ac4c59bcb2b4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pandora
Presents: Josh Groban, ¡°Stages,¡± an Exclusive Performance in NYC</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pandora</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pandora&nbsp;(NYSE:P), the leading Internet radio service, has
partnered with Josh Groban to present an exclusive live performance on June 1,
2015 in New York City. In addition to this intimate performance, Pandora worked
with the singer to curate a cust...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3bea0e3b-c882-405a-91fc-39f72b02b1bb.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We¡¯re Catching up on Vertex, Glaxo and Lots More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Associated PressHello, everyone, and welcome to another working
week. The weekend respite breezed by, did it not? Well, we hope it was
refreshing and invigorating, because the familiar routine of meetings and
deadlines and what-not has returned once...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3f68b92f-a2bb-46f7-a928-02de7534df42.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
Receives FDA Approval for cobas(R) KRAS Mutation Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HSMN NewsFeed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Molecular PCR test identifies KRAS mutations to aid in
determining therapy for metastatic colorectal cancer&gt; PLEASANTON, Calif.,
May 11, 2015 -- (Healthcare Sales &amp; Marketing Network) -- Roche (SIX: RO,
ROG; OTCQX: RHHBY) today announced that the U....</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3f9e9dfd-adf7-4beb-8804-a8ec66c5cace.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Malaria Test Could Lead to Global Eradication of the Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>WASHINGTON, May 11, 2015 /PRNewswire-USNewswire/ --&nbsp;One of
the biggest difficulties faced by worldwide programs aimed at eliminating
malaria is that the tests they use are not sensitive enough to detect all
people who have the disease and need treat...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/eab00de7-212e-4854-844a-73c3beb49b9f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
Wins FDA Approval for cobas KRAS Mutation Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>DeviceSpace.com Breaking News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Roche Receives FDA Approval for cobas KRAS Mutation
TestMolecular PCR test identifies KRAS mutations to aid in determining therapy
for metastatic colorectal cancerPLEASANTON, Calif., May 11, 2015 /PRNewswire/
-- Roche (SIX: RO, ROG; OTCQX: RHHBY) to...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:50:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/adf3fc60-8a61-46de-a9a3-68ec4c69c3a8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
ApproveRoche KRAS Mutation Test for Metastatic Colorectal Cancer Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e6f2bae5-fc7e-4dde-8392-9b58c1dc0a18.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Easton
Pharmaceuticals / BMV Announce Engaging Ackerman Pharma S.A. de C.V. Towards
Mexican Government Regulatory Approval Filing on the Company's New
White-Labeled, Patented, Women's Diagnostic Product From Common Sense Inc.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Marketwired - Medical and Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Common Sense Has Begun Document Flow to Easton / BMV Towards the
Filing of a &quot;Fast-Track&quot; Approval, for a Patented, Point-of-Care
Diagnostic Test to Determine Causes of Vaginal Infection (Vaginitis), a
Condition for Which 1 in 3 Women Will Suffer Fr...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7e3f3796-5932-4e13-ba7a-c63dd8b9bf4b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amarantus
Reports Preliminary Data From Blood-based Version of MSPrecise(R) Diagnostic
for ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/855be61e-457a-4d68-a90a-8ae16ac0015f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
announces FDA approval of cobas KRAS Mutation Test for diagnostic use</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e296d319-b112-423d-9502-63e167fd6297.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>¡°2015
World Medical Innovation Forum¡± Cites ¡°Early Diagnosis and Treatment of
Alzheimer¡¯s Disease¡± as the Top Field Where Breakthroughs Will Be Made</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cognoptix</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡°2015 World Medical Innovation Forum¡± cites ¡°Early Diagnosis and
Treatment of Alzheimer¡¯s Disease¡± as the top field where breakthroughs will be
made</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:39:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/78c92a8b-1344-44e4-9fc4-64c01b6c0b1b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kalorama:
Expect Growth in The $56 Billion IVD Market</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Kalorama Information says a number of trends
bode well for testing and will drive growth in the next five years, including
new markets and private healthcare expansion globally. &nbsp;The market for all
in vitro diagnostic testing kits, in...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2dc89b1d-68d6-4049-89f4-2105bf18b3c3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Goodwin
Biotechnology was Selected by Panacea Pharmaceuticals for a Highly Specialized
Vaccine Fill / Finish Project</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PLANTATION, Fla., May 11,&nbsp;2015 /PRNewswire/ --&nbsp;Goodwin
Biotechnology, Inc., a biological Contract Development and Manufacturing
Organization (CDMO) that specializes in bioprocess development and GMP manufacturing
of biopharmaceuticals utilizing Mamma...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/eb385c9e-7868-47b2-82ad-570337987067.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>StimGuard
Receives FDA IDE Approval to Launch a US Clinical Trial for a Revolutionary
Wireless Device to Alleviate OAB Symptoms</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>StimGuard</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>StimGuard Receives FDA IDE Approval to Launch a US Clinical
Trial for a Wireless Device to Alleviate OAB Symptoms</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><a name=profile-n1uh></a><span lang=EN-US style='font-size:
10.5pt;font-family:"Verdana","sans-serif";color:black'>Clinical Chemistry</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ca25c000-f1a2-4d51-a30f-937fb3216e2d.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nephros
Announces $1.2M Private Placement</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Nephros, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device
company that develops and sells high performance liquid purification
ultrafilters and an on-line mid-dilution hemodiafiltration system for use with
a hemodialysis machine for the treatmen...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/accbbd56-88fa-4c77-8db8-1e5c3a483050.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
key to stopping sarcomas' spread</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>When sarcomas become large enough and outgrow their blood
supply, they become vulnerable to hypoxia¡ªa lack of oxygen. That adaptation not
only enables them to survive the stress of low oxygen¡ªit also enables them to
withstand cancer drugs.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/80262b09-533c-4248-896f-2aca08c0222e.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Child
immigrant detainees: 'There's an overwhelming sadness among them'</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Network Front | The Guardian</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Despite hopes that the end of immigration detention centers
could be near, for some kids, the psychological damage has already been
doneRead more: Many migrant families held by US could soon be free from
detention ¡®nightmare¡¯Related: Many migrant fa...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/71e0fab2-fc3e-4461-a8df-db28413249b5.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Micromax
launches Yu Yuphoria, priced at Rs 6,999; pre-booking starts today on Amazon</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Yu Yuphoria was launched in India on Tuesday. Powered by
Cyanogen OS 12, the smartphone is priced at Rs 6,999.Excited about the
#Yuphoria launch. #LetsDoThis #MakeInIndia, tweeted Rahul Sharma. (Image:
Twitter)Yu Yuphoria smartphone launched in Indi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3d78be1a-094a-4a92-9383-047c6bbe987f.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Collaboration
at Eskenazi Health Explores Ways to Personalize Medicine How genetics
influences treatments may significantly shrink medical costs and
hospitalizations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- In cooperation with Eskenazi Health,
the Indiana Institute for Personalized Medicine, the Indiana University School
of Medicine and the Regenstrief Institute are evaluating how genetics impact
the responsiveness and efficac...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/10d925e6-4456-4f5f-b62d-6143d04ffdd8.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Findings Support Less Frequent Dosing in Hemophilia B Patients Treated with
Coagulation Factor I...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CSL Behring News Release Archive</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Data showing improved pharmacokinetic profile to be presented at
World Federation of Hemophilia World Congress</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2bdf0cec-9e0e-4a2f-9091-5a0007420b0a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerulean
to Present at the UBS Global Healthcare Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cerulean Pharma Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cerulean today announced that Christopher Guiffre, J.D., M.B.A.,
President &amp; CEO, will present at the UBS Global Healthcare Conference in
New York on Tuesday, May 19, 2015, at 9:00 am ET.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/77f07b20-f3d9-4d59-b48c-e478087aafa0.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BRIEF-Biohit:
modern colorectal cancer screening test on the market from Finland</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Reuters: Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>* Says Colonview was superior to conventional fecal occult blood
(FOB) test in colorectal cancer screening due to its significantly higher
sensitivity and specificity</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/014a8f71-3293-4782-bd9c-5147259750d6.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Course
and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving
Androgen-Deprivation Therapy: A Controlled Comparison [Urologic Oncology]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PurposeMen receiving androgen-deprivation therapy (ADT) for
prostate cancer may be at risk for cognitive impairment; however, evidence is
mixed in the existing literature. Our study examined the impact of ADT on
impaired cognitive performance and ex...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/938bd284-b5c7-4511-8810-244f0da637c9.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>National
Briefing | Science: New Test Could Spare Patients From Biopsies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NYT &gt; Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The tests, called liquid biopsies, capture cancer cells or DNA
that tumors shed into the blood, instead of taking tissue from the tumor
itself.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:50:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cb9f9ae4-e9c7-4801-9cba-628790b9c76a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
type of blood test called liquid biopsy transforms, eases cancer treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>TribLIVE Today's Stories RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A blood test is starting to transform cancer treatment, sparing
some patients the surgical and needle biopsies long needed to guide their care.
The tests, ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/84055c02-8890-4fde-8015-4887748fc221.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
donation camp held</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>To help blood banks deal with seasonal shortage, Rotary Club
Visakha Port City organised a blood donation camp at Samsung Plaza,
Dwarakanagar, on Monday.President of the club P.L.K. Murthy c...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:46:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0c78fadf-8226-42d4-8513-dd5f1c3c6482.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CORRECTING
and REPLACING Shockwave Medical Announces Positive Six-Month Results from Study
of Novel Lithoplasty System for the Treatment of Peripheral Artery Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Shockwave Medical</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Please replace the release with the following corrected version
due to multiple revisions.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 6:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0e46b731-1ee6-4909-a2c7-a954622aa17c.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Group
B Streptococcus breaches the blood-brain-barrier</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bacterial meningitis is a life-threating infection of the
central nervous system. Group B Streptococcus (GBS) is the leading cause of
meningitis in newborn babies and can cause severe complications in those that
survive the infection. GBS must cross...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6d58dc00-1015-4256-915a-f1a3c1f43370.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Researchers
identify gene responsible for hypertension and brachydactyly</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Individuals with this altered gene have hereditary hypertension
(high blood pressure) and at the same time a skeletal malformation called
brachydactyly type E, which is characterized by unusually short fingers and
toes. The effect on blood pressure ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/eb62ed4b-8699-4ac4-a710-ff8fab1211aa.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
blood tests, liquid biopsies, may transform cancer care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Top Headlines</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New blood tests, liquid biopsies, may transform cancer
careAssociated Press - 11 May 2015 15:35-04:00Copyright 2015 The Associated
Press. All rights reserved. This material may not be published, broadcast,
rewritten or redistributed.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 3:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7e28cd19-26bc-4514-8d77-26658b153773.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hematologic
Malignancies [6.2]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Leaders in Pharmaceutical Business Intelligence</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Hematologic Malignancies [6.2] Larry H. Bernstein, MD, FCAP,
Writer and Curator
http://pharmaceuticalintelligence.com/2015/05/11/lhbern/Hematologic_Malignancies_%5B6.2%5D
Hematologic Malignancies&nbsp; Hematologic Malignancies [6.2] Not excluding
lymphom...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 2:46:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/68784d98-2969-4af3-9f43-540448925e40.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Eduardo
M. Sotomayor, M.D., Renowned Cancer Researcher and Physician-Scientist, to Lead
GW ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 1:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a28fde5b-e805-42bc-895b-758397b55cd8.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
may suggest new strategies for myelodysplastic syndromes treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A study revealing fresh insight about chromosome
&quot;tails&quot; called telomeres may provide scientists with a new way to
look at developing treatments or even preventing a group of blood cell
disorders known as myelodysplastic syndromes (MDS).</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 12:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/77716e4e-d311-4e12-ae38-b3fa3492d723.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Odd
genetic syndrome suggests increased blood vessel resistance could cause
hypertension</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The culmination of two decades of research, a new study reveals
the genetic causes of a curious, rare syndrome that manifests as hypertension
(high blood pressure) accompanied by short fingers (brachydactyly type E). Six
unrelated families with the ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 11:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/64436863-6411-49a1-80a8-9145442cf020.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Chester,
N.J. Woman Wins Bayer's Breathless Moments Contest Photo contest designed to
raise awareness about CTEPH, a chronic disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Bayer is pleased to announce the winner of
Breathless Moments, a photo contest designed to raise awareness about chronic
thromboembolic pulmonary hypertension (CTEPH) by showcasing inspirational
events, sights or moments in time that ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 11:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/140bce00-2184-4db0-8ea4-169d834b5946.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Acute
kidney injury linked to pre-existing kidney health, study finds</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Physicians treating hospitalized patients for conditions
unrelated to the kidneys should pay close attention to common blood and urine
tests for kidney function in order to prevent incidental injury to the organs
that help cleanse the body of toxins...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7d31dbee-7fba-42fd-b201-e9fbb5ecef70.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Method
for determining possible stress marker in blood samples</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A research collaboration between the universities of Oslo and
Aarhus has resulted in the development of a new method with diagnostic
potential. The new method that combines phase extraction with an enzymatic
reaction may eventually be used for an im...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/216e8823-ff62-4a78-99d3-1897c51b9147.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Blood Tests, Liquid Biopsies, May Transform Cancer Care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Drug Discovery &amp; Development All</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Read more about New Blood Tests, Liquid Biopsies, May Transform
Cancer CareComments</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3cb79a9f-0652-4a9e-83a4-d1af655dd9b4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Jenna
Ushkowitz and Reid Scott Celebrate the Oceans at 3rd Annual Nautica Oceana
Beach House Party Celebrities gather to raise awareness for leading ocean
conservation group at Santa Monica Beach</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- Celebrity ocean activists gathered at
the Marion Davies Guest House on Friday May 8th at the 3rd Annual Nautica
Oceana Beach House.&nbsp; The event benefited Oceana, the largest international
advocacy organization focused solely...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:14:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d005d9b9-ebbd-42d3-85e6-cb9e5c0bcb88.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ViaCyte
to Present at Cavendish Global Health Impact Forum</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;ViaCyte, Inc., a privately-held
regenerative medicine company with the first pluripotent stem cell-derived
islet replacement therapy for the treatment of diabetes in clinical trials,
today announced two presentations at the upcoming h...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f137dd04-6f91-4da5-8193-c5a02030a435.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aethlon
Medical Announces Institutional Review Board Approval of Multi-Indication
Cancer Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Aethlon Medical, Inc. (OTCQB:AEMD), a pioneer in
developing targeted therapeutic devices to address infectious diseases and
cancer, announced today that the Institutional Review Board (IRB) of the
University of California, Irvine (UCI...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cd3113db-54c8-4c0f-a409-dea65c3a652c.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Results
from Pulmonary Non-Tuberculous Mycobacteria (PNTM) Study Using Aradigm¡¯s
Liposomal Ciprofloxacin to be Presented at the American Thoracic Society 2015
International Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Aradigm Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>OSU and Aradigm will present results at the ATS conference on
May 20 that demonstrate that Aradigm¡¯s inhaled ciprofloxacin significantly
reduced the growth of non-tuberculous mycobacteria in mice.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e5b9b59b-8e46-4314-8492-e14ce14fd234.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Influenza
coinfections often overlooked</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Doctors who diagnose patients with bacterial infections during
flu season should consider the possibility of influenza coinfection, according
to a study published in The Journal of Infectious Diseases.¡°Only a fraction of
all persons with influenza a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/aa985e2a-bce1-4790-9ddd-3be7aca6c876.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDAnews
Announces ¡ª HCT/P Donor Compliance Risks: Best Practices for Testing, Screening
and Determining Eligibility Webinar, May 28, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRWeb - Daily News Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDAnews has partnered with David Smith of Pepper Hamilton for an
analysis of the FDA¡¯s current inspection and enforcement actions regarding 21
CFR part 1271, subpart C which requires human cells, tissues, and cellular and
tissue-based product (HCT/P...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 12:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6e5bee54-7f2b-4f28-8638-ed95afac7367.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Quest
Launches QNatal Advanced to Replace Sequenom's MaterniT21 Plus</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>https://www.genomeweb.com</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b396eb46-940c-40a0-b7a8-549c99700f21.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celsion
Corporation Reports First Quarter 2015 Financial Results and Provides Business
Update Recruitment for the OPTIMA Study is Well Underway in U.S., Europe and
Asia Pacific</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology
drug development company, today announced financial results for the quarter
ended March 31, 2015 and provided an update on its development programs,
including ThermoDox&reg;, its proprietary...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 8:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8780755b-a089-4d90-82a5-ce11713c3c4b.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Courtagen
Life Sciences Appoints Dr. Joe Keegan to the Company¡¯s Board of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Courtagen Life Sciences, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Courtagen Life Sciences, Inc., a commercial-stage, innovative
molecular information company that sells proprietary genomic diagnostic and
drug metabolism assays for pediatric neurology disorders, announced today the
appointment of Dr. Joe Keegan to ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/393bad1a-f86d-480b-a96b-6010b977971a.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MediSapiens
Expanding Rapidly Into Precision Medicine and Genomic Diagnostics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0500b7b7-ee62-4a3d-be1e-d513ba667ffa.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HIV-1
infection accelerates age according to the epigenetic clock</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background.&nbsp;Infection with the Human Immunodeficiency
Virus-1 (HIV) is associated with clinical symptoms of accelerated aging, as
evidenced by increased incidence and diversity of age-related illnesses at
relatively young ages that is supported by f...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 6:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9f0c97af-3424-4970-b86c-d37c3dc0b5a4.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>GeneWEAVE
Receives Two Prestigious Awards from the DxMA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRWeb - Daily News Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Molecular Diagnostics Company Wins First-Place at 2015 DxMA
Global Marketing Summit(PRWeb May 12, 2015)Read the full story at
http://www.prweb.com/releases/2015/05/prweb12715709.htm</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 12, 2015 4:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/393f1929-f845-46ab-882e-0a0ad9873e14.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WaferGen
Bio-systems Appoints Life Sciences Industry Veteran, Rolland D. Carlson, Ph.D
...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 6:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/280e36f2-557c-4f95-b60f-3546c84408bd.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WaferGen
Bio-systems Appoints Life Sciences Industry Veteran, Rolland D. Carlson, Ph.D.,
President &amp; CEO Ivan Trifunovich, Ph.D., Appointed Executive Chairman of
the Board</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS)
announced today that the Company has appointed Rolland D. Carlson, Ph.D.,
President &amp; CEO, effective immediately.&nbsp; Dr. Carlson assumes this role
from Ivan Trifunovich, Ph.D., who has served as...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ec5d612e-93a8-4f6f-8425-5eb67881d658.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WaferGen
Bio-systems Reports Results for First Quarter 2015 Company Continues to Advance
Single Cell Analysis Technology, Full Commercial Launch Expected by End of 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- WaferGen Bio-systems, Inc. (NasdaqCM: WGBS)
announced today its financial results for the first quarter ended
March&nbsp;31, 2015, and provided a corporate update.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2938ca23-edb8-4631-9af1-52c3296372ee.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics unveils $50M IPO for genomic profiling technology</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceDiagnostics News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HTG Molecular Diagnostics launched a $50 million initial public
offering to support development of its next-generation molecular profiling
technology, months after the company unveiled plans for an IPO to boost R&amp;D
and commercialization for its sequ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 12:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9c6af794-a7f5-4889-9c93-a551092f7022.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MEDITE
Cancer Diagnostics, Inc. Reports 2014 Year End Results along with Expectations
for 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ORLANDO, Fla., May 11, 2015 /PRNewswire/ --&nbsp;MEDITE Cancer
Diagnostics, Inc., (MDIT) specializing in the development, manufacturing and
marketing of molecular biomarkers and premium medical devices for detection,
risk assessment and diagnosis of canc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2311af38-9ab6-4049-b679-85fb125f625e.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Helomics&#8482;
CEO Named to Pennsylvania Bio Board of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Helomics Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Helomics Corporation, a privately-held personalized healthcare
company that provides comprehensive tumor profiling products and services based
on both live and fixed cell assays, announced today that the Company¡¯s
President, CEO and Founder, Neil Ca...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 10:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/070222bf-afe2-4d60-9ba4-f77bf5474d30.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Osteoporosis:
Patients suffering unnecessary fractures due to missed diagnoses, doctors say</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Each year more than 100,000 Australians suffer a fracture due to
Osteoporosis. Yet leading doctors say very few patients are actually properly
diagnosed or treated for the condition, causing their bones to break.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 1:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/af0f8439-50ec-4dec-9e34-bf1f9cc5e25d.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PTHrP-related
Hypercalcaemia in Infancy and Congenital Anomalies of the Kidney and Urinary
Tract (CAKUT)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Canadian Journal of Kidney Health and Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Severe hypercalcaemia is a rare but clinically
significant condition in infancy and childhood. Parathyroid hormone-related
peptide (PTHrP)-mediated hypercalcaemia resulting from a malignancy is rare and
only a handful of case reports hav...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 10:28:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ac054cf2-c512-49f5-8d6a-d83e446167c0.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WCCT
Global Sets Focus on Respiratory Clinical Research in Honor of National Asthma
&amp; Allergy Awareness Month</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-iReach/ -- WCCT Global, a full service CRO located
in Southern California, is supporting the 2015 National Asthma &amp; Allergy
Awareness Month, celebrated each year by the Asthma and Allergy Foundation of
America, by strongly advocating the ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7e978b0b-2ae7-4244-8718-b9c209186fa6.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>A
Patient¡¯s Perspective: On Open Heart Surgery from Diagnosis and Intervention to
Recovery</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Leaders in Pharmaceutical Business Intelligence</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A Patient¡¯s Perspective: On Open Heart Surgery from Diagnosis
and Intervention to Recovery ¨C&nbsp;A New Day, a New Lease and Unfolding
Questions! Guest Author: Ferez S. Nallaseth, Ph.D. Life Sciences Institute of
New Jersey, Belle Mead, NJ 08502; Complex...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 11:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/80d83c02-43bd-4292-b8ea-722d473ffca7.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Revolution
Lighting Technologies Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Revolution Lighting Technologies, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Revolution Lighting Technologies, Inc., a leading provider of
advanced LED lighting solutions, has announced financial results for the
quarter ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/67dba66d-22b9-4fa5-99bb-1ff01ac10cf4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Frost
&amp; Sullivan Commends Sensus for the Development of SRT-100&#8482; and SRT-100
Vision&#8482;, its Low-energy Radiation Therapy Systems for Treating Skin Cancer The
products have demonstrated safety, clinical efficacy, and potential for
widespread adoption to treat a host of dermatological and oncological
conditions</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Based on its recent analysis of the
non-melanoma skin cancer therapy market, Frost &amp; Sullivan recognizes Sensus
Healthcare LLC with the 2014 North American Frost &amp; Sullivan Award for New
Product Innovation Leadership. Sensus uses a te...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e019022f-80cc-45ef-b93b-742dcc6e7dbd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PTC
Therapeutics Launches STRIVE Grant Award Program -Focused on nonprofit
organizations that are committed to serving the rare disease community-</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today
announced it has launched STRIVE (Strategies to Realize Innovation, Vision and
Empowerment), an awards program aimed at providing funds to patient advocacy organizations
to develop unique an...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3ee190e3-38e3-4ff9-a274-54806cb4328f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AbbVie
to Present New Data from Studies of Five Oncology Pipeline Assets in Multiple
Cancers at the 51st American Society of Clinical Oncology Annual Meeting 17
abstracts include data from:</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- AbbVie (NYSE: ABBV) announced 17 abstracts from
studies of the company's oncology pipeline are being presented at the 51st
Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 -
June 2, in Chicago. Notably, data ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1dc4f96f-b911-45d1-bd53-1321d0c76923.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SI-BONE,
Inc. Announces INSITE RCT Recipient of Leon L. Wiltse Award for Best Overall
Paper at the 2015 ISASS Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- SI-BONE, Inc., a medical device company that
pioneered the use of the iFuse Implant System, a minimally invasive surgical
(MIS) device indicated for fusion for certain disorders of the sacroiliac (SI)
joint, announced that results fro...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b2959d8c-bacc-4855-8e62-6fbac8f58dbb.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Seventh
Sense Biosystems Receives Notice of Allowance for Additional U.S. Patents for
TAP Blood Collection System</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Seventh Sense Biosystems, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Seventh Sense Biosystems, Inc., (7SBio), a leading developer of
blood collection and diagnostic platforms, announced today the receipt of
notice of allowances from the United States Patent and Trademark Office for two
patent applications (U.S. Paten...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/356c86db-a36b-4513-83fa-b72d43631735.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aradigm
Announces First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Aradigm Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Aradigm announced first quarter 2015 financial results, Total
revenue increased $2.2 million over first quarter 2014.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ce623b04-3e18-4e57-b4d7-324f63a606c5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Actavis
Reports Exceptional Performance in First Quarter 2015 with 59% Increase in Net
Revenue to $4.2 Billion and 23% Growth in Non-GAAP EPS to $4.30 -- Adjusted
EBITDA Increases 107% to $1.8 Billion in First Quarter 2015 --</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Actavis plc (NYSE: ACT) today reported continued
exceptional performance with net revenue increasing 59 percent to $4.23 billion
for the quarter ended March 31, 2015, compared to $2.66 billion in the first
quarter 2014. On a non-GAAP ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 6:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7a1b17e8-ce27-4428-b7e8-26b0c74d4440.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>iPHEX
2015 to be held in Mumbai from May 13-15</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Launches a mobile app called iPHEX Mobile AppThe third edition
of iPHEX 2015 will be held at Bombay Exhibition Centre from May 13 to 15. The
event will be promoted by the Pharmaceutical Exports Promotion Council of India
(Pharmexcil), and supported ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 6:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ffddfd35-6b52-4bd7-91d2-a85465f883b8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Enhancements
to Toshiba¡¯s Aquilion ONE Family Improve Patient Safety</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Toshiba America Medical Systems, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Toshiba America Medical Systems, Inc.¡¯s new detector and CT
software enhancements for its AquilionTM ONE Family of CT systems, which are
designed to offer customers the right technology to meet their business needs
for improving patient safety, have...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3a929254-d305-460a-9811-9e25b71c02f4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
Receives FDA Approval for cobas&reg; KRAS Mutation Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharma News from PharmiWeb.com</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Roche Receives FDA Approval for cobas&reg; KRAS Mutation TestRoche
Receives FDA Approval for cobas&reg; KRAS Mutation Test...Roche</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 5:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/959b3fae-6e95-4a8d-8d61-4e479070a5ca.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Metropolis
Healthcare reports ovarian cancer data</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>7945 tested positive for high CA125 levels out of the 36,515
samples processed at Metropolis Healthcare in MumbaiOvarian cancer has emerged
as one of the most common cancer affecting women in India. An analysis of
samples collected over the past two...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2c94c515-83c2-4fec-9328-5eaf369c1c87.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
Obtains FDA Approval For Cobas KRAS Mutation Test - Quick Facts</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ that the U.S. Food and Drug Administration has approved the
cobas KRAS ¡­ with both the U.S. Food and Drug Administration (FDA) and the
European Medicines ¡­ NHL and multiple myeloma. The FDA recently granted
Breakthrough Therapy Designation ¡­</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 3:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/be008654-6105-4d0c-8c81-526e4d5b0ed9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
Receives FDA Approval for cobas&reg; KRAS Mutation Test Molecular PCR test
identifies KRAS mutations to aid in determining therapy for metastatic
colorectal cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PLEASANTON, Calif., May 11,&nbsp;2015 /PRNewswire/ --&nbsp;Roche
(SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug
Administration (FDA) has approved the cobas&reg; KRAS Mutation Test for diagnostic
use. The real-time PCR test is designed to ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 1:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a609e7b2-ea13-418d-be5c-65a736f66a20.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pivotal
Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genentech</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
RHHBY), today announced that data from 10 of its approved cancer medicines and
10 investigational medicines will be presented during the American Society of
Clinical Oncology (ASCO) Annual...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 1:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/93ab36aa-a5f5-41e1-b056-2f94bd80a021.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>UNC-Chapel
Hill and GSK announce novel partnership to accelerate search for HIV cure
Unique public-private collaboration will create HIV Cure center and a new
company to bring together academic and pharmaceutical research scientists</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ --&nbsp;The University of North Carolina
at Chapel Hill, a leading global public research university with significant
expertise in HIV basic and clinical research, and GSK, a global, research-based
pharmaceutical and healthcare com...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 10:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cdb012de-bef3-44dc-9936-53f065712b97.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Age-
and sex-specific differences in blood-borne microvesicles from apparently
healthy humans</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Biology of Sex Differences</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Sex differences in incidence of cardiovascular
disease may reflect age-associated intravascular cellular activation resulting
in shedding of cell membrane-derived bioactive microvesicles (MV or
microparticles) into the blood. Concentrati...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 8:26:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8b5ea93a-1db5-44cd-901c-803a6652b78c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epitope
Diagnostics Expands Infectious Disease Product Line with Clostridium Difficile
Family of ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 12:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9f98982c-9642-46a5-9519-00cb616ed242.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Singer
and &quot;Pretty Little Liars&quot; Actress Lucy Hale Lends Her Voice to Voices
of Meningitis&#8482; to Help Improve Teen Booster Vaccination Rates Despite CDC
recommendations, fewer than 30% of teens received the second vaccination to
help protect against meningococcal meningitis; new survey reveals potential
reasons why</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Best known for her leading role on ABC
Family's hit show &quot;Pretty Little Liars,&quot; actress and singer Lucy Hale
is lending her voice to the Voices of Meningitis&#8482; public health initiative to
educate moms and teens on how to help protect a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:39:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1b901434-2bcf-4649-8296-32fd01f8f622.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Audentes
Therapeutics Announces New Data to be Presented at American Society of Cell and
Gene Therapy Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Audentes Therapeutics, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Audentes Therapeutics announces compelling additional
preclinical data supporting the potential of gene therapy treatments for XLMTM
and Pompe Disease will be presented at the ASGCT Annual Meeting.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0c4303e2-1745-4d44-8946-90e126a3356b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WebMD
Magazine Celebrates a Decade of Health and Wellness in 10th Anniversary Issue
Featuring Robin Roberts, Debi Mazar, Reba McEntire and 10 &quot;Top 10&quot;
Lists that Highlight Major Milestones and Stories from the Last Decade</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;WebMD is celebrating the 10th anniversary
of WebMD Magazine with the release of a special issue featuring a cover-story interview
with Robin Roberts called, &quot;Profile of Courage&quot; where she reflects on
10 heroes in her life who helped h...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 7:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/198a6148-3587-49cb-9f13-9c23a366affe.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Havahart&reg;
Adds Deer Off&reg; Deer Repellent Stations to Product Line-up</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRWeb - Daily News Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Deer Off Deer Repellent uses 100 percent dried blood - a proven
scent deterrent that is odorless to humans, yet easily detectable by deer¡¯s
heightened senses - to trigger flight response in deer.(PRWeb May 11, 2015)Read
the full story at </span><span lang=EN-US><a href="http://www"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>http://www</span></a></span><span
lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>....</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 6:33:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0ff8ea5c-e6f0-400e-96b9-f4d696f442c3.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PNP:
Another lab test needed to determine cause of milk tea deaths</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>INQUIRER.net</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>THE Philippine National Police affirmed the findings of the
Manila Police District, which concluded that the milk tea victims had ingested
&quot;oxalic acid,&quot; but it could not say yet that the poisonous substance
caused their death until another examinat...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:32:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f2d4b840-c2b4-4208-9fae-e5f9d5930a0c.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Gadkari
denies wrongdoing as Congress guns for his head</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>With Congress baying for his blood, Union Minister Nitin Gadkari
on Monday broke his silence on the CAG report on irregularities in loan
extended to his family-linked Purti Group, saying the govern...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 4:25:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5940de7b-e406-433d-84df-f52274485a00.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Making
A Mark children's art exhibit opens at McAllen-Miller airport</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 3:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ff39dad4-54ca-46b6-b135-6930f81f232b.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Real
Medicine Foundation Joins Health eVillages Collaborative Coalition to Aid Nepal
Earthquake Victims Donations will support Real Medicine Foundation's food,
medical and shelter relief efforts</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Health eVillages, a program founded by global
healthcare activist Donato Tramuto and Physicians Interactive in partnership
with the not-for-profit Robert F. Kennedy Human Rights organization, today
announced that its Collaborative Coa...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/711696cd-a595-4ff3-a476-97d3a0c5b79b.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bone
marrow registry of 1 million potential donors to be reality soon</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>For most patients diagnosed with a blood disorder and in need of
a bone marrow transplant, finding a matching bone marrow is a Herculean task.
While some find a matching bone marrow from a sibling...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 9:25:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6a7ab673-a350-4e7f-af10-c4b93452b87d.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bone
marrow registry of 1 million potential donors to be a reality soon</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>For most patients diagnosed with a blood disorder and in need of
a bone marrow transplant, finding a matching bone marrow is a Herculean task.
While some find a matching bone marrow from a sibling...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 8:25:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bb8f0b31-bd39-4d69-aa25-804530a153ba.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioTime,
Inc. Reports First Quarter 2015 Results and Recent Corporate Accomplishments</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc. (NYSE MKT:BTX) today reported financial results
for the first quarter ended March 31, 2015 and provided a corporate update.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/418a2aa1-7038-498c-a1ab-8ed24fbf7bc5.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Medicine Shoppe&reg; and Medicap Pharmacy&reg; Franchisees Go Tobacco-Free</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Smoking is the leading cause of preventable
death worldwide, killing more than 480,000 Americans and causing illnesses that
cost more than $300 billion to treat each year, according to the Centers for
Disease Control and Prevention. I...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e9ec6ab4-13e7-48a8-a72b-e6866178b958.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Interleukin
Genetics Announces Conference Call to Discuss First Quarter 2015 Financial
Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Interleukin Genetics, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it
will host a conference call and webcast on Friday, May 15, 2015, at 8:30 a.m.
(ET), to provide a corporate update and discuss the Company¡¯s first quarter
2015 financial results. To acce...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 11, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bcc7c500-4ce7-40cf-8050-54bbbe0a104f.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
2nd meeting of the Bridging Biomedical Worlds series: ¡°From Neural Circuitry to
Neurotechnology¡±</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fondation Ipsen</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Neural circuits are central to our understanding of how the
brain works. Promoting basic research into the form and function of neural
circuits and the translation of this research into neurotechnologies for both
studying the brain and for treating ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 7:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/89406922-b1d7-4f6d-b63c-bf48ecc95acd.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>2-day
national conference on Molecular Diagnostics concludes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 4:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0a6fe6ca-615f-471f-87f1-952ed14e56b3.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Survey
finds lupus patients suffer more than physicians perceive</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- As many people in the lupus community
prepare to come together in support of World Lupus Day (May 10), a global
survey shows that systemic lupus erythematosus (SLE) patients have difficulty describing
their symptoms to thei...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7b6a8510-ca8b-4487-9f51-a2c6f1578f7f.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Osteoporosis
cases going undiagnosed and untreated, doctors say</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Osteoporosis is not being properly diagnosed or treated by
doctors in Australia, causing thousands of unnecessary fractures and costing
the health system more than a billion dollars, leading doctors say.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 4:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/49e74a04-33eb-41f8-8ab1-40d8bbbe05e4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cutting
risk of mother-to-baby transmission of HIV ¨C video</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Network Front | The Guardian</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Treatment to prevent mother-to-child transmission of HIV, or
PMTCT, reduces the risk of expectant mothers passing on the virus to 5% or
less. The PMTCT process involves antiretroviral drugs for the mother, and then
diagnostic tests for the child eve...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 5:45:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f0af5f81-bf52-4150-9989-0713b3586505.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epitope
Diagnostics Expands Infectious Disease Product Line with Clostridium Difficile
Family of Tests</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR.com Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Epitope Diagnostics, Inc. developed and produced a new ELISA Kit
and rapid test with accessories for the detection of Clostridium difficile
specific glutamate dehydrogenase (GDH). [PR.com]</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 3:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7f3429c3-cb1b-403b-8703-7def923e5fd9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Effect
of diagnostic testing on medicines used by febrile children less than five
years in 12 malaria-endemic African countries: a mixed-methods study</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Malaria Journal</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: In 2010, WHO revised guidelines to recommend testing
all suspected malaria cases prior to treatment. Yet, evidence to assess
programmes is largely derived from limited facility settings in a limited
number of countries. National surveys ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 8:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/239420c0-d761-4e6a-af2a-745b2abd59c1.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Analysis
of Erythrocyte Invasion Mechanisms of Plasmodium falciparum Clinical Isolates
Across 3 Malaria-Endemic Areas in Ghana</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background.&nbsp;Plasmodium falciparum invades human
erythrocytes by using an array of ligands that interact with several receptors,
including sialic acid (SA), complement receptor 1 (CR1), and basigin. We
hypothesized that in malaria-endemic areas, para...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5d9fd0b3-f304-4918-aca0-3dc17cdbe483.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Anti-impotence
drug Viagra may prevent malaria transmission</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Treatments for malaria target the asexual forms of this parasite
that cause symptoms, but not the sexual forms transmitted from a human to a
mosquito when it bites. (Reuters)The anti-impotence drug Viagra helps eliminate
malaria from the blood circu...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 5:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0440958d-4e8f-43e6-971b-0bd412b4d493.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clinical
significance of day 5 peripheral blast clearance rate in the evaluation of
early treatment response and prognosis of patients with acute myeloid leukemia</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Journal of Hematology &amp; Oncology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Minimal residual disease detection in the bone
marrow is usually performed in patients with acute myeloid leukemia undergoing
one course of induction chemotherapy. To optimize the chemotherapy strategies,
more practical and sensitive mar...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 8:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e1e3a2bd-d4aa-4837-bcd7-aa16456a79c8.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Immune
Response to Marburg Virus Angola Infection in Nonhuman Primates</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background.&nbsp;The 2005 outbreak of Marburg virus (MARV)
infection in Angola was the most lethal MARV infection outbreak in history,
with a case-fatality rate (90%) similar to that for Zaire ebolavirus (EBOV)
infection. However, very little is known ab...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/239420c0-d761-4e6a-af2a-745b2abd59c1.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Analysis
of Erythrocyte Invasion Mechanisms of Plasmodium falciparum Clinical Isolates
Across 3 Malaria-Endemic Areas in Ghana</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background.&nbsp;Plasmodium falciparum invades human
erythrocytes by using an array of ligands that interact with several receptors,
including sialic acid (SA), complement receptor 1 (CR1), and basigin. We
hypothesized that in malaria-endemic areas, para...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/49e74a04-33eb-41f8-8ab1-40d8bbbe05e4.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cutting
risk of mother-to-baby transmission of HIV ¨C video</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Network Front | The Guardian</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Treatment to prevent mother-to-child transmission of HIV, or
PMTCT, reduces the risk of expectant mothers passing on the virus to 5% or
less. The PMTCT process involves antiretroviral drugs for the mother, and then
diagnostic tests for the child eve...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 5:45:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f0af5f81-bf52-4150-9989-0713b3586505.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epitope
Diagnostics Expands Infectious Disease Product Line with Clostridium Difficile
Family of Tests</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR.com Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Epitope Diagnostics, Inc. developed and produced a new ELISA Kit
and rapid test with accessories for the detection of Clostridium difficile
specific glutamate dehydrogenase (GDH). [PR.com]</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 10, 2015 3:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/83400aa1-0244-4a2c-9656-809ffb8a6f4a.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hospitalization
Rates and Reasons Among HIV Elite Controllers and Persons With Medically
Controlled HIV Infection</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background.&nbsp;Elite controllers spontaneously suppress human
immunodeficiency virus (HIV) viremia but also demonstrate chronic inflammation
that may increase risk of comorbid conditions. We compared hospitalization
rates and causes among elite control...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4a947664-45dc-43ec-b0b5-751d4f31a816.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>High
Transmissibility During Early HIV Infection Among Men Who Have Sex With
Men--San Francisco, California</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>We estimate the relative transmission rate in early versus later
infection among men who have sex with men (MSM) in San Francisco, California,
by studying the characteristics of a sample of transmitters, recruited through
newly diagnosed, recently i...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8ce54135-5693-42b1-bdd0-98d70234cb38.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Drug-loaded
microbubbles can diagnose, treat thrombosis</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>(HealthDay)¡ªTargeted theranostic microbubbles (TT-MB), that
consist of a fusion construct combining urokinase, echo-enhancing microbubbles
for visualization by ultrasonography, and an activated platelet-specific
single-chain antibody for specific ta...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 6:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/502fe741-0521-4543-bd00-307913d8fc10.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Next-generation
sequencing panel cost-effective for CRC</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>(HealthDay)¡ªUse of a next-generation sequencing (NGS) panel
including genes associated with highly penetrant colorectal cancer and
polyposis (CRCP) syndromes is cost-effective for CRCP diagnosis, according to a
study published online May 4 in the Jo...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 5:32:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/17ca6032-654f-4a69-beca-cd93862f7982.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>High-sensitivity,
imaging-based immunoassay analysis for mobile applications</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 7:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/419a3a52-6642-42eb-a376-d7509dac9e95.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>West
Coast Biotech Roundup: Adaptive, Gilead, Juno, aTyr &amp; More</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Alex Lash Out west this week there was news, there was an event,
and there was coincidence. It just happened that two executives who spoke at
Xconomy¡¯s annual Seattle biotech forum Wednesday represented local companies,
Adaptive Biotechnologies and ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 2:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c5d7d84e-d6e6-4623-a303-263a8c75648a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ministro
do Esporte mostra confian&ccedil;a em certifica&ccedil;&atilde;o de laborat¨®rio antidoping do Rio</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Brasil</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>O ministro do Esporte, George Hilton, expressou confian&ccedil;a na
reacredita&ccedil;&atilde;o do Laborat¨®rio ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 2:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f056cb9f-cdd9-4a76-8953-d71c288231d6.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
review challenges Vertex's case for crucial cystic fibrosis combo</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceBiotech News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA reviewers plan to put Vertex's&nbsp;cystic fibrosis team to
the test on Tuesday. In a review of the big biotech's data for its closely
watched combination therapy for CF, the reviewers raised doubts about the
efficacy of the drug, posing a challenge ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b8b42da5-a864-4349-b703-d1530417b898.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Haemostasis
testing ¨C the way forward</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The diagnostic segment today comprises a wide array of
specialties. With the availability of high-end technologies, it is possible to
conduct an in-depth analysis of just about any parameterPaul Francis PremCoagulation
remains one of the most import...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/41b76e7a-abb9-400e-b641-1c9387c450b8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Strand
Life Sciences names Scott Storrer as Global President, introduces US management
team</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>US team focused on National Launch of StrandAdvantage ¨C
company¡¯s pan-cancer genomic profiling serviceStrand Life Sciences announced
the appointment of Scott Storrer to the position of Global President. In this
new role, Storrer, who joined Strand i...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3a9a17b6-be9f-441f-9b80-51a48ed20d5e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Eurofins
to acquire Canada's Experchem Laboratories</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA and Over The Counter News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ the Food and Drug Administration (FDA) in the US, Experchem
provides ¡­ US, reports indicate that the FDA is increasingly likely to
strengthen ¡­ control (QC) testing services for over the counter (OTC) drugs,
providing a ¡­</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/502ce149-b66a-41fa-b810-982ad9245d76.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies and Collaborators to Present 5 Studies Demonstrating Utility of
Immunosequencing to Determine T-cell Function in Chronic and Infectious
Diseases at the 2015 American Association of Immunologists Annual Meeting Data
on High-Throughput Pairing of T-cell Receptor Alpha and Beta Sequences to be
Presented</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Adaptive Biotechnologies, the leader in next
generation sequencing (NGS) to profile T- and B-cell receptors of the adaptive
immune system, and its collaborators will present data demonstrating how
profiling a patient's T-cell repertoi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e6b09fbb-f558-4246-8114-bb67211f34c7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>¡®Deprived¡¯
neighbourhood could make you obese: Study</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Certain regions in the US are characterised by a higher
prevalence of obesity, which suggests that a person¡¯s socioeconomic, physical
and social environments can affect opportunities for healthy behaviours that
might prevent excess weight gain, rese...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 9, 2015 6:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ebc23af9-91d8-4fe2-bb95-ff53deb46c05.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>World
Thalassemia Day</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Nation News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Patients during blood transfusion at Sundas Foundation Centre as
world observed World Thalassemia Day.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c02600ee-aeb6-45aa-9499-cc91e24dd9dc.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pre-marriage
blood test to save generations</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Nation News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>LAHORE - Like other parts of the globe, World Thalassaemia Day
was observed across the country including Lahore on Friday to raise awareness
about the genetic disease. Seminars, walks and workshops were arranged both at
the government and private le...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0f74ede7-3b06-4a81-bf2b-8fee3ea64650.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Evolving
Toward Universal Blood</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Chemical &amp; Engineering News: Latest News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bioengineering: Researchers improve the efficiency of an enzyme
that turns A-type red blood cells into a universal type</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 3:32:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4f636281-da76-42f5-be0b-de512b8fcbbe.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Assisi
Animal Health Discusses the Latest Equine Herpes Virus Scare</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-iReach/ -- Assisi Animal Health is the developer of
the Assisi LoopTM, an effective non-pharmaceutical and anti-inflammatory device
(NPAID). The Loop can help cure chronic wounds and treat a range of
debilitating medical conditions includ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 3:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/569c4c11-4177-4115-b009-5cdae705ee60.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Studies
Provide Additional Validation of the Benefits of Automated Glucose Management
for Both IV and SubQ Insulin Dosing</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Glytec</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Glytec, a provider of innovative glucose management software
solutions, announced it will present 6 research posters at the International
Hospital Diabetes Meeting, May 8-9th in San Francisco.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 2:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/31cbb48c-098e-494c-b4cf-66f39ae749fd.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WHO
Adds Hepatitis C and Cancer Drugs to its List of Essential Medicines</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>As the debate over the cost of prescription drugs accelerates,
the World Health Organization has added several treatments for cancer and
hepatitis C to its list of so-called essential medicines, which the agency
believes should be made available at ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 12:41:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4fdbb8ee-ebba-4a4a-9c42-169eb6dcfa56.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Short-Acting
Antiplatelet Drug Cilostazol Safely Helps Patients Stop Dual Antiplatelet
Therapy During Surgery OUTSIDE START Study Finds Bridge Therapy Effective Even
in High-Risk Patients</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Patients with a high-risk paclitaxel
drug-eluting stent who were given the shorter-acting antiplatelet drug
cilostazol prior to a surgical procedure safely transitioned off of dual
antiplatelet therapy (DAPT) to reduce the risk of ble...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 12:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/59092d69-a1e7-44b7-8f37-c121a1840bf6.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Risk
Algorithm Helps Interventional Cardiologists Identify Patients Who May Benefit
From More Intensive Antiplatelet Medication Clinical Risk Assessment Plus
Platelet Function Testing Identifies High-&shy;Risk Patients in Whom a Tailored
Approach to Potent Antiplatelet Treatment May Potentially Be Beneficial</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 12:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ba78182f-4433-4bda-af76-d85e92a9efc1.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epigenomics
AG Reaches 99.5 % Adherence for Epi proColon in ADMIT Study</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>DeviceSpace.com Breaking News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Berlin, Germany, May 8, 2015 - Epigenomics AG (Frankfurt Prime
Standard: ECX; ISIN: DE000A11QW50) announces results from the ADMIT trial
(ADherence to Minimally Invasive Testing - NCT02251782) for its non-invasive
blood-based test for colorectal can...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:29:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f773c56c-fd4a-422c-a901-e46621f60ab3.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. As the Weekend Nears: We¡¯re Catching up on Amgen, Sanofi and
Much More!!</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>And so, another working week will soon draw to a close. Good
things come to those who wait, yes? This is, you may recall, our treasured
signal to daydream about weekend plans. As usual, the agenda is rather modest.
We have to manicure the official g...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5707c40d-7676-4e56-97a5-10dca4e76d53.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Golden
Meditech Proposes to Purchase CCBC Convertible Notes Held by Magnum and CCBC
Convertible Notes and CCBC Shares Held by CGL</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Golden Meditech Holdings Limited (&quot;Golden
Meditech&quot;, or the &quot;Company&quot;, together with its subsidiaries
collectively as the &quot;Group&quot;, 801.HK; 910801.TW), a leading integrated
healthcare enterprise in China announced today that it has ent...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/13e7141d-0c60-46dd-8392-dbd3eb5c3840.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Researchers
Report that Long-Term Administration of Thymosin B4 in a Diabetic Animal Model
Prevents Progression of Peripheral Neuropathy and Restores Sciatic Nerve
Function</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;RegeneRx Biopharmaceuticals, Inc. (OTCQB:
RGRX), a clinical-stage drug development company focused on tissue protection,
repair and regeneration, today announced that independent researchers have
reported that diabetic mice treated lo...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/502ce149-b66a-41fa-b810-982ad9245d76.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies and Collaborators to Present 5 Studies Demonstrating Utility of
Immunosequencing to Determine T-cell Function in Chronic and Infectious
Diseases at the 2015 American Association of Immunologists Annual Meeting Data
on High-Throughput Pairing of T-cell Receptor Alpha and Beta Sequences to be
Presented</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Adaptive Biotechnologies, the leader in next
generation sequencing (NGS) to profile T- and B-cell receptors of the adaptive
immune system, and its collaborators will present data demonstrating how
profiling a patient's T-cell repertoi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/32354983-d8e1-49f6-aaaf-93065c220331.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>American
Red Cross Commits $4 Million More to Help People of Nepal American Red Cross
President to Visit Nepal</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- The American Red Cross is committing
an additional $4 million to help the people of Nepal recover after the
devastating earthquake which hit the country on April 25, bringing the total
American Red Cross contribution thus f...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 11:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d507e73b-a137-4d74-adbe-2848d2255896.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ebola
detected in eye of US physician months after recovery</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>An American physician diagnosed with Ebola virus infection in
September continued to carry the virus and developed serious ocular
complications 14 weeks after his diagnosis, according to research published in
the New England Journal of Medicine.¡°Amo...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 6:26:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/51a219a4-f21d-4ded-ab19-31e1fcfb6bf1.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bayer
letter to editor of The New York Times regarding recent story about Essure&reg;
permanent birth control</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;In response to a May 4, 2015 story in The
New York Times about Essure&reg; permanent birth control, Bayer submitted the
following letter to the editor, which The New York Times refused to publish in
its entirety: </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 5:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dbaef01a-095d-4c65-a3ac-f3d840d82187.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clinical
features, T cell phenotypes similar in RA, chikungunya</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Patients with the chikungunya virus had similar clinical
presentation and T cell counts compared to patients with new, symmetric rheumatoid
arthritis, according to recently published research.Ten patients who returned
to the U.S. from Haiti during a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 2:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/502ce149-b66a-41fa-b810-982ad9245d76.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies and Collaborators to Present 5 Studies Demonstrating Utility of
Immunosequencing to Determine T-cell Function in Chronic and Infectious
Diseases at the 2015 American Association of Immunologists Annual Meeting Data
on High-Throughput Pairing of T-cell Receptor Alpha and Beta Sequences to be
Presented</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Adaptive Biotechnologies, the leader in next
generation sequencing (NGS) to profile T- and B-cell receptors of the adaptive
immune system, and its collaborators will present data demonstrating how
profiling a patient's T-cell repertoi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/70120454-bfd4-44cc-a323-f618947c546e.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>High-value
research of 2014 presented for hematology</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>(HealthDay)¡ªArticles relating to malignant hematology,
transfusion medicine, and bleeding and clotting disorders are included in a
special update summary published online April 30 in the Annals of Internal
Medicine.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 11:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/502ce149-b66a-41fa-b810-982ad9245d76.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies and Collaborators to Present 5 Studies Demonstrating Utility of
Immunosequencing to Determine T-cell Function in Chronic and Infectious
Diseases at the 2015 American Association of Immunologists Annual Meeting Data
on High-Throughput Pairing of T-cell Receptor Alpha and Beta Sequences to be
Presented</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Adaptive Biotechnologies, the leader in next
generation sequencing (NGS) to profile T- and B-cell receptors of the adaptive
immune system, and its collaborators will present data demonstrating how
profiling a patient's T-cell repertoi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3e62d2fc-b4de-4bd6-afff-319a48f0f8d3.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Exact
Sciences Grants Inducement Restricted Stock Unit Awards to New Employees</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exact Sciences</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exact Sciences Corp. today announced that, in support of the
Company's continued growth plans, it issued restricted stock units covering a
total of 55,114 shares.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9cf0a616-f971-463b-b1b0-972a4201f739.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tracking
defects caused by brain tumor mutation yields insight to advance targeted
therapy St. Jude Children's Research Hospital scientists show that mutations in
the DDX3X gene lead to different molecular defects; findings will aid efforts
to develop more individualized therapy of medulloblastoma</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ --&nbsp;St. Jude Children's Research
Hospital scientists have gained ground toward developing more targeted
therapies for the most common childhood brain tumor. The findings appear today
in the Journal of Molecular Biology.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 1:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/41b76e7a-abb9-400e-b641-1c9387c450b8.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Strand
Life Sciences names Scott Storrer as Global President, introduces US management
team</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>US team focused on National Launch of StrandAdvantage ¨C
company¡¯s pan-cancer genomic profiling serviceStrand Life Sciences announced
the appointment of Scott Storrer to the position of Global President. In this
new role, Storrer, who joined Strand i...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 10:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f2ca9a73-b110-4563-a3b7-7bd685b21a39.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Current
Immunological and Molecular Tools for Leptospirosis</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Latest Vaccine News on BioPortfolio</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Learn more about the diagnostic tests and vaccines available for
leptospirosis and which biomarkers may predict severity of infection. Annals of
Clinical Microbiology and Antimicrobials</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 9:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/db671f0a-e2ca-4cdf-a46a-e06a185f42ac.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardiovascular
Systems Features Two-Year ORBIT II Coronary Data and Long-Term Economic Data in
Late-Breaking Presentation at SCAI 2015 Scientific Sessions</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cardiovascular Systems, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), featured
two-year data from its ORBIT II study of the company¡¯s Diamondback 360&reg;
Coronary Orbital Atherectomy System (OAS), the only U.S. Food and Drug
Administration (FDA) approved Atherectomy Tech...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e0e3b431-15be-4e70-9a16-6f067af6d004.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>VolitionRx
Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating
NuQ&reg; Assays in Most Prevalent Cancers Study expanded to evaluate VolitionRx's
proprietary Nucleosomics&reg; platform in 4,200 patient samples across 27 of the
most prevalent cancers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), a life
sciences company focused on developing blood-based diagnostic tests for a broad
range of cancer types and other conditions, today announced that it has
accelerated its large independent pros...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/424924c4-e7cb-4656-a864-cdcdbc350f04.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Antiplatelet
Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients New
Study Finds Ticagrelor Works More Quickly When Given at the Time of PCI</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7391152a-5ea6-4752-9be1-d9f387cbe20f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ad-hoc:
Epigenomics Reaches 99.5 % Adherence for Epi proColon&reg; in ADMIT Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Epigenomics AG Ad hoc Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Berlin - Epigenomics AG (Frankfurt Prime Standard: ECX; ISIN:
DE000A11QW50) announces results from the ADMIT trial (ADherence to Minimally
Invasive Testing - NCT02251782) for its non-invasive blood-ba...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 8:41:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dd387aa6-da18-4586-a885-9eb0486a941f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epigenomics
Reaches 99.5 % Adherence for Epi proColon&reg; in ADMIT Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Epigenomics AG Ad hoc Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Berlin - Epigenomics AG (Frankfurt Prime Standard: ECX; ISIN:
DE000A11QW50) announces results from the ADMIT trial (ADherence to Minimally
Invasive Testing - NCT02251782) for its non-invasive blood-ba...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 8:41:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9ebc3a26-4fd3-4cbe-925c-2d36cc92d5d9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Imprimis
Pharmaceuticals to Launch its New Hep-Lido-A and Lyophilized Tri-Mix Compounded
Formulations at the American Urological Association Annual Meeting in New
Orleans Introducing the Defeat IC&#8482; Education Campaign for Interstitial Cystitis
and the ED Free&#8482; Education Campaign for Erectile Dysfunction</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Imprimis Pharmaceuticals, Inc. (NASDAQ:
IMMY), a pharmaceutical company focused on the development and
commercialization of proprietary compounded drug formulations, today announced
its participation in and the launch of its Defeat IC...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/69ecdcf2-132a-4bec-a0f7-83f9812e7218.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Report:
Prescription Renewals Driving Visits to Retail Clinic</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Prescription renewals are a key reason for
visits to the small clinics located within drugstores or grocery stores,
according to Kalorama Information. &nbsp;Nearly a third of visitors to retail
health clinics have used the clinics for a re...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 7:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cd82067f-e0e8-48ed-871c-bacfd6c2c4df.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agenus
to Host Research and Development Day on May 14, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agenus Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agenus Inc. (NASDAQ: AGEN), today announced additional details
for the Company¡¯s upcoming analyst and institutional investor meeting to be
held on&nbsp;Thursday, May 14, 2015, from&nbsp;4:30 to 6:30 PM Eastern
Time&nbsp;in&nbsp;New York City. The event will&nbsp;provide&nbsp;an ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dbf1d362-54ab-4b8e-871f-dba0aa5d88be.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TGA
Approves AKYNZEO(R) (netupitant/palonosetron) for the Prevention of
Chemotherapy-Induced Nausea and Vomiting (CINV) -- First New Fixed Combination
Targeting Two Critical Pathways Involved in CINV</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Australian biopharmaceutical company Specialised
Therapeutics Australia (STA) and Helsinn, a Swiss group focused on building
quality cancer care, announce that the Therapeutic Goods Administration (TGA)
has approved AKYNZEO&reg; for the p...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 6:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/267c22bb-7534-47f0-af5e-1e9bcb2a4dd9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
impact of physical fitness and body mass index in children on the development
of acute mountain sickness: A prospective observational study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Pediatrics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Acute mountain sickness (AMS) is commonly found
among people traveling above 2500&nbsp;m. We investigated whether the
occurrence of AMS is related to differences in individual physical fitness and
BMI in subjects 11¨C13 years of age. Methods: ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b61d5b8c-87e2-4fd9-a800-1457cbc01bce.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Drug
Maker Sues FDA Over Free Speech Right to Promote Off-Label</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CorbisIn a move that may have broad ramifications for the
pharmaceutical industry, a small drug maker called Amarin has filed a lawsuit
against the FDA to argue that its right to distribute information about
unapproved uses of a medicine is protecte...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 6:33:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/af988560-dfaa-4cc4-a84f-1a21c206b6af.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Light
at the end of the tunnel for Colombia¡¯s home-ridden school kids</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="http://colombiareports.co"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>http://colombiareports.co</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Colombia¡¯s striking teachers&nbsp;came to a pre-agreement with
the government over salary increases on Wednesday morning, though striking
action will continue until at least Thursday, when classes are to resume
following a fortnight of disruption for 9 m...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 6:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/acbfe4f4-faf6-4a3f-b105-161e5beb4cc9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cepheid
to Webcast Upcoming Financial Presentations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Cepheid (NASDAQ: CPHD) today announced that
its executives will be speaking at the following conferences, and invited
investors to participate via webcast.Bank of America Merrill Lynch Health Care
Conference, Las Vegas, NVWednesday, M...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a14fa1dd-414d-4ccd-bd9e-4a003408b1d0.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celator&reg;
Pharmaceuticals Announces Business Update and First Quarter 2015 Financial
Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Celator Pharmaceuticals, Inc. (Nasdaq:
CPXX), a biopharmaceutical company that is transforming the science of
combination therapy and developing products to improve patient outcomes in
cancer, today reported business highlights and fi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a752f375-9c84-45b8-8a3e-72de23e4d7f4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Research
Now Launches Dermatology Panel for Online Market Research</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Research Now today announced the launch of
its Dermatology Panel, providing a resource for deeper insights into the
practices, treatments and sentiments related to dermatology. This is the
seventh market research panel based around th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/58b587d4-dfaf-4219-a953-06b4f339a8ad.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roka
Bioscience Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Roka Bioscience, Inc. (NASDAQ: ROKA), a
molecular diagnostics company focused on providing advanced testing solutions
for the detection of foodborne pathogens, today reported its financial results
for the three months ended March 31, ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dda24dd6-9607-4b34-93c0-598e89d8439c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Spectrum
Pharmaceuticals Reports Continued Advancement of Robust, Late-Stage Pipeline
and First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Spectrum Pharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Spectrum Pharmaceuticals Reports Continued Advancement of
Robust, Late-Stage Pipeline and First Quarter 2015 Financial Results</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/49143c8f-fe35-44be-b94c-9364d1292ff7.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Theranos
hires high-powered lawyer, former Clinton advisor (Video)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>San Francisco Business News - Local San Francisco News | The San
Francisco Business Times</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Growing lab test company Theranos Inc. hired former Hillary
Clinton policy advisor Heather King as its general counsel. King had been a
partner at Boies, Schiller &amp; Flexner LLP, the firm led by David Boies that
has represented Oracle Corp. (NYSE: OR...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 3:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b0138777-a9c2-4839-8fa7-940047097529.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Device
to Sand Away Severe Calcium in Coronary Arteries Shows Long-Term Positive
Results in a Difficult-to-Treat Patient Population ORBIT II Study Continues to
Demonstrate Positive Results After Two Years</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;After two years, patients treated with
orbital atherectomy, a device that sands away severely calcified plaque in the
coronary arteries prior to stenting, continued to show positive results,
according to new data from the ORBIT II tri...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a22a72da-55f1-4d60-bb34-3ce759263dbd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>El
Camino Hospital Performs First In-Human Use of RenovoCath&#8482; Catheter Catheter
Provides Targeted Delivery of Fluids to Peripheral Vascular System</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;RenovoRx,&nbsp;today, announced the first
in-human use of the RenovoCath&#8482; catheter. RenovoRx is a leading developer of
innovative solutions for targeted delivery of fluids, including therapeutic
agents, to selected sites in the vascular sy...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 1:57:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/33fc69d5-0d78-48a1-b9bf-b4f44592fc4e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kalorama:
Clinical Chemistry Market Reaches $7.9 Billion</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Kalorama Information says that the world market
for clinical chemistry reached $7.9 billion in 2014. Growth will be fair, driven
by new tests and contributing factors such as an aging population and the
growing number of people with m...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 1:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2a14c7e8-293e-4d31-87a9-bcf0dde54af9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>West
Nile virus spreads in Greece</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>West Nile virus appears to have gained a foothold in Greece,
spreading to new parts of the country since the first documented outbreak
occurred there in 2010, according to data presented at ECCMID 2015.Researchers
from the University of Athens repor...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 12:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1df96fbf-3972-4835-9422-26917192da7d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>N-of-One
Selected by Affymetrix to Provide High-Quality Copy Number Variation Analysis
Interpretation for OncoScan&reg; FFPE Assay Kit</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>N-of-One, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>N-of-One has signed a business partner agreement with
Affymetrix, a leading provider of DNA microarrays.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 11:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a2e22247-0e31-48a6-9744-a2615ef3ceff.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genomic
Health Awaiting Prostate Test Reimbursement; Shifting R&amp;D Toward Liquid
Biopsy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 11:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ba1b6661-5094-40a2-8dd4-669955bca1d0.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>First-of-its-kind
West Nile virus vaccine now in Phase I clinical trials A commercially available
human vaccine for West Nile virus does not yet exist</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;A novel investigational West Nile virus
vaccine discovered and developed by scientists at the Oregon National Primate
Research Center at Oregon Health &amp; Science University is being evaluated in
an NIH-sponsored Phase 1, first-in-human...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 11:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e2896ad3-2ecb-41e9-aa03-2fc97006f659.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmaceutical
Companies Support Cure Duchenne Cares to Provide Standard of Care for Duchenne
Muscular Dystrophy Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CureDuchenne</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Three pharmaceutical companies have partnered with CureDuchenne
to support CureDuchenne Cares, a physical therapy, education and outreach
program for the Duchenne muscular dystrophy community to help establish and
provide consistent standard of care...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e377d567-a1d1-4bbd-8b2c-4c977278095c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We¡¯re Catching up on Gilead, Akorn and Lots More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bart ZieglerHello, everyone, and welcome to yet another busy,
busy day. The sun is shining, the short people are gainfully occupied and the
official mascots are snoozing as we attack our ever-growing to-do list. This
sounds like a familiar routine, ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 9:33:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e2531fe1-9f32-491b-878c-f3ab35720aeb.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Medicare
Program; Public Meeting on July 16, 2015 Regarding New and Reconsidered
Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee
Schedule for Calendar Year 2016</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Federal Register: 'Health &amp; Public Welfare' Section</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>This notice announces a public meeting to receive comments and
recommendations (including accompanying data on which recommendations are
based) from the public on the appropriate basis for establishing payment
amounts for new or substantially revise...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 9:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/58f5dcfc-ef83-4d01-99d9-301741eea2d5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>INSIGHT-Safety
switches may redeem potent CAR T cancer therapies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CANCER-SWITCHES/ (INSIGHT, GRAPHIC, VIDEO,UPDATE
1:INSIGHT-Safety switches may redeem potent CAR T cancer therapies</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 9:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clinical Chemistry</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9b6ea19f-b7ab-4406-87ea-ad29b4d70868.html?CU=ocd3258&amp;PROFILE=n1uh&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AACC
Welcomes Lauren Kramer as Vice President of Education and Meetings</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>WASHINGTON, May 7, 2015 /PRNewswire-USNewswire/ -- AACC is
pleased to announce that Lauren Kramer was named vice president of education
and meetings, effective May 4. Prior to joining AACC, Kramer served as director
of meetings at the International ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 10:33:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c9d4157f-ad4a-45bd-881a-ca216b3be4db.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>VolitionRx
Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating
NuQ&reg; Assays in Most Prevalent Cancers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NAMUR, Belgium, May 8, 2015 /PRNewswire/ -- VolitionRx Limited
(NYSE MKT: VNRX), a life sciences company focused on developing blood-based
diagnostic tests for a broad range of cancer types and other conditions, today
announced that it has accelerat...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 8:39:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/acbd6cd9-ebca-4ccf-be4b-fcfbdfe07322.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior
Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares
Held by Cordlife</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HONG KONG, May 8, 2015 /PRNewswire/ -- China Cord Blood
Corporation (NYSE: CO) (&quot;CCBC&quot; or the &quot;Company&quot;), China's
leading provider of cord blood collection, laboratory testing, hematopoietic
stem cell processing and stem cell storage services, today...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 7:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8bccd52c-cc7c-4af6-956c-80b21744a283.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hospitals
Are Passing Out Poisoned Blood</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 6:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dabb9890-3eaa-4e82-b5f5-65028ebad066.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Delhi
Traffic Police personnel screened for lung function</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Very high percentage of shortness of breath, abnormal lung
function, allergy and high blood pressureIn view of World Asthma and Allergy
Awareness Month, BLK Super Speciality Hospital had organised a health check-up
camp for the highly vulnerable Del...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 5:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/90c99b09-e9a3-4517-b56c-341fd4b7a82f.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
app can aid tropical disease treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmafile - News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A new smartphone app is able to automatically detect parasites
in the blood and may mark a fundamental shift in handling tropical
diseases.Treating the parasitic diseases river blindness and elephantiasis with
the drug ivermectin (originally develop...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 3:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c2ca5e1d-4f68-42b6-a765-cb70d33d0939.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Factor
XIII B Subunit Accelerates Fibrin Cross-linking [Molecular Bases of Disease]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Covalent cross-linking of fibrin chains is required for stable
blood clot formation, which is catalyzed by coagulation factor XIII (FXIII), a
proenzyme of plasma transglutaminase consisting of catalytic A (FXIII-A) and
non-catalytic B subunits (FXII...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 1:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5163f49c-95f0-4bc3-b926-6962bbc32281.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Telomere
Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza
in Older Adults</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background.&nbsp;Telomeres provide a key mechanism for
protecting the integrity of chromosomes and their attrition after cell division
and during aging are evident in lymphocytes. However, the significance of
telomere shortening in age-associated decline...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 10:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8063a5ca-911a-4742-8b48-b4d0824fe443.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Drastic
drop in number of blood donors in Krishna</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The number of people donating blood has dropped significantly in
Krishna district, causing anxiety among patients.As against close to 300 people
who donate blood during blood donation camps...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 9:26:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ffed0276-13ab-4ea9-99e7-28536840c793.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>[Report]
A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium
falciparum invasion</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Efforts to identify host determinants for malaria have been
hindered by the absence of a nucleus in erythrocytes, which precludes genetic
manipulation in the cell in which the parasite replicates. We used cultured red
blood cells derived from hemato...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4c1b09ce-4878-4c1c-8e91-c2a6fdf2aede.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Reducing
tumor growth and angiogenesis using a triple therapy measured with
Contrast-enhanced ultrasound (CEUS)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Cancer</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: To evaluate the in vivo response by detecting the
anti-angiogenic and invasion-inhibiting effects of a triple-combination-therapy
in an experimental-small-animal-squamous-cell-carcinoma-model using the
¡°flash-replenishment¡± (FR) method t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/406296a0-351f-405e-86d1-d7a7f7888fb0.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>World
Thalassemia Day</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Nation News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Children suffering from the blood disorder thalassaemia receive
blood at a medical center, a day ahead of World Thalassemia Day in Hyderabad.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/20b62b67-ec87-473c-b36e-a66a3bee06a2.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Traffic
cops fail lung capacity test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Half of the Delhi Traffic personnel screened for lung capacity
function in the city were found to have shortness of breath, abnormal lung
function, allergy and high blood pressure. ¡°Many also had s...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:25:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8bdf703b-5e4c-48d0-9adb-f5a08cd714b1.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cop
jailed for biting man's testicles during fight</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>News | Local</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Cinco De mayo tussle was over a woman, and it landed Michael
Flaig in jail. &quot;Mr. Flaig had blood shot eyes, slurred words and a strong
odor of (alcohol) coming from his person,&quot; documents showed.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:32:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a20dc85c-2238-49c9-8e21-e90605aea8e7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>American
Academy of Ophthalmology Issues Statement Regarding New England Journal of
Medicine Study Linking Ebola and Uveitis Case study supports prior findings
that risk of viral infection from casual contact remains unlikely</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- The American Academy of Ophthalmology&nbsp;today
issued a statement following a report in the New England Journal of Medicine
about an Ebola patient with uveitis, a type of eye inflammation common in Ebola
survivors. The Academy is reitera...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:26:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7f888c12-ddcd-45b8-92e9-66061677d908.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Americans'
blood triglyceride levels dropping: CDC</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>(HealthDay)¡ªAmericans' levels of triglycerides¡ªa type of fat in
the blood¡ªhave dropped significantly in the past decade, according to a new
federal study.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 3:33:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3c74b59d-fc56-43c5-be11-e068232a936b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Combined
Blood Pressure and LDL Cholesterol-Lowering Medication Therapy Reduces Harmful
Coronary Plaque Both Standard and Aggressive Treatment Provide Similar Benefit
in Reducing Atherosclerosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Treating both low-density lipoprotein
(LDL), or &quot;bad,&quot; cholesterol with statins and blood pressure with
calcium channel antagonists reduces harmful coronary plaque, according to a new
study presented today as a late-breaking clinical ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9db139e1-d5a0-429f-82ee-da33b11b3212.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Blood Product Industry Report, 2015-2018</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NEW YORK, May 7, 2015 /PRNewswire/ -- Recombinant blood products
have developed for many years in foreign countries, but China's blood products
are still proteins extracted from human blood. Thus, reserves and control of
plasma resources are the key...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/396b8b5d-1b98-4623-8920-95864e16c05e.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Blood Product Industry Report 2015-2018</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharma News from PharmiWeb.com</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>China Blood Product Industry Report 2015-2018China Blood Product
Industry Report 2015-2018PR NewswireLONDON May 7 2015LONDON...ReportBuyer</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/de2fdc85-a92c-4317-a930-64d5aba405a5.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Northwestern
Medicine Neurologists Determine Best Treatment for Severe Stroke Cases The FDA
has only approved one treatment for ischemic strokes -tPA. When given it time,
tPA can unblock blood clots and aid recovery. But what about patients who don't
get tPA in time?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ --&nbsp;On average, one American dies
from a stroke every four minutes. Stroke is also the leading cause of adult
disability in the United States and is the fifth leading cause of death among
Americans. When a stroke occurs, rapid ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 11:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/53a4a408-5398-4a72-a028-9632ebae7e7c.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hammacher
Schlemmer Introduces The LED Foot Pain Reliever</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Continuing its 167-year history of offering
the Best, the Only and the Unexpected, Hammacher Schlemmer introduces The LED
Foot Pain Reliever, the only device for the feet that produces safe infrared
heat to stimulate blood circulation...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 10:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/291dd69d-ddf3-4ed1-a355-f0298bf69142.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dr.
Harold Agbahiwe Joins Virginia Cancer Specialists</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The US Oncology Network</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Virginia Cancer Specialists, Virginia¡¯s premier cancer care
center with 40 years of service to patients battling cancer and blood diseases,
has added a new radiation oncologist to the practice.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4dec54cc-bb48-43f2-8a6c-fd114206ead2.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Theranos
Hires Heather King as General Counsel</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Theranos, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Theranos, Inc., the ground-breaking consumer health care
technology company, announced today that Heather King has been hired as General
Counsel. King has been a partner at Boies, Schiller &amp; Flexner in their
Washington, D.C. office and has worked cl...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/87254817-fe73-4ea0-ad5a-93c23cf73ab1.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LabStyle
Innovations Launches Online Store for Dario Diabetes Management Solution eShop
is a platform for people with diabetes to directly purchase Dario &amp; get
support, knowledge and tools to manage their diabetes personally and thrive</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;LabStyle Innovations Corp. (OTCQB: DRIO),
developer of the Dario&#8482; Diabetes Management Solution, today reported it has
opened its first ecommerce store for the Dario Smart meter and Dario
accessories. The eShop serves the Israeli marke...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 9:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4f75ff47-1c5a-43f9-9e85-37788694f494.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TDK
Launches SDS1B Series of Serial ATA 6Gbps with High Reliability SSDs</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>JCN Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>TOKYO, May 8, 2015 - (JCN Newswire) - TDK Corporation announces
the new SDS1B series of 6 Gbps serial ATA compatible 2.5 inch solid state
drives for industrial applications, featuring the NAND flash memory controller
chip GBDriver GS1. The new produ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 5:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/833ec12b-c1e0-4e2d-918c-423a94c90de0.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Smarter,
cheaper technologies offer improved point-of-care medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Scientists have developed and combined new paper and flexible
polymer substrates with special sensing devices for rapid and accurate
detection of pathogens such as HIV, as well as other biotargets. These novel
technologies offer the type of robust, ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 6:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cc3ebc77-cc0c-4538-8511-b47c7aeeffe6.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Global
and United States Molecular Diagnostics in Infectious Disease Testing Market
2015-2020</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/93ba8b11-fab5-455d-9862-84fc2f291491.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Global
Molecular Diagnostics in Infectious Disease Testing Market 2015-2020</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 10:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/581faf2e-2d43-4a5b-a43e-a27ceca6cd22.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IDEXX
Launches Canine Influenza Test Targeting H3N2 in Response to Outbreak H3N2
Influenza Virus RealPCR&#8482; Test allows rapid, accurate and specific diagnosis
that may help slow the spread of disease; IDEXX adds new test to all
Comprehensive Canine Respiratory Disease RealPCR panels in the U.S. at no additional
charge</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today
announced that the company has developed, validated and made available a new
test for the detection of H3N2 canine influenza virus. An avian-origin H3N2
strain identified in Asia around 20...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f60ef468-7cee-481a-953f-d6167d4f685e.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>High-Value
Research of 2014 Presented for Hematology</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 9:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/911c4b35-ca1b-4c70-8c51-a438fb1eeeb0.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fluidigm
Reports Q1 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluidigm Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluidigm Corporation (NASDAQ:FLDM) today announced its financial
results for the first quarter ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d2dd465c-1f7d-4a48-a124-22628fe1a48c.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pressure
BioSciences Selected to Present at Cavendish Global Health Impact Forum Forum
uniquely brings together leading family offices and their foundations seeking
impact investment, grant-giving, and philanthropy opportunities within health
and life sciences</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Pressure BioSciences, Inc. (OTCQB: PBIO)
(&quot;PBI&quot; or the &quot;Company&quot;), a leader in the development and
sale of broadly enabling sample preparation solutions using pressure cycling
technology (&quot;PCT&quot;)-based instruments and consumables to th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 8:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4176822d-4adb-4bca-a690-a47de8025e50.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>GenomeDx's
Decipher Test and Tissue-based Genomics Platform to be Featured in Nine
Presentations at the American Urological Association Annual Meeting
Presentations to Include Data from Bladder Cancer Application of Decipher</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- GenomeDx Biosciences today announced that eight
abstracts featuring the Decipher&reg; Prostate Cancer Classifier, a genomic test
for prostate cancer, will be presented at the American Urological Association
Annual Meeting in New Orleans. ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e677b19c-8b15-4d83-90db-8aa31b02b8ea.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MicroRNA-7
Increases Glycolysis by Targeting RelA [Neurobiology]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Parkinson disease is associated with decreased activity of the
mitochondrial electron transport chain. This defect can be recapitulated in
vitro by challenging dopaminergic cells with 1-methyl-4-phenylpyridinium
(MPP+), a neurotoxin that inhibits co...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 1:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/208c2154-01e5-47c4-98bc-887f8e0ddefb.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genetic
architecture of variation in heading date among Asian rice accessions</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Plant Biology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Heading date, a crucial factor determining regional
and seasonal adaptation in rice (Oryza sativa L.), has been a major selection
target in breeding programs. Although considerable progress has been made in
our understanding of the molec...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 8, 2015 12:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/54ddfc8c-f64a-4301-9a43-99f87ae15ad1.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fluidigm
Appoints Steve McPhail General Manager of Production Genomics Business</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluidigm Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluidigm Corporation (NASDAQ:FLDM) has recruited industry
veteran Steven C. McPhail to lead its new organization specifically focused on serving
its production genomics customers.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/87aabca2-cbb9-448a-85ca-7e7ede463b73.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics Might Just Have The Next Hot Biotech Device</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>All Articles on Seeking Alpha</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 11:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0aacbe5c-f6e4-416e-883f-681a30ed2791.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Monsanto
Insect Management Knowledge Program Announces Grants</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Monsanto Company</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Monsanto Company has announced that six recipients will be
awarded research grants as part of the Insect Management Knowledge Program
(IMKP). The program, which started in early 2013 as the Corn Rootworm Knowledge
Program, provides merit-based award...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/21c17ab6-9fca-4506-8a1a-8bae8bb844f5.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Longitudinal
associations of nutritional factors with glycated hemoglobin in youth with type
1 diabetes: the SEARCH Nutrition Ancillary Study [Nutritional epidemiology and
public health]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Improved glycated hemoglobin (Hb A1c) delays the
progression of microvascular and macrovascular complications in individuals
with type 1 diabetes (T1D). We previously showed that higher baseline intakes
of n¨C3 (-3) fatty acids and leucin...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 12:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/aab5c260-32d1-464b-9ded-842fd7eed432.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fashion
Icon, Chef and Actor Join Together to Share Personal Stories of Managing
Life-Threatening Allergies in New Campaign EpiPen&reg; On Location&#8482; Ambassadors
Share Videos to Help Raise Awareness of How to Be Prepared if a
Life-Threatening Allergic Reaction Happens</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Mylan N.V. (Nasdaq: MYL), a leading global
pharmaceutical company, today announced the launch of EpiPen&reg; On Location&#8482;.
This campaign is a national call-to-action to help those living with
potentially life-threatening (severe) allergie...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 6:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6fb1981f-c4a2-4d3e-baca-3d6a90255cae.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dihdyroceramides:
From Bit Players to Lead Actors [Molecular Bases of Disease]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Sphingolipid synthesis involves a highly conserved biosynthetic
pathway that produces ceramides, the fundamental precursors of complex
sphingolipids. The final reaction involves the insertion of a double bond into
dihydroceramides to generate the mo...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 12:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ef87eb0d-9508-4c3f-b142-008d38d43b2c.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Portable
Device to Measure Troponin Levels and Help Diagnose Infarcts</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medgadget</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>One way of diagnosing a heart attack involves detecting
increased levels of the protein troponin in a patient¡¯s blood. The equipment
necessary to do that tends to be bulky and expensive, preventing its use in
poor and remote locations. Korean resear...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 1:33:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1cd3027c-9031-4034-a49c-f0714e603b1b.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Apollo
Hospitals Harvest 23 Different Organs from Five Brain Dead Donors in a Day;
Perhaps a First Ever</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire IndiaIn a unique coincidence and perhaps for the
first time ever,&nbsp; five grieving families agreed to donate the organs of
their beloved brain dead relatives resulting in a remarkable act of humanity in
the toughest situation setting a r...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d213bb2f-265d-4ab2-8477-769bb8dc0ac4.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amway
Develops Exclusive Skincare Technology for Men Artistry&reg; Men skincare
collection targets specialized skincare needs for the modern male: oil control
and hydration</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ADA, Mich., May 6, 2015 /PRNewswire/ --&nbsp;Men and women are
biologically different ¨C and so are their skincare needs. This premise fueled
the development of the Artistry&reg; brand's latest scientifically advanced
skincare collection, Artistry&reg; Men. </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d840c163-6259-4184-ba79-a43d3ee9dd00.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Philips
ActiveSite Takes to Cloud for First-Ever Connected Lighting Platform That
Manages Dynamic LED Lighting on Skyscrapers, Bridges, &amp; Monuments</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Royal Philips</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Royal Philips (NYSE: PHG, AEX: PHIA), the global leader in
lighting, today announced the commercial availability of Philips ActiveSite, a
cloud-based connected lighting management platform that allows Philips Color
Kinetics architectural LED lightin...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/86cbf4fb-c547-48c3-8f2c-2508fa1d7ae5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Breakthroughs
in Immunotherapy Hold Promise for Mesothelioma Patients Said Researchers at the
5th International Symposium on Lung-Sparing Therapies for Malignant Pleural
Mesothelioma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;The 5th International Symposium on
Lung-Sparing Therapies for Malignant Pleural Mesothelioma was held on Saturday,
May 2, in Santa Monica, CA and focused on research aimed at preserving lung
function in mesothelioma patients. Physicia...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:45:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5606d3fe-4356-4658-b80f-43a5f311ac26.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>US
Hemp Wholesale is Now Selling Wholesale CBD Oil on their Website
USHempWholesale.com is the Leading Wholesale Hemp Provider, Specializing in
High Quality Hemp Nutritional and Dietary Products</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- The founders of USHempWholesale.com are pleased
to announce that they are now selling wholesale CBD oil on their website. As a
company spokesperson for US Hemp Wholesale explained, cannabidiol, or CBD for
short, is a chemical compound...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b306e4dc-ba9f-41eb-98ad-7482fcbec01b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bonnie
J. Addario Lung Cancer Foundation Launches First Ever Spanish Language
Resources to Help Patients Navigate Care, Diagnosis and Treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bonnie J. Addario Lung Cancer Foundation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bonnie J. Addario Lung Cancer Foundation Launches First Ever
Spanish Language Resources to Help Patients Navigate Care, Diagnosis and
Treatment</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4c55e10b-02e2-4952-a402-19054fb5d472.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genomic
Expression secures funding from Seattle Women¡¯s Impact Fund</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genomic Expression, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genomic Expression, Inc., a leader in the development of
innovative sequencing technology for personalized medicine, today announced the
successful closing of financing from the Seattle Women¡¯s Impact Fund and the
appointment of its co-founder, Kim ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b18feb42-cd33-47c3-9366-ed60abd3a310.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Applied
Proteomics Appoints Erwin Estigarribia as Vice President, Commercial Operations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Applied Proteomics Inc., the leading developer
of protein-based molecular diagnostics, announced today the appointment of
Erwin Estigarribia as Vice President, Commercial Operations. Mr. Estigarribia
has more than 15 years of progress...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a42c1def-8dd9-4d5d-90af-e39700ea4032.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aerie
Pharmaceuticals Elects Richard Croarkin to the Company¡¯s Board of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Aerie Pharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage
pharmaceutical company focused on the discovery, development and
commercialization of first-in-class therapies for the treatment of patients
with glaucoma and other diseases of the eye, ann...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1118f240-8b5c-46cb-9907-0cc806d2e157.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genomic
Health to Present Multiple Oncotype DX&reg; Studies and Positive Liquid Biopsy
Results at American Urological Association Annual Meeting May 15-19 New Results
Demonstrate Unique Clinical and Health-economic Value of the Oncotype DX
Prostate Cancer Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today
announced that results from five studies will be presented at the American
Urological Association Annual Meeting, which will take place May 15-19 at the
New Orleans Ernest N. Morial Convention...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cac636e0-14bb-48c9-8764-8ec5968c47c0.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Veracyte
to Host Conference Call and Webcast to Discuss First Quarter 2015 Financial
Results on Thursday, May 14, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Veracyte, Inc.&nbsp;(NASDAQ: VCYT), a
molecular diagnostic company pioneering the field of molecular cytology,
announced today that its first quarter 2015 financial results will be released
after close of market on Thursday, May 14, 2015. ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 7:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/80e4de1a-59c3-4dfd-b0bb-f30ea59016e5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Concordia
Healthcare Corp. works to expand treatment options for patients with rare
cancers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -&nbsp;Concordia Healthcare Corp.
(&quot;Concordia&quot; or the &quot;Company&quot;) (TSX: CXR) (OTCQX: CHEHF), a
diverse healthcare company focused on legacy pharmaceutical products, orphan
drugs, and medical devices for the diabetic population, today provided ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0cd4dcfa-243e-48bb-b3be-1dd0135ca065.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>RPT
- INSIGHT-Safety switches may redeem potent CAR T cancer therapies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CANCER-SWITCHES/ (INSIGHT, GRAPHIC, VIDEO):RPT - INSIGHT-Safety
switches may redeem potent CAR T cancer therapies</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dd0a15ac-9aa7-4a73-a007-36b071751e07.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BD
Announces Results For 2015 Second Fiscal Quarter - Announces revenues of $2.051
billion, an increase of 4.9 percent on a currency-neutral basis. Revenues
decreased 1.0 percent, which reflects the unfavorable impact of foreign
currency translation.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;BD (Becton, Dickinson and Company) (NYSE:
BDX), a leading global medical technology company, today reported quarterly
revenues of $2.051 billion for the second fiscal quarter ended March 31, 2015,
representing a decrease of 1.0 percen...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 6:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6e2328c7-3965-4149-a4e9-4e1993209492.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Eurofins
signs agreement to acquire Experchem Laboratories, Inc. in Canada</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDA and Over The Counter News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡­ US2, reports indicate that the FDA is increasingly likely to
strengthen ¡­ control (QC) testing services for over the counter (OTC) drugs,
providing a ¡­ pre-market approval process (</span><span lang=EN-US><a
href="http://www.fda.gov/Food/DietarySupplements/"><span style='font-size:10.0pt;
font-family:"Verdana","sans-serif"'>http://www.fda.gov/Food/DietarySupplements/</span></a></span><span
lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>) whilst NHPs ¡­</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 4:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/73bf0b90-9a4d-4cf6-beb7-21f4ae68c8be.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Quest
Diagnostics announces LeukoVantage, advancing precision medicine for
haematologic malignancies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PharmaBiz.com</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>World's leading provider of diagnostic information services,
Quest Diagnostics announced LeukoVantage, an evidence©¤based genomic test
service that aids in the diagnosis, prognosis, monitoring and selection of</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 1:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1a6b006f-7823-4a22-b104-a88fed028273.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IPO
roundup: Adaptimmune, CoLucid, OpGen, HTG</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Daily Extra</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cancer immunotherapy company Adaptimmune Therapeutics plc
(NASDAQ:ADAP), migraine treatment developer CoLucid Pharmaceuticals Inc.
(NASDAQ:CLCD), diagnostics company OpGen Inc. (NASDAQ:OPGN), and HTG Molecular
Diagnostics Inc. (NASDAQ:HTMG) all lost...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 11:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/31609055-f6a4-4b15-9652-c9b5db5b91d3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BreathID
May Offer Biopsy-free Screening for Non-alcoholic Steatohepatitis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medgadget</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exalenz Bioscience (Modiin, Israel) just announced that its
BreathID test system is starting a trial to gauge whether it can be used to
diagnose non-alcoholic steatohepatitis (NASH). The disease causes the buildup
of fat in the liver, as well as inf...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 4:33:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/79892bc9-2ecd-4cd0-b41d-8b4ce98ace38.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PDL
BioPharma Announces First Quarter 2015 Financial Results -Net Income Increased
16 percent-</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>, and may be accessed by dialing (855) 859-2056 from the United
States and Canada or (404) 537-3406 internationally. The replay passcode is
38498993.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ff73f6f2-c4b5-44ae-9d77-8bb48dfac72f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clovis
Oncology Announces First Quarter 2015 Operating Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Clovis Oncology, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Clovis Oncology Announces Q1 2015 Operating Results</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ecdceb37-9a0d-4b7d-8d59-d5cabfac19f2.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Laboratory Study Shows that NovaBay Pharmaceuticals¡¯ Avenova Completely
Inactivates the Bacterial Enzyme that Contributes to Blepharitis and Meibomian
Gland Dysfunction</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Phoenix Eye Care and NovaBay&reg; Pharmaceuticals, Inc. (NYSE MKT:
NBY) announced that Dr. Arthur B. Epstein, Director of Clinical Research and
head of the Dry Eye - Ocular Surface Disease Center at Phoenix Eye Care,
discussed the benefits of NovaBay¡¯s ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 3:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0af4233b-09a9-4086-8bf3-fa8a6345dede.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NovaBay
Pharmaceuticals¡¯ Avenova Brings Significant Improvement to Patients With
Blepharitis, New Study Finds</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NovaBay Pharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Family Eye Care Optometry and NovaBay&reg; Pharmaceuticals, Inc.
(NYSE MKT: NBY) announced that Guru Sharma O.D. Ph.D., Optometrist at Family
Eye Care Optometry and Assistant Professor at Western University of the Health
Sciences¡¯ College of Optometry, ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 3:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e07ecc62-551a-4935-86a6-1bd784d578c4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biomecite
Diagnostics Options Molecular IBD Test Tech from UM Baltimore</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 3:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ef9b5312-163c-4d25-8127-4cac90cee449.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clinical
Analysis Looks at Pyrroluria Test for Mental Disorders and Metabolic Imbalances</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- Pyrroluria (Mauve Factor,
Kryptopyrrole) has been studied for well over 40 years[1-6]. Pioneers in
Orthomolecular Medicine[7] such as Abram Hoffer, Carl Pfeiffer, Hugh Riordan,
Donald Irvine, Arthur Sohler, Humphry Osmond, ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 3:21:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b9ec7e71-e996-4a1f-b192-5c43317e6228.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IDSA
Ignores IOM Recommendations in Lyme Disease Treatment Guidelines' Development,
According to the Lyme Disease Association &amp; LymeDisease.org</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- It's been forty years since Lyme
disease was first recognized in the US&#8722; when researchers studied an unusually
large number of children diagnosed with juvenile rheumatoid arthritis around
Lyme, CT. Their investigation was i...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 1:41:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6548eeb1-7424-4248-859e-79966ac3e8e8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>23andMe,
Pfizer recruiting patients for joint genetic study of lupus patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceMedicalDevices News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Controversial genetic testing company 23andMe is finding new ways
to stay relevant after the FDA yanked its popular--and once
lucrative--direct-to-consumer diagnostic from the market in 2013.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 12:32:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c105f7fd-f1bf-4930-ba86-2e353c2be9c4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Wisconsin
Roundup: Uber Bill, Angel Deals, Exact Sciences, &amp; More</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Jeff Engel Here are some of the latest headlines from
Wisconsin¡¯s tech and innovation community:¡ªGov. Scott Walker signed a bill late
Friday night that enacts statewide regulation of ridesharing services like Uber
and Lyft. The bill had bipartisan s...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 11:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dc071570-cb11-4cb4-a09b-6907b9606910.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Makes Progress in Inspecting Generic Drug Facilities, But¡­.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Under pressure to validate the safety of the pharmaceutical
supply chain, the FDA in recent years has inspected more facilities belonging
to generic drug makers, a new government report finds. But at the same time,
the agency fell short in other are...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 10:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cdf5fcd3-13e1-4cb9-9e17-1a10f8898d3d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CEFALY
to Present Breakthrough Data in Migraine Treatment at International Headache
Society Congress Best known in the U.S. for its unique FDA-approved device to
prevent migraines, next week Cefaly leaders are set to present new patent
pending neuromodulation systems and reveal results from a clinical PET scan
trial</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;CEFALY Technology, the creators of the first
FDA-approved transcutaneous electrical nerve stimulation device specifically
authorized for use prior to the onset of migraine pain, is set to announce
significant breakthroughs in migraine...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 10:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/16e38e66-8ff8-43ec-adf7-4c4fc02d7b6b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Extension
Healthcare Celebrates Nurses and Its Clinical Solutions Team During ANA¡¯s
National Nurses Week</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Extension Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Extension Healthcare, an alarm middleware and patient safety
company, today announced its participation in National Nurses Week.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0710dccd-14ea-4210-9817-c4256a312042.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NanoPass
Technologies Grants an Exclusive License to Circassia Pharmaceuticals, for use
of its MicronJet600&#8482; Device in Allergy Testing in the US</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clinical Chemistry</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7ff8288d-ce95-41c2-9b5e-306719852420.html?CU=ocd3258&amp;PROFILE=n1uh&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Arrowhead
Presents Data on Potential RNAi Candidate Targeting Factor 12 Mediated
Angioedemic and Thromboembolic Diseases</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Arrowhead Research Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Arrowhead Research presented preclinical data at the 2015 TIDES
conference on an RNAi therapeutic for factor 12 (F12) mediated angioedemic and
thromboembolic diseases.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 3:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c8f71dc5-4a27-4ae1-96fa-fdc84ad067de.html?CU=ocd3258&amp;PROFILE=n1uh&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AACC
Urges CMS to Delay Enforcing Regulations That Could Limit Diabetes Patients'
Access to Medical Testing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>WASHINGTON, May 6, 2015 /PRNewswire-USNewswire/ -- Today AACC
sent formal comments to the Centers for Medicare and Medicaid Services (CMS)
addressing CMS' proposal to enforce more stringent regulatory requirements for
testing with blood glucose moni...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 11:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0ff89dc4-0e67-4197-9df4-bf9d637fe103.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Selenide
protects heart muscle in the wake of cardiac arrest ¨C Science Daily</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Leaders in Pharmaceutical Business Intelligence</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Damage to heart muscle from insufficient blood supply during
cardiac arrest and reperfusion injury after blood flow is restored can be
reduced by nearly 90 percent if selenide, a form of the essential nutrient
selenium, is administered¡­ Source: www....</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cca49424-c115-4a45-bace-177bb92faf6b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>&quot;2015
Billboard Music Awards&quot; Will Open With The World Premiere Of Taylor
Swift's Epic New Music Video &quot;Bad Blood&quot; The &quot;2015 Billboard
Music Awards&quot; will be Hosted by Ludacris and Chrissy Teigen and Broadcast
LIVE on ABC Sunday, May 17 at 8:00 PM ET From The MGM Grand Garden Arena</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Billboard and dick clark productions
announced today that Taylor Swift, a seven-time Grammy winner, will open the
&quot;2015 Billboard Music Awards&quot; with the world premiere of the
most-highly anticipated new music video for &quot;Bad Blood.&quot; Th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/847af30b-d36f-45e1-96ee-7f21b19a49ff.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Guardant
Health Appoints Mort Minaee, Former Roche Senior Director, as VP of Regulatory
Affairs Role created to expand company's continued commitment to quality and
clinical impact of cell-free tumor DNA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Guardant Health&reg;, the leader in biopsy-free
tumor genomic testing, today announced the hire of Mort Minaee as Vice
President of Regulatory Affairs. Minaee brings to Guardant more than 25 years
of experience in regulatory, clinical aff...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/457ba64f-277b-4bd0-9d75-f437dce2e79d.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hualan
Biological Engineering Inc. 002007 Pharmaceuticals &amp; Healthcare Deals and
Alliances Profile</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Latest Vaccine News on BioPortfolio</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SummaryHualan Biological Engineering Inc. Hualan Biological is a
biopharmaceutical company. The company research develops produces and
commercializes human blood products viral vaccines bacterial vaccines and
recombinant biologics. Its blood prod...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 5:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/824fe12a-b262-485f-93cb-dd70a4744195.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Neurovive
Pharmaceutical: Published Data Indicates Protective Effect of Cyclosporine in
Patients with Stroke</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Neurovive Pharmaceutical</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Regulatory News:</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/04a86843-e730-4570-b3aa-6fdb71f1aa56.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kiadis
Pharma Appoints Dr. Vincent Brichard to its Supervisory Board</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a1858fa1-83b7-4b6e-a3fb-fa6b90e67bf8.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Higher
usual alcohol consumption was associated with a lower 41-y mortality risk from
coronary artery disease in men independent of genetic and common environmental
factors: the prospective NHLBI Twin Study [Cardiovascular disease risk]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Evidence that alcohol consumption is inversely
associated with long-term coronary artery disease (CAD) mortality independent
of genetic and early life environmental factors is lacking.Objective: We
evaluated whether alcohol consumption w...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 12:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7bb08d15-79cd-408e-87e4-2ef9a455427b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Impact
of exogenous galectin-9 on human T cells: contribution of the T cell receptor
complex to antigen-independent activation but not to apoptosis induction
[Glycobiology and Extracellular Matrices]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Galectin-9 (gal-9) is a multifunctional ¦Â-galactoside-binding
lectin, frequently released in the extra-cellular medium, where it acts as a
pleiotropic immune modulator. Despite its overall immunosuppressive effects, a
recent study has reported a bim...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 12:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/98692151-3e1e-4599-a6d2-7a221d99f910.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Alpha and Omega of Galactosylceramides in T Cell Immune Function [Immunology]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Glycosphingolipids (GSLs) are a subgroup of glycolipids that
contain an amino alcohol sphingoid base linked to sugars. They are found in the
membranes of cells ranging from bacteria to vertebrates. This group of lipids
is known to stimulate the immu...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 12:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d65f0b03-1ced-45c6-9bcb-40622bca1e98.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hypertension
prevalence, awareness, treatment, and control, in male South Asians immigrants
in the United Arab Emirates: a cross-sectional study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Cardiovascular Disorders</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: South Asian males constitute the largest proportion
of the United Arab Emirates (UAE) population. Minimal data is available on the
prevalence of hypertension among South Asian immigrants in the UAE. We
determined the prevalence, associat...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ad0a9719-b5e1-4b87-8f52-3ecefaca205b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Medical
college students donate blood</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hindu - Home</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A total of 185 students of Government Mohan Kumaramangalam
Medical College in the city donated blood at a day long special blood donation
camp held at the medical college hospital on Wednesday....</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 8:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bac1c8e8-14a9-476d-a0be-3afba7df275a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Omega-3s
may boost performance for cyclists: Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NutraIngredients-USA RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Supplements containing omega-3s may increase concentrations of
NO and boost blood flow, thereby enhancing exercise performance in cyclists,
says a new study from Poland.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 6:45:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/12e10848-a58e-4202-8082-f59a04afcdb7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Petmate
Celebrates National Pet Month with Tips and Tools for Happy Pet Families</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Petmate is passionate about providing fun
trusted quality products to enhance the lives of pets and their families. To
celebrate National Pet Month this May, Petmate offers tips and tools to help
pet families enjoy all the benefits an...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 5:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6c1eab39-531c-4756-97cb-dd365f755666.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abaxis,
Inc. to Present at the Bank of America Merrill Lynch 2015 Health Care Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Abaxis Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UNION CITY, Calif., May 5, 2015 /PRNewswire/ --&Acirc; Abaxis, Inc.
(NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood
analysis systems, announced today that Clint Severson, ch...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 4:41:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/84909fce-4491-4b03-9c87-76de342ba34d.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nephros
Licenses HydraGuard Military Filter to CamelBak&reg;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Nephros, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device
company that develops and sells high performance liquid purification
ultrafilters and an on-line mid-dilution hemodiafiltration system for use with
a hemodialysis machine for the treatmen...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 4:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8b109a16-18ee-4def-8f6c-600601ec0a8f.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Multiple Myeloma Research Foundation Raised $800,000 for Cancer Research at the
13th Annual Laugh for Life Event in New York City</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Multiple Myeloma Research Foundation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>On May 5, 2015, nearly 700 tri-state area patients, patient
families, friends, doctors, businesses and supporters attended the 13th Annual
Multiple Myeloma Research Foundation (MMRF) Laugh for Life: New York and raised
$800,000 to benefit transforma...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 1:50:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/694e57fd-ed96-40ec-b20e-7c9c9639e35d.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ALERT:
The Rosen Law Firm Reminds Accelerate Diagnostics, Inc. Investors of the
Important May 18, 2015 Deadline In the Class Action Filed by the Firm</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Rosen Law Firm, P.A.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Rosen Law Firm Representing Accelerate Diagnostics, Inc.
Shareholders in Securities Fraud Class Action Seeking to Recover Investment
Losses - AXDX</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 1:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/00fe09bb-d4f1-4270-9bbd-dffcb27a6e59.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Omron
unveils smartphone-connected blood pressure monitor, weight scale</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>mobihealthnews</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Japanese medical device company Omron Healthcare has
unveiled&nbsp;two new smartphone-connected devices, a&nbsp;blood pressure
monitor and a weight scale. These offerings are designed to be used as part of
a telemedicine program ¡ª the products are listed&nbsp;on&nbsp;O...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 1:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0177a6a2-f216-4988-b620-e1f1133060d4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Oncologist to Join Hematology Oncology Consultants, Inc.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 1:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5922671d-1c2b-458f-b0e4-660b53a2eba9.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
Shows Pycnogenol&reg; Can Help Improve Endothelial Function In Cases Of Borderline
Hyperglycemia, Hypertension Or Hyperlipidemia Daily use of standardized pine
bark extract found to strengthen metabolic parameters, reduce LDL cholesterol
and curb oxidative stress</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;New research reports further natural
solutions for those at heightened risk of coronary artery disease (CAD) ¨C the
number one killer in America. A study published in the Journal of International
Angiology found that daily supplementat...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 11:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6a30b021-c605-4260-90c0-bd1fa0e707dd.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bay
Area's Theranos Sticks It to Critics Wins Plans to Expand Lab Services</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>DeviceSpace.com Breaking News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Theranos Inc. wants more than the finger; it's going for the
whole range of blood tests.The upstart Palo Alto company has added a full-blown
reference lab, founder and CEO Elizabeth Holmes said, meaning it now can offer
more-specialized tests, such ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:29:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2630bdef-643b-4dc8-a3ce-7b3a9e3885fb.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vitals
SmartShopper Pays People to Use Lower-Cost, Similar Quality Medical Care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Vitals</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Can people get paid to go to the doctor? Vitals is doing just
that - and generating significant savings for consumers and health plans in the
process.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/43d4c844-cdbb-48d4-a147-2a6135f87667.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Drug
Trial Results for Remedy Pharmaceuticals' CIRARA Could Change Stroke Treatment
Forever, Saving and Improving Millions of Lives</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Remedy Pharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Remedy Pharmaceuticals, Inc. today announced that the GAMES-RP
study of the drug CIRARA&#8482; (RP-1127) in severe stroke has successfully ended
enrollment with 83 patients. Results from the study are expected in September
2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f3c0b46c-c178-409e-a65c-96db8be51e76.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Biologic Reports Financial Results for the First Quarter of 2015 1Q15 Total
Sales Increases 25% to $70.4 Million</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO,
&quot;China Biologic&quot; or the &quot;Company&quot;), a leading fully
integrated plasma-based biopharmaceutical company in China, today announced its
unaudited financial results for the first quarter of 2015...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 5:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/087b46e9-6347-48c4-ad66-9de39a51a9f3.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Austin
Mayor Douglas Campbell Welcomes AHF and New HIV Treatment Clinic &amp;
Prevention Efforts</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AIDS Healthcare Foundation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Austin Mayor Douglas Campbell Welcomes AHF and New HIV Treatment
Clinic &amp; Prevention Efforts; Mayor Campbell requested assistance on the
recent HIV outbreak, and AHF steps up to assist</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 1:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6ca61f4d-4534-41ab-8e5f-0205f51cadd8.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Long-Term,
7-Year Study of Nulojix&reg; (belatacept) Regimen Demonstrates Statistically
Significant Relative Risk Reduction of Death or Graft Loss over Cyclosporine
Regimen in Kidney Transplant</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bristol-Myers Squibb</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Long-Term, 7-Year Study of NULOJIX&reg; (belatacept) Regimen
Demonstrates Statistically Significant Relative Risk Reduction of Death or
Graft Loss over Cyclosporine Regimen in Kidney Transplant</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/626e4700-508c-4d0a-8edb-30634e1fb2ac.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Proposed
Data Collection Submitted for Public Comment and Recommendations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Federal Register: 'Health &amp; Public Welfare' Section</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Centers for Disease Control and Prevention (CDC), as part of
its continuing efforts to reduce public burden and maximize the utility of
government information, invites the general public and other Federal agencies
to take this opportunity to com...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 9:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/123615bf-19d5-4e08-b3c9-c2985c54c7d8.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Applied
Proteomics Appoints Erwin Estigarribia as Vice President Commercial Operations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Latest Vaccine News on BioPortfolio</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SAN DIEGO May 7 2015 PRNewswire Applied Proteomics Inc. the
leading developer of proteinbased molecular diagnostics announced today the
appointment of Erwin Estigarribia as Vice President Commercial Operations. Mr.
Estigarribia has more than 15 year...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 7, 2015 8:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6f715355-dc68-4538-8eab-877fe368477d.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tucson's
HTG Molecular goes public</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 6:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e7243d61-46ca-4739-97ae-12b3a00a1f3e.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Renowned
Molecular Biologist Dies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Scientist RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Alexander Rich, discoverer of Z-DNA, RNA-DNA double helix, and
the structure of collagen, has passed away at age 90.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 5:26:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a162a579-d358-42bb-8117-e27f1e05d941.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bruker
Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bruker Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bruker Corporation (NASDAQ: BRKR) today reported financial
results for its first quarter ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5fd09a28-bb29-4353-8248-b37b126b491c.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics prices IPO at $14 midpoint and begins trading Wednesday</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 2:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/822e9f5c-6f33-4a57-8d3a-75223caad7a9.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Paradigm
CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference Emphasis
on the importance of pristine biorepositories to the translational success of
personalized medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- Paradigm today announced that Dr.
Robert Penny, CEO will give the keynote address at the International Society
for Biological and Environmental Repositories (ISBER) 2015 Annual Meeting in
Phoenix, AZ at 9:45 AM MST.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 1:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/74b89121-7edb-481c-9319-3ba8c481f441.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Texas
Health Dallas Honored for Excellence in the Care and Treatment of Lung Cancer
Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bonnie J. Addario Lung Cancer Foundation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bonnie J. Addario Lung Cancer Foundation Awards Texas Health
Dallas with Designation as a Community Hospital Center of Excellence</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3ec75c66-f01b-4526-ad7b-22af1d9e8e1f.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics Announces Pricing of Initial Public Offering</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 10:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8dc27d09-c1fd-4458-820f-d4e3b6651308.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics (HTGM) Prices 3.57M Common IPO at $14/Share</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 10:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6b9b99c0-e4b6-4eb6-9c6f-c09b843aa4bb.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ERBA
Diagnostics, Inc. Appoints Ernesina Scala as Chief Financial Officer and
Chandra Krishnan ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 6, 2015 10:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b5f897f3-fe93-41c1-b978-8eef40645784.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Boehringer
Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society
International Conference - Presentations include new data and analyses from
Phase III trials across the respiratory portfolio, including chronic
obstructive pulmonary disease (COPD), asthma and idiopathic pulmonary fibrosis
(IPF)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Boehringer Ingelheim Pharmaceuticals, Inc.
announced today that 29 abstracts from the company's respiratory portfolio will
be presented at the 2015 American Thoracic Society (ATS) International
Conference taking place May 15-20 in Den...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7083b80b-9e87-4d51-a0be-d9845c1bcadf.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Technavio
Publishes Global Osteoporosis Drugs Market Analysis 2015-2019</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Technavio Research</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Technavio has published a new industry analysis report on the
global osteoporosis drugs market, which is expected to grow at a CAGR of more
than 4% from 2015-2019.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 11:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/acadf984-2566-4e1c-a180-385de46a2b15.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Registration
is Open for the 2015 SDMS Annual Conference Join us October 1 - 4 in Dallas,
Texas</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¨C 4 in Dallas, Texas.The premier conference for the diagnostic
medical sonography community, the 2015 SDMS Annual Conference and
Pre-Conference Sessions, offer you the opportunity to:</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:54:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9049984b-e2ee-4574-9d14-7bb774d6b190.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Essential
Medical Inc. Announces Successful Additional Clinical Studies For MANTA&#8482; Large
Bore Vascular Closure Device</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Essential Medical, Inc., a privately held
medical device company, announced today that it has successfully completed
additional clinical studies using its MANTA 14F Large Bore Vascular Closure
device, a revolutionary vascular closure ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fbe0db48-99b3-45c6-b1c6-fabb0eb030f2.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Owner
Of Durable Medical Supply Company Sentenced to 6 &frac12; Years In Prison</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Policy and Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Last week, the owner of a durable medical equipment (DME) supply
company was sentenced to 6 &frac12; years in prison for her role in submitting more
than $7 million in fraudulent claims to Medicare. &nbsp;Adeline Ekwebelem¡¯s Los
Angeles-based DME company, Adelc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:39:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/01ecffa1-dbca-42b7-a100-3f975f7ea75d.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ambucor
Customers¡¯ 85 Percent Pacemaker and ICD Remote Compliance Rate Leads the
Industry</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The ScottCare Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ambucor customers lead the industry with an 85% remote
compliance rate for pacemakers and ICDs. Ambucor is the cardiac device
monitoring services division of ScottCare Cardiovascular Solutions.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:59:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5a0a6c45-2960-405c-8e32-6d28f63c68b9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Merrimack
Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of
MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer Trial
is enrolling prospectively selected patients with high serum levels of free
IGF-1, a tumor-binding protein that drives tumor growth and resistance</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Merrimack Pharmaceuticals, Inc.&nbsp;(Nasdaq:
MACK) today announced the initiation of a randomized, double-blinded,
placebo-controlled Phase 2 clinical trial of MM-141, a bispecific antibody
targeting IGF-1R and ErbB3, in combination with ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3856309d-475e-4da9-af66-5f47f79dc4a9.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novocure
Kicks Off Brain Tumor Awareness Month with New Activities to Address Challenges
in the Glioblastoma Community</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Novocure</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Novocure, a commercial stage oncology company, announced today
that it is sponsoring its Tune-In to GBM campaign during Brain Tumor Awareness
Month for the third consecutive year. Novocure is launching a series of
activities to help spread awareness...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/91e3329f-6a96-4cf1-8134-5f8ff657782f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Astellas
Announces New Data To Be Presented During Late Breaking Plenary Session At AUA
Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Astellas announced that two abstracts
detailing clinical data from studies of enzalutamide and one abstract detailing
clinical data from a study of mirabegron as an add-on treatment to solifenacin
will be presented during a late break...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7104705d-de20-4e39-b09e-d2fb7e6f1ad1.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bio-Techne
Releases Third Quarter Fiscal 2015 Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Bio-Techne Corporation (NASDAQ:TECH) today
reported its financial results for the third quarter ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c9e270b1-6b8f-4673-8ae3-ec0abbb48a5c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alere
Reports Preliminary First Quarter 2015 Financial Results and Announces 2014
Restatement -- Net revenue of $610.4 million; non-GAAP adjusted net revenue of
$610.7 million</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Alere Inc. (NYSE: ALR), a global leader in
rapid diagnostic tests, today announced its preliminary financial results for
the quarter ended March 31, 2015.&nbsp; Net revenue was $610.4 million, a
decrease of 2.4 percent, compared to $625.2 ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/eabea974-4dff-480f-9b03-03c9fca55b7d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Indivior
PLC Announces Positive Top-line Results From Pivotal Phase 3 Trial of RBP-7000
in Schizophrenia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SLOUGH,&nbsp;England, May 5, 2015 /PRNewswire/ --&nbsp;Indivior
PLC (LON: INDV) today announced top-line results from its phase 3 clinical
trial of RBP-7000, an investigational drug in development for the treatment of
schizophrenia. In this pivotal study, both...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/77528a7a-7095-47d7-addc-a4b11be4c86f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Researchers
question safety of off-label device use in atrial fibrillation, call for 510(k)
review process</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceMedicalDevices News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Physicians conducted a systematic review of database reports of
the outcomes associated with the off-label use of the Lariat device to prevent
stroke in patients with atrial fibrillation. They found several instances of
deaths and follow-up emergenc...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d9f9be75-5584-46cd-b0cc-d14e3f4dcd8b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
test 'boost' on ovarian cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BBC News - Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Regular blood tests can detect 86% of ovarian cancers before the
point at which normally women would be diagnosed, according to a 14-year trial.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a16f7bdc-99f8-426d-a854-47720ffba9ba.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ovarian
cancer trial boosts hope of screening programme</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UK headlines</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New ovarian cancer test diagnoses twice as many cases as
previous tests</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:45:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7974cbe4-b569-44a0-a333-8af71016cd2b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
ovarian cancer test twice as effective as existing methods</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Network Front | The Guardian</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fourteen-year global trial finds 86% of women can be diagnosed
correctly by tracking level of protein in bloodA new screening test that tracks
changing levels of a protein in the blood can detect twice as many ovarian
cancers as conventional methods...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:45:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e81c4d24-95cf-4a54-8cf4-ad9766b198ae.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Predictors
of Influenza Diagnosis among Patients with Laboratory-Confirmed Influenza</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Objective.&nbsp;To determine predictors of clinical influenza
diagnosis among patients with laboratory-confirmed influenza.Method.&nbsp;From
a prospective, laboratory-confirmed influenza surveillance of hospitalized or
emergency department patients of all age...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/87162752-d883-4db7-ad15-78a5d649c34d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cancer
Targeted Technology Receives $2 Million Small Business Innovation (SBIR) Grant
to Advance its PET Imaging Diagnostic to Clinical Trials in Prostate Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cancer Targeted Technology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cancer Targeted Technology (CTT), a privately-held Seattle-based
biotechnology firm focusing on cancer diagnostics and therapeutics, today
announced that the NIH awarded a 2-year, $2M SBIR grant to CTT to develop a new
agent that will help diagnose ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 6:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d5a00f74-992a-42a6-b189-c450073684ac.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agilent
Technologies to Acquire Cartagenia, Leading Provider of Software to Enable
Clinical Analysis...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agilent Technologies Newsroom</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agilent Technologies Inc. (NYSE: A) and Cartagenia today
announced that they have signed a definitive agreement under which Agilent will
acquire Cartagenia, a leading provider of software and service...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 6:13:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/77abe1c9-fa9d-4244-916c-faaaae0a18f5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Illumigyn
Introduces the Gynescope at ACOG</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Illumigyn</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Illumigyn Introduces the Gynescope at ACOG; New Device Increases
the Speed and Accuracy of Cervical Exam Diagnosis</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 4:48:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/77b71897-f399-48d5-8f23-5f897352fd70.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
shows cost-effective expert recommended asthma test underutilized by physicians</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Researchers from the University of Texas Medical Branch at
Galveston have found, for the first time, that spirometry was underutilized for
asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it's
accuracy, cost effectiveness an...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:48:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/85e61043-736c-4924-9d57-cb94952e7fce.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Extension
Healthcare Wins Prestigious Health Tech Award</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Extension Healthcare</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Extension Healthcare announced today that it has received the
Health Tech Award for TechPoint's 16th annual Mira Awards program.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/faba816d-a67f-4a8b-856a-725e63129e3b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AARP,
Sony Pictures Classics and Sony Pictures Home Entertainment Team Up to Support
Family Caregivers and Alzheimer's Awareness with National AARP I Heart Caregivers
Screening Program of Academy Award&reg;-Winning STILL ALICE, Arriving on Blu-ray&#8482;
May 12th</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- To celebrate the release of STILL
ALICE&nbsp;on Blu-ray&#8482; and DVD May 12, Sony Pictures Classics and Sony Pictures
Home Entertainment are collaborating with AARP Movies for Grownups&reg; for a
nationwide series of screenings to suppo...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:45:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5fcd7aac-c359-402b-a8e4-fbcdf62cb5ac.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hohman
on Clinical Research</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PhRMA</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>It takes years for even the most promising experimental drugs to
transition through laboratory development, clinical trials, and FDA evaluation
in order to reach patients. FDA, collaborating with advocacy organizations and
industry, has implemented ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/40ee3086-1499-4a4e-813d-ddb5c309f535.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Foundation
Medicine CSO Calls for Caution on Clinical Use of ctDNA Assays, CTC Test
Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/00195878-e559-4fc9-8d10-d956ef532b40.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Foundation
Medicine CSO Calls for Caution on Clinical Use of ctDNA Assays, CTC Test ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:36:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9a2d9e6c-6032-4549-8b83-771e7c3635e6.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PCORI
Awards $14 Million to Determine Best Aspirin Dose to Protect Patients with
Heart Disease First PCORnet Demonstration Study Could Help Guide Treatment
Options for Millions</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- The Patient-Centered Outcomes
Research Institute (PCORI) Board of Governors today approved a three-year, $14
million clinical trial designed to determine the best dose of aspirin to use to
prevent heart attacks and strokes ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:08:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ee197595-a0af-414e-922d-71dccd434aa5.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clearblue&reg;
Honors All Moms And Moms-To-Be By Featuring Real, Personal Pregnancy
Announcements In A New Mother's Day Video Former &quot;Bachelorette&quot; Star
DeAnna Pappas Stagliano and Country Music Artist Jessie James Decker Join in
the Celebration by Sharing Their Personal Pregnancy Announcement Stories</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;For more than 30 years, Clearblue&reg; has
connected women across the globe, allowing them to share in the same first
&quot;Mother's Day&quot; moment ¨C the moment when they see their positive home
pregnancy test. With a little help from former &quot;Bac...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 2:50:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dd668e95-a1c5-4482-b84c-07cc2fe9cdf7.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fagron
Acquisition of JCB Laboratories to Reshape U.S. Sterile Compounding Industry</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>JCB Laboratories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fagron reshapes U.S. sterile compounding industry through
acquisition of JCB Laboratories and construction of $15 million drug
outsourcing facility.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 1:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/52739e20-72d9-4b2f-8a44-3ab4baa5a20f.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Quest
Diagnostics Announces LeukoVantage&#8482;, Advancing Precision Medicine for
Hematologic Malignancies Genomic service detects 30 gene mutations to aid in
the diagnosis, prognosis, monitoring and treatment selection for several
myeloid neoplasms</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Quest Diagnostics (NYSE: DGX), the world's
leading provider of diagnostic information services, today announced
LeukoVantage&#8482;, an evidence-based genomic test service that aids in
the&nbsp;diagnosis, prognosis, monitoring and selection of t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 12:54:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ba3176dd-cf54-4d29-9803-fa8483785fcc.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Funding
milestone reached for 'light up' cancer cell research in both lung and ovarian
cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-iReach/ -- On Target Laboratories LLC&nbsp;is
receiving a financial boost from both private and public sectors as they close
in on developing a groundbreaking method to illuminate previously hidden cancer
cells during surgery. </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 12:34:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a68a9d93-3740-48d9-95b8-b12c0388550c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agilent
Technologies to Acquire Cartagenia, Leading Provider of Software to Enable
Clinical Analysis of Genomics Data</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agilent Technologies Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agilent Technologies Inc. (NYSE:A) and Cartagenia today
announced that they have signed a definitive agreement under which Agilent will
acquire Cartagenia, a leading provider of software and services for clinical
genetics and molecular pathology lab...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9e4d6e0e-2841-450a-9e07-b04308dce88d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We¡¯re Catching up on Myriad, Drug Prices and Lots
More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Zuma PressGood morning, everyone, and welcome to another working
week. Another weekend respite has flown by, although we hope it was
invigorating because, as you know, the routine of meetings and deadlines and
what not has now returned. This means t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:44:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/363aee72-2d38-4f55-85ff-646a66db1dde.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>You¡¯ve
come a long way, baby, but still a long way to go</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioWorld Perspectives</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Patients have come a long way to get a say in the drug
development and approval process. But there¡¯s still some ground to cover if
they¡¯re going to move from the passive subject role to a 50-50 partnership that
reminds researchers, drugmakers and re...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a33c636b-c251-4ea2-a640-a2d83c530685.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>St.
Jude Medical Completes Acquisition of Spinal Modulation, Inc.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>St. Jude Medical, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>St. Jude Medical, Inc., has completed the acquisition of Spinal
Modulation, Inc., developer of the Axium&#8482; Neurostimulator System. The
acquisition was completed on May 1, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:13:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c505b9ac-c1f7-4380-94d7-711664fc51d3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>POCARED
Presents a Novel Gram Stain Methodology</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --POCARED announces a breakthrough in
pre-analytical technologies and systems with its novel Gram stain methodology.
POCARED introduces the first system that can perform both &nbsp;direct,
automated Gram staining and sample concentration. The...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3d79e862-c95e-429d-9c3c-0b65091d92fc.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kill
Microorganisms on Instruments Safely, Efficiently, and Cost Effectively with
3M&#8482; Steri-Vac&#8482; Sterilizer/Aerator GS Series</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>3M</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>For facilities looking for effective reprocessing methods for
heat- and moisture-sensitive equipment, the new 3M&#8482; Steri-Vac&#8482;
Sterilizer/Aerator GS Series may be the solution. go.3M.com/lowtemp</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/696f82c3-89dd-4771-9b0f-3f0fffb5a5fc.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Blood Pressure Monitor And Scale Allow Chronically Ill Patients To Stay At Home
While Connected To Healthcare Professionals Omron's Advanced Devices Sync with
Bluetooth&reg; Smart for Everyday Monitoring</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Omron Healthcare, Inc., the leader in home
blood pressure monitoring, announced today the launch of a new blood pressure
monitor and scale with connectivity via smartphone, tablet, or other gateway
devices for telemedicine and telehea...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 8:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5ab424c4-3b63-4c5a-947e-61a5b3f6862e.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kineta
Announces Promising Top-line Clinical Results for Dalazatide; Target Implicated
in Broad Array of Autoimmune Diseases</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Kineta, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Kineta, Inc., a biotechnology company focused on the development
of immune modulating drugs for critical diseases, today announced safety and
clinical results from its proof-of-concept Phase 1b clinical trial of
dalazatide in patients with active pl...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3252434a-478a-4c87-876b-13faf2a70fbc.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Intermatic
Donates Essential Defrost Timers to Ebola Treatment Mission</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Intermatic Incorporated</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Intermatic, a leader in energy management solutions, today
announced the company¡¯s donation of six defrost timers to support efforts to
find a cure for the Ebola Virus Disease (EVD).</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ee40049e-22e3-465d-b260-b71a15d4d020.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NorthStar
VETS Partners with American Red Cross to Host Blood Drive for People and Pets</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NorthStar VETS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NorthStar VETS partners with American Red Cross to host blood
drive for people and pets on May 12, 2015 from 9:00am - 2:00pm</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/52730580-b42d-4349-8b76-15cc23ed95b2.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OMEICOS
Appoints Dr. Ulrich Dauer as Chief Executive Officer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>OMEICOS Therapeutics GmbH</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>OMEICOS Appoints Dr. Ulrich Dauer as Chief Executive Officer</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 3:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/541f9017-3c3f-4be5-b7f5-f0e4e4831d67.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ERYTECH&nbsp;announces
positive DSMB annual review of its Expanded Access Program in ALL</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ERYTECH Pharma</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Regulatory&nbsp;News:</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/58bf26d5-7df8-4d83-9b19-a0a6a5422936.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novo
building $225M plant for hemophilia treatments</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FiercePharmaManufacturing News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>With longer-acting hemophilia drugs expanding the market of
treatments for the rare blood disorder, drugmakers are trying to get out ahead
with new production. Novo Nordisk today started construction of a $225-million
plant in Denmark. That comes ju...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:56:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5ad5907c-75a1-4ce5-8165-19f8d58c5df3.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dog
owners are warned of risks from disease-carrying ticks</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UK headlines</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The small blood-sucking creatures are growing in number, with
new arrivals from Europe feared to be carrying a disease that can kill dogs</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:45:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f5484fb4-d7a0-4d70-be30-df0af1c723c7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Efficacy
of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally
advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized
controlled clinical trial</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Cancer</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Despite the well-described benefits of laparoscopic
surgery such as lower operative blood loss and enhanced postoperative recovery
in gastric cancer surgery, the application of laparoscopic surgery in patients
with locally advanced gastr...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e410c9d5-cf84-4d44-9684-19a1dfe30833.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TaiGen
starts burixafor trial in China</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Daily Extra</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>TaiGen Biopharmaceuticals Holdings Ltd.(GreTai:4157) began a
Phase I/II trial in China of burixafor (TG-0054), a CXC chemokine receptor 4
(CXCR4) inhibitor, to treat relapsed or refractory acute myelogenous leukemia
(AML).The open-label, dose-findin...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/91c950e6-d521-4d55-bcef-cfcfa4f17921.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Update
in General Internal Medicine: Evidence Published in 2014</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Annals of Internal Medicine Current Issue</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>This Update summarizes studies published in 2014 that the
authors consider highly relevant to the practice of general internal medicine.
Topics include atrial fibrillation; venous thromboembolism; acute bronchitis;
ambulatory blood pressure monitori...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:39:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ca7bee98-88a6-4a48-b398-5538ee0aeba4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
screening method may identify more ovarian cancers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Reuters: Health News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>(Reuters Health) - A personalized method for interpreting blood
tests identifies more ovarian cancer cases than a generalized approach, a new
study suggests.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:39:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f00a650a-60ed-48db-9424-b2da581ef87d.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>St.
Jude Earns National Recognition as an Advanced Comprehensive Stroke Center
Designation earned by less than 100 of the nation's hospitals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;St. Jude Medical Center (SJMC) has been
certified by The Joint Commission as an Advanced Comprehensive Stroke Center, a
level of recognition reserved for an elite group of hospitals capable of
treating the most complex stroke cases. S...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 5:45:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5c7b3716-ab99-4bc0-ad8c-f18c1f5e69ed.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Artificial
Vessels Designed to Degrade and Be Replaced by Natural Vasculature</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medgadget</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Researchers at the Vienna University of Technology and Vienna
Medical University in Austria have developed artificial blood vessels that are
already proving themselves in animal models. Created out of&nbsp;thermoplastic
polyurethane, the implants biodegr...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:48:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/469b7aa5-7101-4225-b426-b9208ba1ecc3.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PROTEK
Duo Emergency Cannula for Veno-Venous Extracorporeal Life Support</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medgadget</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CardiacAssist (Pittsburgh, PA) won European regulatory approval
to introduce its PROTEK Duo veno-venous cannula for ¡°venous drainage and
reinfusion of blood via an internal jugular vein during extracorporeal life
support procedures,¡± according to th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:48:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ec833331-ea74-4b63-af38-2d503cf2bb41.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Trapped
in his garden, 101-year-old man rescued alive from rubble of Nepali quake</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>National Post - Top Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BIDUR, Nepal&nbsp;¡ª&nbsp;It was an unlikely escape. By his own
account, he should have died. But when the humble hut of stacked grey stones
collapsed onto Funchu Tamang, who believes himself to be 101 years old, his
daughter-in-law quickly pulled him from the...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 3:41:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/31d01f3f-43ef-4e1f-b580-140e4d85ebcf.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Frederick
Alt, PhD, awarded 2015 Szent-Gyorgyi Prize for Progress in Cancer Research
Prize honors history of fundamental discoveries toward our current
understanding of cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- Frederick Alt, PhD, director of the
Program in Cellular and Molecular Medicine at Boston Children's Hospital, has
been honored with the 2015 Szent-Gy&ouml;rgyi Prize for Progress in Cancer Research.
Awarded by the National Found...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 12:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b9976b59-29d1-42bf-baff-445be3f6e7e0.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Guitar
Center And Multi-Platinum Grammy&reg; Award Winning Artist/DJ/Producer Zedd
&quot;Play It Forward&quot; With Cover Me Program ANNOUNCEMENT HIGHLIGHTS:</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Guitar Center has partnered with
multi-platinum Grammy award-winning artist Zedd to present Cover Me, an artist
discovery program offering aspiring musicians the chance to take their careers
to the next level. The new program embodies...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 11:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/95ed35e3-2be7-40e2-87dd-4077789347a2.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Edinburgh
University student 'wrote note with serial killer William Burke's blood'</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UK headlines</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A note written with blood taken from the head of the serial
killer William Burke has gone on display at Edinburgh University</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/38c7013a-efc0-4222-88d2-6e5ae6b692ef.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Elevated
C-reactive protein predicts poorer outcomes in melanoma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com HEMATOLOGY ONCOLOGY RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Higher blood levels of C-reactive protein were associated with
poorer OS and melanoma-specific survival in patients with invasive melanoma,
according to study results.¡°The relationship between changes in [C-reactive
protein] and melanoma disease pro...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c5f37a3e-9920-4717-b351-4629e0e9df15.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Researchers
Closer to Being Able to Change Blood Types</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Drug Discovery &amp; Development All</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>What do you do when a patient needs a blood transfusion but you
don¡¯t have their blood type in the blood bank? It¡¯s a problem that scientists
have been trying to solve for years but haven¡¯t been able to find an economic
solution ¨C until nowRead more...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:39:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0af4a9cc-8794-428d-a3dc-07fb34cbce95.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mosquito
and Tick Prevention Critical for Outdoor Spaces Frequented by People and Pets</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ehrlich</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Mosquitoes and ticks are increasingly finding their way into the
landscape of suburban areas across the U.S. and becoming a potential health
threat to people and their beloved animals.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ccc8c91b-0fc3-4964-8ed7-ced6017d1751.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IDEXX
Introduces Exclusive New Intestinal Parasite Screening Tests to Protect Pets
New antigen tests offer highest accuracy/specificity available, enabling
earlier diagnosis and treatment; IDEXX to add their new antigen tests to all
reference laboratory fecal panels at no additional charge</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today
announced that hookworm and roundworm antigen tests will be added to all IDEXX
Reference Laboratories fecal panels¡ªthat already include whipworm antigen¡ªat no
additional charge. The new ho...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c3dec736-293c-4417-8b7c-4318e1e7bdea.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Top
&quot;Team Up For St. Jude - Spirited By Varsity&quot; Fundraisers Gather In
Memphis For Recognition Cheerleaders and Dancers from twelve teams recognized
for their fundraising efforts on behalf of St. Jude Children's Research
Hospital&reg;.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Members of twelve squads who raised the
most donations as part of the &quot;Team Up For St. Jude -&nbsp;Spirited By
Varsity&quot; campaign were invited to visit Memphis as a reward for their
fundraising efforts benefiting the St. Jude Children's Res...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cec55158-32ab-444a-a7df-61af79dfa3fb.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roger
J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program
and oncology pipeline</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ - Fluorinov Pharma (Fluorinov), a FACIT portfolio
company, is pleased to announce the appointment of Dr. Roger J Garceau, to its
Board of Directors. With extensive experience guiding biotech companies in
matters including corporate devel...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c1d86dc0-f465-4818-951f-09c4c7a9c130.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Webcast
Alert: Heska Corporation's Annual Meeting of Stockholders Webcast</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Heska Corporation (Nasdaq: HSKA) announces the
following Webcast: </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e94e4382-1c13-4433-b3ca-ff8545e4bf14.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Two
North Dakota Youth Honored for Volunteerism at National Award Ceremony in
Washington, D.C.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Prudential Financial, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>North Dakota's top two youth volunteers of 2015, Nichole Hanzel,
18, of Killdeer and Lauren Knoll, 13, of Fargo, were honored in the nation¡¯s
capital last night for their outstanding volunteer service during the 20th
annual presentation of The Prude...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 2:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cd194329-6e57-4775-a2a8-0e3ae34772e1.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alere
to Report First Quarter 2015 Financial Results and Provide Update on May 5,
2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Alere Inc. (NYSE: ALR), a global leader in
rapid diagnostics, today announced that it will host a conference call
beginning at 8:30 a.m. ET on Tuesday, May 5, 2015, to discuss its financial results
for the first quarter of 2015, which...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 4:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b758b08e-8505-4ab7-b6fa-45138d6af6e9.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>European
HIV/aids diagnostics market 2015 just published</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 10:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6d88f2cb-6b5c-49d7-a384-3346161a85b4.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Update
in Hematology: Evidence Published in 2014</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Annals of Internal Medicine Current Issue</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>This Update summarizes studies published in 2014 that the
authors consider highly relevant to the practice of hematology. Topics include
malignant hematology, transfusion medicine, and bleeding and clotting
disorders.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:38:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/329f9cca-c7ff-4bcb-95ed-a583eca4fda4.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>XIFIN
Acquires Imaging Informatics Company VisualShare</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>XIFIN, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>XIFIN, Inc., the healthcare cloud computing company
revolutionizing the business of healthcare diagnostics from patient to payment,
today announced the acquisition of VisualShare, a Salt Lake City-based medical
informatics company specializing in di...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 8:45:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0414b622-e92d-456c-a002-771dfc9b1b12.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Courtagen
Life Sciences Appoints Reymundo Lozano, MD to the Company¡¯s Clinical And
Strategic Advisory Board</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Courtagen Life Sciences, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Courtagen Life Sciences, Inc., an innovative molecular
information company, announced today the appointment of Reymundo Lozano, MD to
the company¡¯s Clinical and Strategic Advisory Board.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 7:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/982b1aa5-9d31-4e62-b2a5-a55cf87ba839.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IMS
Health Finds Global Cancer Drug Spending Crossed $100 Billion Threshold in 2014</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>IMS Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Earlier diagnosis, longer treatment duration and increased
effectiveness of drug therapies are contributing to rising levels of spending
on medicines for cancer care. According to a new report released today by the
IMS Institute for Healthcare Infor...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 5, 2015 7:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7bdc0c9f-5004-42f0-91cb-c11ebf69d061.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PerkinElmer's
and Covaris offer next gen sequencing grade nucleic acid purification and
automated sample prep from FFPE tissue samples</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PerkinElmer, Inc. - All News Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PerkinElmer's chemagicTM research instrumentation and kits are
now available with the Covaris &quot;truXTRAC FFPE DNA microTUBE Kit for
chemagen Technology&quot; for DNA/RNA purification powered by Adaptive Focused
Acoustics&reg; (AFA&#8482;) technology. &quot;truXTRAC...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/90b442a6-0ca7-4141-9b5c-f48cdd6be267.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BTIG
Reiterates a Neutral Rating on Affymetrix</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:39:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9f59fada-435b-4054-9eb0-ca79d225b652.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BGI
will offer QIAGEN¡¯s Ingenuity Variant Analysis to 10,000-plus customers,
beginning in China and ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Qiagen NV Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Shenzhen, China, and Redwood City, California, May 4, 2015</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0508c594-b3c7-4c62-be93-46c32acb0380.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>QIAGEN
Partners With World's Largest Sequencing Provider BGI will offer QIAGEN's
Ingenuity&reg; Variant Analysis to 10,000-plus customers, beginning in China and
expanding worldwide, for seamless interpretation of sequencing data</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --QIAGEN N.V., a Netherlands-based holding company,
is the leading global provider of Sample to Insight solutions to transform
biological materials into valuable molecular insights. QIAGEN sample
technologies isolate and process DNA, RNA...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2f152354-7bb7-4be3-ab2f-9100ac95d98d.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ignyta
to Report 2015 First Quarter Company Highlights and Financial Results and Host
Conference Call on May 11, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ignyta, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Ignyta, Inc. (Nasdaq: RXDX),&nbsp;a precision oncology
biotechnology company, today announced that it will release its first quarter
2015 financial results after the market closes on Monday, May 11, 2015. Ignyta
management will host a conference call tha...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dd91e5f7-9a96-4349-a330-e7839393f55d.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AIT
Bioscience Appoints New Group Leader, Ligand Binding Assay Department</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AIT Bioscience, LLC</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>AIT Bioscience, LLC announced today that Franklin P. Spriggs,
BS, MS, will join the company as the group leader of the Ligand Binding Assays
(LBA) department. Spriggs¡¯ appointment further strengthens AIT Bioscience¡¯s
expertise in molecular biology a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 2:21:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c779efd3-2283-408b-b92d-4a04caa3199b.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>QIAGEN
Posts 2014 Annual Report on Its Website</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --QIAGEN N.V., a Netherlands-based holding company,
is the leading global provider of Sample to Insight solutions to transform biological
materials into valuable molecular insights. QIAGEN sample technologies isolate
and process DNA, RNA...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 11:58:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8642b9aa-cfaa-430a-89c8-c36f28203c2c.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Data
from Recently Published Studies Provide Strong Support for Current and Future
Applications of Pressure BioSciences' PCT Platform Results of Studies by Three
Key Opinion Leader Laboratories Demonstrate Significant Advantages in Drug
Discovery, Cancer Detection, and in the Analysis of Microorganism Diversity in
Soil</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO)
(&quot;PBI&quot; or the &quot;Company&quot;), a leader in the development and
sale of broadly enabling sample preparation solutions using pressure cycling
technology (&quot;PCT&quot;)-based instruments and consumables to th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b21160f7-877e-4a89-ad5a-8f8b432e1661.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Larry
Horn of MPEG LA to Present at NewYorkBIO 25th Anniversary Conference on May 5</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>MPEG LA, LLC</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>MPEG LA, LLC today announced that President and CEO Larry Horn
will speak at the NewYorkBIO 25th Anniversary Conference on May 5 in a session
entitled &quot;Strategic IP Management of Biomarker and Diagnostic
Technologies&quot; to be held at 10 on the Park at...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ad65195e-8f70-4c14-b2f4-f0437dd0895c.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tactical
Therapeutics, Inc. Selected to Present at Cavendish Global Health Impact Forum</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tactical Therapeutics, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Tactical Therapeutics, Inc., Selected to Present at Cavendish
Global Health Impact Forum</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7d2c7eb0-bad1-4eb0-be41-856337eedb53.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardiovascular
Systems to Feature ORBIT II Two-Year and Long-Term Economic Data in
Late-Breaking Presentation at the SCAI 2015 Scientific Sessions</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cardiovascular Systems, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), will feature
two-year results from its ORBIT II trial as well as a long-term economic
analysis of the company¡¯s Diamondback 360&reg; Coronary Orbital Atherectomy System
(OAS) in treating severely calcifi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/159efd9f-5c48-41fa-bbad-6f9d0d1bbf63.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Garvan
Institute of Medical Research Selects BiOptix Biosensor For Drug Development
Research</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BiOptix</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Garvan Institute of Medical Research, one of Australia¡¯s leading
biomedical research institutes, announced today they have selected the BiOptix
404pi for their drug discovery research.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/44de3242-8111-440d-9c98-87ec6c84dd51.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Is
Pennsylvania Ready For Telemedicine Expansion? Recent Report Card, Poll
suggests barriers stalling progress</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ --&nbsp;While national trends are
pushing adoption of telemedicine across the country and patient demand is
growing, barriers including lack of standards of care, insurance payment, and
patient trust levels may be slowing progress ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/37987041-8fd2-4da5-bd6e-8d2bf76bb04f.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioLineRx
Initiates Expansion Stage of Phase 2 Clinical Trial for Novel Treatment for
Acute Myeloid Leukemia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioLineRx Ltd.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioLineRx announced successful completion of the dose escalation
stage of its ongoing Phase 2 study of BL-8040, and commencement of the
expansion stage at the optimal dose of this novel treatment</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6b1bc87d-2348-44f5-8a09-a4991cc5d323.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Urine Sediment as a Biomarker of Kidney Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>American Journal of Kidney Diseases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The modern era of medicine has ushered in new diagnostic
technologies to assist the clinician in evaluating patients with kidney
disease. The birth of automated urine analysis technology and centralized
laboratory testing has unfortunately made exam...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 8:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4a647db4-4aa0-43ef-8e38-df4cc54a0b9c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Eagle
Telemedicine Supports Partnership Model to Add Speed, Value and Greater Access
to Resources for Hospital and Health System Telemedicine Initiatives New
collaborative paradigm to be topic of panel discussion at 20th annual ATA
meeting in Los Angeles</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;The benefits of telemedicine programs to
rural hospitals are consistently demonstrated today, and a partnership model
makes it easier for hospitals to implement them. Eagle Telemedicine, together
with a health system and a technology ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:50:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/491801cd-2e1c-40c8-a938-5ed732b9077c.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>hi
HealthInnovations' Hearing Test Kit For Primary Care Physicians Receives U.S.
Patent</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>hi HealthInnovations</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>hi HealthInnovations' new hearing test kit is an affordable and
easy-to-use resource to test for hearing loss, a condition that affects more
than 48 million people nationwide.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c14203d4-e144-4db3-a51f-26ca09e24371.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With
Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk
For Cardiovascular Disease First-ever meta-analysis of pitavastatin confirms no
significant adverse effect compared with placebo or other statins on fasting
blood glucose, HbA1c, or new-onset diabetes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Kowa Pharmaceuticals America, Inc., announced
that the results of a meta-analysis of 15 randomized, controlled clinical
trials, to assess the effects of LIVALO&reg; (pitavastatin) on glycemic parameters
and new-onset diabetes (NOD) in non...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4767adef-ff4e-40b7-bde6-267c5452d9d7.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cost
Benefit Analysis of Trovagene's Precision Cancer Monitoring Solution to Be
Presented at the Association for Value-Based Cancer Care in Washington, DC
Analysis concludes that use of Trovagene's urinary liquid biopsy significantly
reduces costs when compared to tissue biopsy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Trovagene, Inc., (NASDAQ: TROV) a developer
of cell-free molecular diagnostics, announced today that Gary Gustavsen, Vice
President, Health Advances, LLC, will present a health economic analysis
highlighting the potential cost savings...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/42fddefc-1e40-4000-8628-98327310950e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Generon
Received US FDA Clearance to Initiate Phase IIa Study With F-652, a
First-in-Class Biologic, to Treat Patients With Acute GvHD</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Generon Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Generon Received US FDA Clearance to Initiate Phase IIa Study
with F-652, a First-in-Class Biologic, to Treat Patients with Acute GvHD.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b25b5ea9-e86f-4854-bf2f-28ac6f6b05bc.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SI-BONE,
Inc. Announces Medicare Contractor Cahaba to issue positive coverage of MIS SI
Joint Fusion Four of Eight Medicare Contractors now cover MIS SIJ Fusion</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- SI-BONE, Inc., a medical device company that
pioneered the use of the iFuse Implant System, a minimally invasive surgical
(MIS) device indicated for fusion for certain disorders of the sacroiliac (SI)
joint, announced today that Cahab...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9db00559-a142-42e8-8097-3f2ab5c1686e.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Exact
Sciences Reports Strong Growth Trajectory for Cologuard&#8482; in First-Quarter 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exact Sciences Corp.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exact Sciences Corp. today announced its business and financial
results for the quarter ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 5:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8de3a2a1-db93-4165-a604-4f10d7ad345a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Immune
Therapeutics Inc, Announces the official publication announcement of the NAFDAC
approved 90-Day Bridging Trial of Lodonal&#8482; with HIV/AIDS Patients. Immune
Therapeutics Inc - Lodonal&#8482; an Adjunct Immune Therapy for Treatment of Patients
with HIV/AIDS</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Immune Therapeutics Inc
(IMUN)&nbsp;&quot;Immune Therapeutics&quot;, through its fully owned
subsidiary, TNI Biotech International, today announced the dosing of the first
patient with Lodonal&#8482; (Once-daily Oral Treatment) for the 90-Day bridging
cli...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/04a7f1b9-76b0-4e78-9c0d-12db60663afa.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NxStage
Establishes New Scientific Advisory Board to Build Clinical Evidence and Drive
Adoption of Home Hemodialysis Therapy Leading dialysis manufacturer forms group
of esteemed experts to advance leadership and the standard of care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;NxStage Medical, Inc.&nbsp;(Nasdaq: NXTM),
a leading manufacturer of dialysis products, today announced the Company's new
Chronic Scientific Advisory Board, an esteemed group of thought leaders focused
on evaluating and advancing home dial...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/514ce1c3-74e4-4541-afcd-2e1783183b7f.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Allegro
Ophthalmics Begins Phase 2 Clinical Study of Luminate&reg; for Non-Proliferative
Diabetic Retinopathy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Allegro Ophthalmics, LLC</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Allegro Ophthalmics announced that it has begun enrolling
patients in a Phase 2 clinical trial that will evaluate Luminate&reg; in inducing
PVD in patients with non-proliferative diabetic retinopathy.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8934cb20-6ee7-448a-9a18-539907444045.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Golden
Meditech Proposes to Purchase Convertible Notes Held by KKR</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Golden Meditech Holdings Limited (&quot;Golden
Meditech&quot; or the &quot;Company&quot;, together with its subsidiaries
collectively as the &quot;Group&quot;, 801.HK; 910801.TW), a leading integrated
healthcare enterprise in China announced today that it has ente...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:55:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/44632a50-d216-4e71-93cd-6a021929f13c.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NeuroSigma's
Thin Film Nitinol Flow Diverting Stent Results Presented at the American
Society of Neuroradiology Meeting Pre-Clinical Study Conducted at Mayo Clinic</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;NeuroSigma&reg;, Inc. (NeuroSigma), a
California-based life sciences company, today announced&nbsp;that results of an
animal study of its Thin Film Nitinol (TFN) flow diverter were presented on
April 30th by Mayo Clinic researchers at the 53rd...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3a0badd4-6973-4b4e-a509-40e4a4a4fc47.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CytoSorbents
to Report Q1 2015 Operating and Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- CytoSorbents Corporation (NASDAQ CM: CTSO), a
critical care immunotherapy company commercializing its CytoSorb&reg;
extracorporeal cytokine adsorber to treat critically-ill and cardiac surgery
patients in multiple countries worldwide, wil...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/46014b45-d403-4b27-b97b-7b6210164636.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior
Convertible Notes Due 2017 Held by KKR</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- China Cord Blood Corporation (NYSE: CO)
(&quot;CCBC&quot; or the &quot;Company&quot;), China's leading provider of cord
blood collection, laboratory testing, hematopoietic stem cell processing and
stem cell storage services, today announced that the Comp...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8e5faf02-8342-4e1a-b3fd-1f18d5225775.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Envarsus&reg;
XR Demonstrates Improved Pharmacokinetic Profile in African-American Transplant
Recipients Data presented at the American Transplant Congress</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>, in Philadelphia, in a presentation entitled &quot;PK and
Pharmacogenomics of Once-daily MeltDose&reg; Tacrolimus (Envarsus&reg; XR) vs.
Twice-daily Tacrolimus: A Randomized Cross-over Study in Stable
African-American Kidney Transplant Patients (ASERTAA)&quot;. There...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4127561c-d3c2-40ea-a6f7-4a341646f584.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HealthMine
Consumer Wellness Report Can Guide Plan Sponsors in Wellness Programs in Light
of Recent EEOC Ruling 1,929 Consumers Surveyed to Uncover Consumer Attitudes
and Desires About Sponsored Healthcare Programs</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- In the wake of the EEOC ruling on wellness
programs, HealthMine queried 1,929 consumers to give health plan sponsors
insight into member attitudes about wellness plans. The results of these
surveys are now available in the first issue...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 6:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/87e3f6b1-8014-4d0c-9506-b54726ae3cd4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>High-value
research of 2014 presented for internal medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>(HealthDay)¡ªArticles relating to atrial fibrillation, venous
thromboembolism, acute bronchitis, ambulatory blood pressure monitoring for
hypertension screening, and guidelines relevant to generalist practice are
included in a special update summary ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 5:48:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5df75dbf-a77c-4f75-a878-7f200140849f.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Innovation Challenge: Assessing BioPharma Startups</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Stewart Lyman Developing new medicines is really difficult and
very expensive. A recent report, ¡°Decline In Economic Returns From New Drugs
Raises Questions About Sustaining Innovations,¡± suggests that the newest
medicines are generating a negative ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 5:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e8968d00-4e94-48b4-8f8e-c7cf8399704f.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
banks across state negligent in saving rare 'Bombay blood group'</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="http://www.PharmaBiz.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>www.PharmaBiz.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Even as many government run blood banks have come under scanner
for irregularities in complying with guidelines of National Blood Transfusion Council
(NBTC) in terms of collection, storage and pricing of blood, blood banks across
the state have also...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 1:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6093587f-5770-4244-aef2-ad82df021f65.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>State
of the art blood donor centre</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Red Cross has opened a new blood donor centre in
Broadmeadow, designed to meet the increasing need for plasma.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 10:39:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/69294a57-9028-461e-aef5-1d7592e9dc2e.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novel
APC promoter and exon 1B deletion and allelic silencing in three
mutation-negative classic familial adenomatous polyposis families</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genome Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: The overwhelming majority (approximately 80%) of
individuals with classic familial adenomatous polyposis (FAP) exhibit mutations
in the coding sequence of the adenomatous polyposis coli (APC) tumor suppressor
gene. Families without detec...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 10:39:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9414c7fd-9974-4f7c-b5a5-a815ec06ff5a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Possible
FDA-approved drugs to treat Ebola virus infection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Infectious Diseases of Poverty</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>There is currently no effective treatment for the Ebola virus
(EBOV) thus far. Most drugs and vaccines developed to date have not yet been
approved for human trials. Two FDA-approved c-AbI1 tyrosine kinase inhibitors
Gleevec and Tasigna block the re...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 8:41:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/20df1fd6-f99f-441d-b3e7-5e87623a9021.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aethlon
Medical Announces Withdrawal of S-1 Registration Statement</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD, AEMDD), a
pioneer in developing targeted therapeutic devices to address infectious
diseases and cancer, announced today that on Friday, May 1, 2015, it filed with
the Securities and Exchange Commiss...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/12f2485d-1400-4f11-8e1a-3f7447c669ef.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cell
Cure Neurosciences Announces Preclinical Efficacy Data Demonstrating OpRegen&reg;
Preserves Vision</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure
Neurosciences Ltd. (Cell Cure) today announced that preclinical data
demonstrating that Cell Cure¡¯s product candidate, OpRegen&reg;, preserved vision
and retinal structure when transplanted into...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3be6cdb5-a5a4-4276-91e2-59d843eedd8a.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Soligenix
Announces Presentation and Poster at the 2015 Chemical and Biological Defense
Science and Technology Conference in St. Louis, MO</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Soligenix, Inc. (OTCQB: SNGX) (Soligenix or
the Company), a late-stage biopharmaceutical company developing products that
address unmet medical needs in the areas of inflammation, oncology and
biodefense, announced today that it will ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/27fe3435-aaeb-437b-b42f-1be328c5c160.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
burden of disease on HIV-infected orphaned and non-orphaned children accessing
primary health facilities in a rural district with poor resources in South
Africa: a cross-sectional survey of primary caregivers of HIV-infected children
aged 5&iquest;18 years</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Infectious Diseases of Poverty</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Provider-initiated HIV testing and counseling (PITC)
is offered as part of the normal standard of care to increase access to
treatment for HIV-infected children. In practice, HIV diagnosis occurs in late
childhood following recurrent and...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 8:41:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/831b7164-b6b9-47e9-85d8-16e6bd4a6aec.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Azithromycin
ineffectively treats macrolide-resistant M. genitalium</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Azithromycin appeared to have a high rate of failure among
patients infected with Mycoplasma genitalium who demonstrated pre-treatment
macrolide resistance, according to recent findings.Researchers evaluated 155
adult patients treated for M. genital...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 4:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8d13ab56-3895-4a08-860c-1fd8c8d91f6d.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Top
20 Up-and-Coming Molecular Diagnostics Companies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 4, 2015 1:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/48333338-0018-49e1-a536-56aeb6f811b9.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics (HTGM) Announces May 7th IPO</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 4:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/45dc7136-eaee-4fe6-a48b-cffd7834a7c4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>For
the Very First Time: FDA Clears New Sacroiliac Joint Fusion Screws For Use With
Alternate Posterior Approach on April 24th, 2015</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRWeb - Daily News Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>On April 24th, 2015, SpineFrontier officially received FDA
clearance to begin manufacturing and distributing their new Sacroiliac Joint
Fusion (SIJ Fuse) system, which is 510k cleared for an alternate posterior
surgical approach.(PRWeb May 03, 2015)...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 3:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5218fb06-236f-445f-a148-4923a33e05ab.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Could
a 1968 report have prevented riots in Baltimore and Ferguson?</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>TORONTO STAR</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>¡°This is our basic conclusion: Our nation is moving toward two
societies, one black, one white ¡ª separate and unequal.¡±¡ª Kerner Report,
February 1968To hear the hyperventilating talking heads of CNN tell it, the
riot this week in Baltimore ¡ª as with...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 2, 2015 9:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/15c821d7-a3e8-4681-8720-53aa86c4b389.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genetic
testing in workplace?</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>TribLIVE Today's Stories RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Your employer may one day help determine if your genes are why
your jeans have become too snug. Big companies are considering blending genetic
testing ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 3:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a50f9d52-167b-403a-8418-1f28084a34b7.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
epidemiology and seroprevalence in asymptomatic Plasmodium falciparum
infections of Malagasy pregnant women in the highlands</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Malaria Journal</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Malaria epidemiology in Madagascar is classified
into four different areas, ranging from unstable seasonal transmission in the
highlands to hyperendemic perennial transmission areas in the costal level.
Most malaria studies in Madagascar...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 2, 2015 8:41:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/15fa6908-f653-47bb-ab63-da403efd0641.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Week
in Review: WuXi PharmaTech Announces $3.3 Billion Go-Private Offer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>WuXi PharmaTech, China's largest CRO/CMO, received a $3.3
billion privatization offer from Dr. Ge Li, the company's CEO/founder, and Ally
Bridge Group; China Cord Blood announced a take-private offer of $512 million
from Golden Meditech Holdings, it...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 2, 2015 1:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e9f831c0-974d-4f1f-b598-b36ad923ec24.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Luspatercept
Data Presented at the 13th International Symposium on Myelodysplastic Syndromes</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Acceleron Pharma</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>In lower risk MDS patients, Acceleron's luspatercept increased
hemoglobin levels and enabled transfused patients to become transfusion
independent per preliminary data from ongoing Phase 2 trial</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 2, 2015 10:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f0aaf303-5912-4695-a0b4-5b630e12c50d.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agena
names Bioyong Technology as fifth certified service provider in China</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PharmaBiz.com</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Agena Bioscience, a life sciences and clinical diagnostics
company, has named Bioyong Technology, engaged in life science services and
instrument distribution, as the fifth certified service provider (CSP) for its</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 3, 2015 3:40:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fac61071-a7be-422b-a43f-711d6aa26087.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abaxis
Reconfigures Executive Management Team</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Abaxis Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UNION CITY, Calif., April 30, 2015 /PRNewswire/ --Abaxis, Inc.
(NasdaqGS: ABAX), a medical products company manufacturing point-of-care
instruments and consumables for the medical, research, and vet...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 2, 2015 8:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ad0125b7-a184-470a-91ef-0801ed1e6579.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>How
Strong Are Your Bones? May is National Osteoporosis Month The National
Osteoporosis Foundation (NOF) Offers Free Resources and a Bone Basics Webinar
to Raise Awareness about Osteoporosis and Fractures</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- NOF is kicking off National
Osteoporosis Month today and issuing a call to action to Break Free from
Osteoporosis. As part of the awareness and educational initiative, NOF is
offering free resources and a webinar to help ra...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 10:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/137b6fda-3a2f-41ee-9826-714ce9c0b061.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Healthcare
Sector Movers: Advaxis, Inc. (ADXS), Synta Pharmaceuticals Corp. (SNTA), Dyax
Corp ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 4:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e6d9a2a7-de6d-41f3-81f5-7e76270d4359.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nancy
Brinker Named May LUNGevity Hero Founder of Patient Advocacy Movement
Recognized for Creating Change in Cancer Conversation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>WASHINGTON, May 1,&nbsp;2015 /PRNewswire-USNewswire/ --
LUNGevity Foundation announces Nancy Brinker as the May LUNGevity Hero in
recognition for her decades-long dedication and trailblazing work in the fight
against cancer. A true pioneer of the advocacy...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 2:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1e3302ba-a1a6-47f8-b9d5-d9e53b150a73.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novel
single-sample test quickly diagnoses any infection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A novel diagnostic platform may be able to quickly and
accurately identify any viral or bacterial infection after analysis of a single
specimen, according to a press release.¡°Our current tests can be expensive,
time consuming and aren¡¯t always accur...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 1:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/aaa02099-dcfd-45b9-9cf7-9b78da9b46ba.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LABSCO
Enters an Exclusive Partnership with BioFire Diagnostics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>LABSCO</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>LABSCO expands its best-in-class clinical diagnostics portfolio
with access to BioFire's FilmArray&reg; product line in specified laboratories in
the 48 contiguous United States.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 1:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/23920d88-9643-4f8e-b726-09673bb78fa8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Products for Exosome Isolation to mRNA Purification</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Hitachi Chemical Diagnostics, Inc. is pleased to
announce the United States launch of the ExoComplete&#8482; 96-Well Plate Kit and
ExoComplete&#8482; Tube Kit, an integrated, fast and easy system for exosome
collection to mRNA purification.&nbsp; The ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 12:36:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/213ac202-845e-416e-8f05-cccaaf3ab19d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
approves pregnancy blood test from Abbott</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FDLI SmartBrief</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>div.c1 {clear:both;margin:20px auto;color:#666;} The FDA has
granted Abbott approval for its i-STAT Total -hCG, a blood test that can
determine the pregnancy status of women&nbsp;-More-&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 10:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2bf9838d-10ec-4840-8452-23de275a7d88.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ac&micro;Ray
System Uses Acoustics to Spot Biomarkers of Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medgadget</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Scientists at Emory University and Georgia Tech have developed a
new device called Ac&micro;Ray that uses sound waves to detect biomarkers,
potentially leading to a general purpose system&nbsp;for diagnosing&nbsp;a
variety of conditions. The device accepts a specia...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/16edb538-a136-4a30-b01d-8ae567b4760d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. As the Weekend Nears: We¡¯re Catching up on Medicare Part D, Novo
and Lots More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>div.c3 {text-align: left;} dl.c2 {width: 262px;} dd.c1
{text-align: right;} Associated PressAnd so, another working week will soon
draw to a close. Not a moment too soon, yes? This is, you may recall, our
treasured signal to daydream about weekend p...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 9:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/92f5ff42-10c5-41e4-b3e8-30fb6415cdeb.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Test
can predict with ¡®100% accuracy¡¯ if someone will develop cancer up to 13 years
in the future, scientists say</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>National Post - Top Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>A test that can predict with 100 per cent accuracy whether
someone will develop cancer up to 13 years in the future has been devised by
scientists.Harvard and Northwestern University discovered that tiny but
significant changes took place in the bod...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 9:16:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5c30be7a-6dd1-4fba-9900-56562d018cf4.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clinical
Trial Moves Stem Cell Therapy for ALS Patients One Step Closer to Reality</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-iReach/ -- Stem cells are a safe therapy for
patients with amyotrophic lateral sclerosis (ALS), according to the results of
a recently completed phase 1 clinical trial. Details of the trial, conducted by
scientists in South Korea, are pub...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/a3402e15-e87f-460d-8685-cabd2c4989f0.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Antithrombotic
Drugs: World Industry and Market Prospects 2015-2025</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d5507526-e547-424c-8be3-1360f7dca957.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Waksal¡¯s
Kadmon Spins Out Gene Therapy Group But Keeps Details Close</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Alex Lash As it heads toward an IPO try, New York biotech Kadmon
is lightening its load. The firm announced today it has spun out a gene-therapy
subsidiary and expects it to have four products in clinical trials next year
with a focus on eye disease...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 6:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8432da81-0d01-4f4e-9d55-430e2e3624d4.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>All
Os</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Soon, for a blood transfusion, it may not be necessary to match
the receiver¡¯s blood type with the donor¡¯s. Scientists at the University of
British Columbia (UBC), Canada, have discovered a method to convert all blood
into type O, the universal dono...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 3:14:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/88c472b2-93fc-4f90-8f3a-3fac7305b20d.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Department
of Health Reminds Pennsylvanians of Prevention and Treatment Options Available
for Hepatitis May is National Hepatitis Awareness Month</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- In observance of National Hepatitis
Awareness Month, Acting Secretary of Health Dr. Karen Murphy today reminded
residents of Pennsylvania that hepatitis A and B are vaccine-preventable
diseases.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 10:12:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/09034193-44ae-4d7e-a1ce-feeb6188a1b0.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Heska
to Present at the 16th Annual B. Riley &amp; Co. Investor Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Heska Corporation (NASDAQ: HSKA - News;
&quot;Heska&quot; or the &quot;Company&quot;), a provider of advanced
veterinary diagnostic and other specialty veterinary products, today announced
that Robert Grieve, Executive Chair, will present at the 16th Ann...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/22c6d1ac-ed70-4faa-81f0-165565cd5e27.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
¡®river¡¯ retreat</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The brainchild of London-based lawyer, Anup Shah, and also his
maiden hospitality project, Resort Rio Goa has established itself as one of the
leading MICE and wedding venues in north Goa in a short span of five years By
Rituparna ChatterjeeAnup Sha...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 11:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8ea5a0b5-4669-4fe0-9fb8-376eecbdb17b.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Technavio
Publishes New Industry Analysis on the Global POC Infectious Diseases Market
2015-2019</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Technavio Research</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>As the prevalence of infectious diseases increases, the global
POC infectious diseases market is expected to grow at a CAGR of 7.50% from
2015-2019, says research firm Technavio.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 11:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bc8fd8e6-9968-4e5b-9bcd-f0fed1ef0af4.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Five-Year
Follow-Up Study Further Supports Effectiveness and Safety of the Essure&reg;
Procedure as a Non-Surgical, Non-Hormonal Option for Permanent Contraception</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Bayer HealthCare announced today that a
study published online this week in The Journal of Minimally Invasive
Gynecology reinforces findings from previous clinical studies that support the
effectiveness and safety of the Essure&reg; inser...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 10:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/eca9fe6e-9ece-4930-b59b-51c9ba79a260.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CytRx
Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;CytRx Corporation (CYTR), a
biopharmaceutical research and development company specializing in oncology,
today reported financial results for the three months ended March 31, 2015, and
provided an overview of recent accomplishments an...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/de9e3c1d-6d8a-4d15-ade2-66eab3117a67.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Jersey Acting Governor Kim Guadagno Joins Siemens to Unveil Major Expansion and
Renovation of Healthcare Diagnostics Facility in Flanders</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Siemens Healthcare Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New Jersey Acting Governor Kim Guadagno today joined Siemens
Healthcare Diagnostics and Siemens Real Estate (SRE) to unveil an expanded
state-of-the-art production facility and new open-plan workspace at Siemens¡¯
Flanders, New Jersey site. Acting Go...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0d1e546b-6632-4d24-bf11-0fb2a9c05533.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tucson
biotech firm HTG about to go public</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 2, 2015 3:37:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/265d8a17-8a62-4b0e-870a-9516f98b865c.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>May
1, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>DiagnoCure Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRESS RELEASE DiagnoCure announces results of its Annual and
General Meeting of shareholders</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 5:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e4de4d04-1fe5-40e4-88ac-582c1ba673f3.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hammes,
Majestic Realty Propose Exciting Plan to Redevelop Judge Doyle Square</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exact Sciences Corp.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Hammes Co. and Majestic Realty today announced that they
have submitted a proposal to the City of Madison that could relocate Exact
Sciences Corp. to downtown Madison.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 3:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9f12763b-7856-4fb8-a2cd-06a51b058d3d.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vermillion
Developing Two New LDTs with Aim of Early Ovarian Cancer Detection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 2:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7d2b357a-5bef-497c-8672-347b47181e3d.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PMC
Paper Asks Policymakers to Consider Impact of Alternative Payment Models on
Personalized Rx</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US><a href="https://www.genomeweb.com"><span
style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>https://www.genomeweb.com</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 2:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/847b8514-0fb4-4f7d-86e1-5bdba03cfe99.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Printer
Friendly Version</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Abaxis Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>UNION CITY, Calif., April 30, 2015 /PRNewswire/ --Abaxis, Inc.
(NasdaqGS: ABAX), a medical products company manufacturing point-of-care
instruments and consumables for the medical, research, and vet...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 11:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0998b414-35f7-46c0-8e4d-a024350d8734.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Calcifediol
Industry 2015-2020 Research for Global and Chinese Markets</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>and Selected Emerging Economies, September 2012-March 2013
Figure 2005-2013 Chinese GDP and Growth Rates Figure 2005-2013 Chinese CPI
Changes Figure 2008-2015 Chinese PMI Changes Figure 2005-2015 Chinese Financial
Revenue and Growth Rate Figure 2005-...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 2:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/11cdd605-de89-45a8-89c1-629e7132a2ac.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NetScientific
Forms Digital Health Company with US Hospital Group, Meridian Health</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NetScientific</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>NetScientific (AIM: NSCI), the biomedical and healthcare
technology group, has formed a new digital health sales and marketing
subsidiary company, Triventis Health LLC (¡°Triventis¡±) in partnership with iMPak
Health, LLC (¡°iMPak¡±), a wholly owned sub...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 7:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f7d49e8a-c4bd-4d9c-b890-50d26c3cc437.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Analysis
of REVLIMID&reg; (Lenalidomide) in Patients with Non-Del-5Q MDS Demonstrated
Improved Health Related Quality of Life Measures</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Celgene Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Celgene Corporation (NASDAQ:CELG) today announced results from a
pre-specified secondary endpoint analysis of MDS-005, a multicenter, randomized,
placebo controlled phase III study of REVLMID&reg; (lenalidomide) compared with
placebo in patients with no...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c16df803-d7a8-42d7-83a7-caf3b7b1c011.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pivotal
Therapeutics Announces 2014 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE:
PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for
cardiovascular disease (CVD) and overall health, announced its operational
highlights and financial results f...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:21:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ea5e66e8-cf6f-4b36-ab5e-aa6d8a507d72.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sorin
Group Announces the Latest Results on Perceval Valve Presented at the 95th
American Association of Thoracic Surgery (AATS) Annual Meeting in Seattle</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Sorin Group</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Data presented at 95th AATS annual meeting demonstrate improved
clinical outcomes after use of the next-generation PERCEVAL sutureless aortic
valves in European patients with severe aortic stenosis.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 11:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/30e14e9a-69e7-4831-8b69-148aaa9d9023.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abbott's
First-of-its-Kind Blood Test to Aid in Detecting Early Pregnancy Could Help
Doctors Make Faster Treatment Decisions for Women ABBOTT RECEIVES U.S. FOOD AND
DRUG ADMINISTRATION (FDA) CLEARANCE FOR ITS I-STAT&reg; TOTAL ¦Â-HCG TEST</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>.1 In emergency situations, it is critical for doctors to know
the pregnancy status of women who are of childbearing age as soon as possible,
since this influences decision-making when it comes to medications, imaging,
surgery and other clinical care...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/eb19ede5-25a1-4e56-9adb-76c23d40264a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Semler
Reports First Quarter 2015 Financial Results Period over Period Growth of 44%;
Quarterly Sequential Growth of 14%</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), an
emerging medical risk assessment company that develops, manufactures and
markets products that assist healthcare providers in monitoring patients and
evaluating chronic diseases, today report...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 8:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f049fe17-0b39-4401-b610-fea9357aee99.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LRI
Brings Lupus Into Focus During Lupus Awareness Month</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI),
the S.L.E. Lupus Foundation and the LRI National Patient Coalition members
recognize Lupus Awareness Month with a wide range of events spotlighting the
need for early diagnosis of lupus a...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/78cb1e97-b214-4c98-b812-75be364fc086.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Americord
Secures an &quot;A+&quot; Rating from the Better Business Bureau Cord Blood
Bank Receives Recognition for Customer Service</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Americord Registry, a private cord blood,
cord tissue, and placenta tissue banking company, announced today that it has
secured an &quot;A+&quot; rating from the Better Business Bureau.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/81063301-1da3-459e-965f-da2471a939bd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Boston
Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Boston Scientific Corporation (NYSE: BSX)
is presenting an overview of its continued business momentum and long-term
growth strategies at a meeting with the investment community today in New York
City. President and Chief Executive Of...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0ba2bbed-2397-4b8e-9a83-ceb950dd827b.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Advanced
Inhalation Therapies Granted European Orphan Drug Designation for Nitric Oxide
for the Treatment of Cystic Fibrosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/e71a711d-5159-4a25-98fc-f062b1c4374a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Atlas
Genetics Annual Summary 2014</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BATH, England, May 1, 2015 /PRNewswire/ -- Atlas Genetics Ltd
(&quot;Atlas&quot; or the &quot;Company&quot;), developer of innovative,
ultra-rapid diagnostics to enable a 'test and treat' solution to infectious
diseases, today announces its Annual Summary for 2014. Com...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 2:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/52fd2c4d-320f-4695-b5af-57e263be0edd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Llamas
as Lab Rats</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Scientist RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>From diagnostics to vaccines, llama antibodies point to new
directions in HIV research.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 2:14:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/f857938c-555f-459a-99d6-ea942ac23fad.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Atlas
Genetics Annual Summary 2014 Setting the new standard in decentralised
molecular diagnostics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 2:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/bcfd5575-85b1-48c0-b9bb-a6c41ee430c1.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Validity
and reliability of the Finnish version of the Functioning Assessment Short Test
(FAST) in bipolar disorder</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>International Journal of Bipolar Disorders</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: The Functioning Assessment Short Test (FAST) was
developed for the clinical evaluation of functional impairment of patients
suffering from bipolar disorder. The aim of this study was to validate the
Finnish version of FAST. Methods: Tran...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4aeec2e1-75c7-46cc-9b90-b7364d724601.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>West
Coast Biotech Roundup: Kythera, Amgen, Otonomy, Versant &amp; More</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Xconomy</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>div.c1 {float:right;margin: 0px 0 5px 15px;} Alex Lash West
Coast news this week was dominated by thumbs. Amgen, Otonomy, and Kythera all
got a regulatory thumbs-up for their products. Some thumbs were down, however.
Celladon¡¯s cardiovascular gene t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:28:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1dcfb4b2-a382-49f8-8039-e32d12f260bd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Immunexpress
to Submit Molecular 'Immune Response' Sepsis Assay to FDA in May</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/86390533-cbb7-4a55-afa6-71a37e5097e6.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abbott
grabs FDA OK for early pregnancy blood test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceDiagnostics News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Abbott got an FDA greenlight for its early pregnancy blood test,
a feather in the company's cap as its diagnostics unit continues to deliver
solid sales gains.&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:33:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/07078893-bf92-4bff-a445-58664c842133.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roka
Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Roka Bioscience, Inc. (NASDAQ: ROKA), a
molecular diagnostics company focused on providing advanced testing solutions
for the detection of foodborne pathogens, announced plans to release its
financial results for the first quarter of ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/37657af2-b808-497a-9818-501265609b33.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cabozantinib
and Cobimetinib to Be Featured in Fourteen Presentations at 2015 ASCO Annual
Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exelixis, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Exelixis, Inc. (NASDAQ: EXEL) today announced that the
Exelixis-discovered compounds cabozantinib and cobimetinib will be the subjects
of fourteen presentations at the upcoming 2015 Annual Meeting of the American
Society of Clinical Oncology (ASCO)....</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:25:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/48c32e14-f8f8-45da-81dd-fe63ffe3cc11.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>France's
Echosens reels in 30M for international expansion</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceDiagnostics News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>French diagnostics outfit Echosens roped in 30 million ($33
million) in funding to build out its liver testing portfolio and generate
international growth.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:19:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/09f3f712-40a9-4f5b-b3cc-5b2dc057a674.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SurModics
Reports Second Quarter Fiscal 2015 Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SurModics, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SurModics today announced results for its fiscal 2015 second
quarter, ended March 31, 2015.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c4e3caed-b1b3-4ca0-b48a-426d09d4fde3.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mammograms
at Coastal Diagnostic Center in Pismo Beach, California: FDA Safety
Communication - Quality Problems</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>MedWatch Safety Alert RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Patients may need a repeat mammogram or additional medical
follow-up.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 3:19:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/012053cd-0a68-4f79-8edd-6b6e19e0c4cc.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Problem
with Quality of Mammograms at Coastal Diagnostic Center in Pismo Beach,
California: FDA Safety Communication</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Food and Drug Adminstration (FDA): CDRHNew</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The FDA is alerting patients who had mammograms at Coastal
Diagnostic Center located in Pismo Beach, California anytime on or after
February 24, 2013, about possible problems with the quality of their
mammograms. This does not mean that the results ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 2:19:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/17e8d3b8-973e-4633-b25c-bf578f0638dd.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>GeneNews
to Present at the 2015 Bloom Burton &amp; Co.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>GeneNews Press Releases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>GeneNews to Present at the 2015 Bloom Burton &amp; Co.
Healthcare Investor Conference</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:51:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/aabd5a45-67b0-4a3a-882f-e2755fab3aac.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Complaint
by Prolias Technologies, Inc. against PDI, Inc. alleges Breach of Contract,
Breach of Covenant of Good Faith and Fair Dealing, Intentional Interference
with Contract, and Breach of Fiduciary Duty</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Prolias Technologies, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Prolias Technologies, Inc. has filed suit against PDI Inc.
(NASDAQ: PDII), a New Jersey-based company. PDI Inc. is alleged to have engaged
breach of contract, breach of covenant of good faith and fair dealing,
intentional interference with contract,...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:47:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/37ed0e5b-d6e9-4d89-93f5-90a771c86b59.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Colored
Pencils Developed for Easy Chemical-based Diagnostic Testing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medgadget</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Thanks to a team of researchers from California Polytechnic
State&nbsp;University, chemicals formed into pencils can be used to react with
each other by simply drawing&nbsp;with them on a piece of paper. The work,
published recently in the journal Lab on a Ch...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/cdf9643a-810f-4f2d-968b-b76bd5d8ce3d.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Navidea
Biopharmaceuticals to Announce First Quarter 2015 Financial Results on May 12,
2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Navidea Biopharmaceuticals, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Navidea to report financial results for the first quarter 2015,
on May 12, 2015 prior to a conference call with the investment community,
scheduled at 8:30 a.m. EDT.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/11c84d4b-f972-4c24-9876-3216ac02c3d8.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PAML
and BloodworksNW Sign Letter of Intent to Collaborate on Innovation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- Pathology Associates Medical Laboratories, LLC
(PAML) and Bloodworks Northwest (formerly Puget Sound Blood Center) have signed
a Letter of Intent to collaborate on the delivery of specialized laboratory
diagnostics and clinical servic...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6a19e042-fbd8-45af-b6bf-e547c4d3bd63.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
wants manufacturers to test APIs in hospital antiseptics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FiercePharmaManufacturing News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Doctors and nurses hundreds of times a day may use over-the-counter
antiseptic before giving shots or doing surgery. But the FDA would like to know
the long-term effects of using that stuff day in and day out.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/79185a9c-004a-4c21-a97b-20d85db97e8a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Apple
research apps to require ethics board approval</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmafile - News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New guidelines will require apps developed for Apple¡¯s
ResearchKit health platform to be approved by an independent ethics board.The
ResearchKit software offering lets people volunteer to join medical research
studies conducted via apps that use iPh...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/7e8981da-e217-4c9f-ab0d-11ec1602a248.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vince
Young Helps CureDuchenne Raise More than $300,000 to Find a Cure for Duchenne
Muscular Dystrophy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CureDuchenne</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>In 2005 while Vince Young was leading his University of Texas
teammates to a coveted national title, the Revell family in Austin was learning
that their young son had Duchenne Muscular Dystrophy and might be
wheelchair-bound by the time he was in co...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d48da232-9e9d-4a74-ac37-6accb63dad2a.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We¡¯re Catching up on Teva, Double Chins and Lots
More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Pharmalot</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>div.c3 {text-align: left;} dl.c2 {width: 262px;} dd.c1
{text-align: right;} Zuma PressGood morning, everyone. How are you doing so
far? Another busy day is upon us, although we are cheered by the presence of a
warm and shiny sun enveloping the unusu...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3dc39666-5335-4309-9b4f-fa358accc9fe.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abbott's
First-of-its-Kind Blood Test to Aid in Detecting Early Pregnancy Could Help
Doctors Make Faster Treatment Decisions for Women</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Abbott MediaRoom</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ABBOTT RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA)
CLEARANCE FOR ITS I-STAT&reg; TOTAL ¦Â-HCG TEST</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:16:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/3c38281f-1f07-46bc-a09b-22b54476a01b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Men's
magazine uses ink containing HIV-positive blood for special issue</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>News - Latest breaking UK news</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Austrian magazine Vanguardist uses ink containing infected blood
to draw attention to plight of HIV sufferers</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 7:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/eaf0e4fa-4365-42c7-ab54-408291ba11b2.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Children's
National researchers uncover new T-cell immunity role in study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Immune System / Vaccines News From Medical News Today</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Children's National Health System researchers, joining other
teams, have uncovered new evidence that T-cells, a type of blood cells, can
effectively restore antiviral immunity after transplantation...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 7:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/572e23e9-5ed8-47da-80e3-e2b2d83fa429.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tattoo
snafu irks inked Apple Watch wearers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>div.c1 {width: 790px} Owners of Apple Watch have found that
their inked skin confuses the sensors on the underside of the device.
(Reuters)Early adopters of the Apple Watch, Apple Inc¡¯s first new product in
five years, are complaining that a number ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 4:14:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b3392278-188b-4d9b-8dba-dcc98dbf2f97.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Patient
education for alcohol cessation intervention at the time of acute fracture
surgery: study protocol for a randomised clinical multi-centre trial on a gold
standard programme (Scand-Ankle)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Surgery</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Background: Patients with hazardous alcohol intake are
overrepresented in emergency departments and surgical wards. These patients
have an increased risk of postoperative complications with prolonged hospital
stays and admissions to intensive care u...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/31ddf6a0-21e1-490e-a34a-8ef3ed49c29b.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Government
Releases Massive Trove of Data on Doctors¡¯ Prescribing Patterns</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>ProPublica: Articles and Investigations</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>by Charles OrnsteinThe federal government released detailed data
today on nearly 1.4 billion prescriptions dispensed to seniors and disabled
people in the Medicare program in 2013, bringing more openness to the
medication choices of doctors nationwi...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 5:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6f4e2bfa-49a6-4948-bb54-8199ceb96b49.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Canadian
Blood Services to close 3 clinics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>CBC | Health News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Canadian Blood Services says it is closing closing three
permanent clinics, discontinuing mobile blood donor clinics in 16 communities
and ending the bloodmobile program.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:33:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/efe456a8-bcc9-414f-85cc-a1b257ee08a9.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abaxis
Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and
Declares a 10% Increase in Quarterly Cash Dividend</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>img.c1 {padding-right:5px;} UNION CITY, Calif., April 30, 2015
/PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care blood analysis systems, today reported financial
results for the fourth quarter and ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d4f55905-2c4c-4c36-a0ff-5bd67effbe0a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Implant
Delivers Antiretroviral Drug to Stop Spread of HIV</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medgadget</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Antiretroviral drugs require patients to adhere to a strict
dosing regimen, but as with other diseases patients tend to slack off, often
paying a high price. Researchers&nbsp;at the Oak Crest Institute of Science in
Pasadena, California have developed a ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:37:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/5f68f613-e525-4c64-85ea-3f37e23c6bad.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Test:
Tweety McxDreamy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Gazette - Business</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Doug Camilli: What¡¯s next for Patrick Dempsey, after his
character was abruptly killed off last week on Grey¡¯s Anatomy? Maybe not all
that abruptly, actually. He and show-runner Shonda Rhimes have been hinting at
this for some time, it turns out. Sh...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:34:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/acf3b19b-1ae2-4662-8adf-5d7e5aef34fa.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nonin
Medical&reg; and IDEAL Life&reg; Announce Telehealth Partnership for COPD Remote
Patient Monitoring New System to be demonstrated at American Telemedicine
Association 2015 show</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Nonin Medical, Inc., the inventor of finger
pulse oximetry and a leader in noninvasive medical monitoring, today announced
it has partnered with IDEAL Life, a Toronto-based leader in remote health
management solutions. IDEAL Life will...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b9eeffb1-adf1-443e-9b00-bd92f4b818bf.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Scientists
Discover a Way To Change Blood Types, University of British Columbia Reveals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioSpace.com Featured News and Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Researchers Closer To Being Able To Change Blood Types What do
you do when a patient needs a blood transfusion but you dont have their blood
type in the blood bank? Its a problem that scientists have been trying to solve
for years but havent been ab...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/d1f28ca8-dfdd-407b-b487-4ef80a81cb72.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Poxel
2014 Annual Results in Line with a Major Post-Closing Event: the Successful
Company IPO in February 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>POXEL</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>2014 Annual Results in Line with a Major Post-Closing Event: the
Successful Company IPO in February 2015</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/07341a60-427e-465d-885b-1a0dfc83e71a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Scientists
Find Ways To Change Blood Types, University of British Columbia Reveals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioSpace.com Featured News and Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Researchers Closer To Being Able To Change Blood Types What do
you do when a patient needs a blood transfusion but you dont have their blood
type in the blood bank? Its a problem that scientists have been trying to solve
for years but havent been ab...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 11:21:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/9159ad62-07b4-4886-af1f-fd7bc0373035.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>University
of British Columbia Researchers Closer To Being Able To Change Blood Types</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BioSpace.com Featured News and Stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Researchers Closer To Being Able To Change Blood Types What do
you do when a patient needs a blood transfusion but you dont have their blood
type in the blood bank? Its a problem that scientists have been trying to solve
for years but havent been ab...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 10:20:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4f13d533-ce2d-4825-a12a-289204347bd2.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PlugMed
Has Been Awarded 2 Million of Funding for an Innovative Device in the
Treatment of Kidney Failure</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PlugMed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PlugMed has been awarded 2 million of funding, as part of the
World Innovation Challenge organized by the French Ministry of Industry. The
funding will enable the company to speed up the Geroneph project that aims at
developing an innovative device...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 10:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/843c80fd-d5e5-498d-831b-f584760c62cc.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PatientSafe
Solutions Leads the Conversations That Will Shape mHealth with Industry Leaders</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PatientSafe Solutions</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PatientSafe Solutions hosted more than 40 industry leaders from
top hospitals, health systems, and technology solution providers during a HIMSS
2015 breakfast event.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/ebc1314d-a73d-4d24-824c-b52e8ef0997a.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Survey
Shows Many Patients Are Not Receiving the Tools and Support They Need to Manage
Chronic Illness</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Family Medicine for America¡¯s Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Family Medicine for America¡¯s Health today released survey
results revealing that many Americans living with chronic diseases are not
getting what they need to manage their health.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/477057ab-2708-466d-84be-33f879df4c08.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Scientists
Are Figuring Out How To Change Blood Types</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Popular Science</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>At some point in your life, you¡¯ve probably been asked to donate
blood. If your blood is type O, you may have been asked to donate even more,
because your blood type is the¡­</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:16:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0da42525-d5fc-4ebd-9452-91afecdb6de8.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ResponseTap
Named a &quot;Cool Vendor&quot; in CRM Customer Service and Support by Leading
Analyst Firm, Gartner Vendors selected for the &quot;Cool Vendor&quot; report
are innovative, impactful and intriguing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dd3deba9-7900-4cf9-8fd5-fb4e2d650414.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Webcast
Alert: Heska Announces First Quarter 2015 Earnings Conference Call Webcast</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Heska Corporation (Nasdaq: HSKA) announces
the following Webcast: </span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/95cc2674-bfc8-478a-b562-d95ef45aad23.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Barnes
&amp; Noble Has All the Best Gifts for Mom this Mother¡¯s Day</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Barnes &amp; Noble, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Barnes &amp; Noble, Inc. (NYSE: BKS), the nation¡¯s largest
retail bookseller and the leading retailer of content, digital media and
educational products, has all of the greatest gifts for Mom this Mother¡¯s Day.
Books make the perfect gift for Mom, and B...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/6cf9281f-f64d-4c83-b1cf-942638bcdc97.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Americord
Secures an &quot;A+&quot; Rating from the Better Business Bureau</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire: Health</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>img.c1 {padding-right:5px;} NEW YORK, May 1, 2015 /PRNewswire/
--&nbsp;Americord Registry, a private cord blood, cord tissue, and placenta
tissue banking company, announced today that it has secured an &quot;A+&quot;
rating from the Better Business Bureau. Logo - ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 8:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/abcff253-bbcc-44fd-8db5-9679a8ba208d.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>[In
Depth] Embryo engineering study splits scientific community</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>On 18 April, a Chinese team published the first-ever report on
genetically altered human embryos. It ignited a firestorm of controversy and
exposed a rift in the scientific community. Researchers at Sun Yat-sen
University in Guangzhou reported how t...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c228f971-a224-4575-b7b5-3d7f1be3580e.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Prayer
for the Pacman</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:28:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/1f28dbd8-43bb-443d-84db-e5b32e63c65c.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bio-Path
Holdings Appoints Tara Sadeghi As Director of Clinical Operations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bio-Path Holdings, Inc.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Bio-Path Holdings Appoints Tara Sadeghi As Director of Clinical
Operations</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 12:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/4cc516f4-60da-4829-abd5-57b5656626e4.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fitch
Rates Bristol-Myers Squibb's Euro Bond Issuance 'A-'</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fitch Ratings</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fitch Ratings has assigned an 'A-' rating to Bristol-Myers
Squibb Co.'s (Bristol- Myers, Bristol, BMY) Euro Bond issuance. The net
proceeds from the issuance are expected to be used to fund, in part, the
redemption of the company's existing 2016 and...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 10:25:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/126bae6e-16b5-4e66-9c18-6113a015d581.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Passive
surveillance fails to detect pertussis in adults, older children</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Healio.com INFECTIOUS DISEASE RSS Feed</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Passive surveillance may be associated with failure to detect
symptomatic pertussis, particularly among adults and adolescents.These findings
suggest that providing clinics with free, rapid laboratory diagnostic testing,
along with improved monitori...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fa39715b-52d6-4289-bb95-eec4f6bf82b2.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>2014
Minnesota HIV report shows increase in new cases Targeted education,
prevention, testing and connection to health care critical</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire-USNewswire/ -- According to statistics released by
the Minnesota Department of Health, 307 confirmed new cases of HIV were
reported in Minnesota during 2014. The 307 new cases represent a 2 percent
increase from 2014. The Minnesota AIDS P...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 3:25:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/fb56efa6-f6a3-4c83-be08-e19c23572e1d.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Optimizing
treatment protocols when diagnostics are costly</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>HIV-1 continues to spread globally. While neither a cure, nor an
effective vaccine are available, recent focus has been put on
'treatment-for-prevention', which is a method by which treatment is used to
reduce the contagiousness of an infected perso...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 2:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/50eb98e1-b63c-4d9a-99bb-156e09e55785.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Center
for Infectious Disease Research Hosts ¡°Rally for Global Health¡±</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Center for Infectious Disease Research</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Center for Infectious Disease Research (formerly Seattle
BioMed) hosted the ¡°Rally for Global Health¡± today to raise awareness for the
Washington state global health and life-sciences industries and formally launch
a petition urging congress to ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:58:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/952069d5-9ff1-482a-8ebd-62deed1e0086.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Screening
for HIV in GP surgeries leads to increased and earlier diagnosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Medical Xpress - latest medical and health news stories</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Training general practices to offer rapid HIV tests leads to
increased detection and earlier diagnosis of patients with HIV infection ¨C
according to a new study led by Queen Mary University of London (QMUL) and
published in The Lancet HIV.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 11:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/0b697814-11ec-48ef-912a-0dab4770552e.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Harvard
point-of-care hand-held cancer diagnostic spinoff WaveGuide raises $13.9M</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>FierceMedicalDevices News</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Startup WaveGuide has raised $13.9 million of an intended
ultimate total of $20 million to fund its point-of-care handheld nuclear
magnetic resonance (NMR) spectrometer that works with nanoparticles for the
diagnosis of cancer and infectious disease...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 10:21:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/dfe132f0-903c-415a-b46c-60efa48292ce.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fluidigm
to Announce Q1 2015 Financial Results and Host Conference Call for Investors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluidigm Corporation</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Fluidigm Corporation (NASDAQ:FLDM) will report its first quarter
2015 financial results on May 7, 2015, after close of market.</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/2492d827-efa9-4450-ade1-62c804b2284e.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fortis
Healthcare to sell RadLink for over Rs 530 cr</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>The Financial Express &raquo;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>div.c1 {width: 790px} RadLink provides diagnostic and molecular
imaging services. (Reuters)Wrapping up sale of its major international assets,
Fortis Healthcare¡¯s Singapore-based arm will offload 100 per cent stake in
RadLink for SGD 111 million (ov...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 5:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/02f1d164-23b1-4f25-9a35-e3d06f4a5e31.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Reactive
Oxygen Species Regulates Cytoplasmic snoRNAs [Cell Biology]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Small nucleolar RNAs (snoRNAs) guide nucleotide modifications of
cellular RNAs in the nucleus. We previously showed that box C/D snoRNAs from
the Rpl13a locus are unexpected mediators of physiologic oxidative stress,
independent of their predicted r...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>May 1, 2015 1:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/8ff4cf52-701f-4af8-9dc1-449f9d685409.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
Diagnostics Market 2017 Forecasts Research Report</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 10:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/b6502409-b6dc-4028-89b9-c69f03f1289c.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>DiagnoCure
announces results of its Annual and General Meeting of shareholders</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) (the
&quot;Corporation&quot;) today announced that its shareholders have approved
all resolutions presented to them in the Management Proxy Circular dated March
5, 2015 and put forth for vote during the ...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 6:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/52633eec-44ed-4f2d-a11f-b2521f9bc2dd.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
England Biolabs&reg; and Universal Wilde announce the release of the NEB&reg; 2015-16
Catalog &amp; Technical Reference The first CarbonNeutral&reg;-certified catalog
produced in the USA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- New England Biolabs (NEB) and Universal Wilde
together announce the release of NEB's 2015-16 Catalog &amp; Technical
Reference. The NEB catalog, which has served as a resource for scientists
around the world for 40 years, will be the firs...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 5:33:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/c6a5b627-975d-42da-85b4-1384975bf233.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Associates
For Breast And Prostate Cancer Studies Honors Chandra Wilson And Brandi
Glanville At Annual Mother's Day Luncheon Actress, Comedienne Lisa Ann Walter
Hosts</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ -- The Associates For Breast and Prostate Cancer
Studies, affectionately known as the ABCs, hosts its annual, star-studded
Mother's Day Luncheon at the Four Seasons Hotel at Beverly Hills, Wednesday,
May 6, 2015 to benefit breast and pro...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 2:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="http://infoviewer.infodesk.com/infodisplay/story/583babad-12c9-4df1-bf4d-ae1ae322f72f.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novel
Environmental Epidemiology Application for Pressure BioSciences' Barozyme HT48
High-throughput System Developed Scientists from the Northwestern University's
Feinberg School of Medicine Report on the Development of an Enhanced Method for
Determining Fetal Exposure to Maternal Smoke and Potentially Other
Environmental Pollutants Using the Recently Released Barozyme HT48 System.
Company Believes These New Applications Will Help Drive Revenue in 2015 and
Beyond.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PR Newswire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>/PRNewswire/ --&nbsp;Pressure BioSciences, Inc. (OTCQB: PBIO)
(&quot;PBI&quot; or the &quot;Company&quot;), a leader in the development and
sale of broadly enabling sample preparation solutions using pressure cycling
technology (&quot;PCT&quot;)-based instruments and consumables to th...</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 9:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150802076572.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abaxis
Reconfigures Executive Management Team</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151600306246.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardiovascular
Systems Reports Fiscal 2015 Third-Quarter Financial Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151600306246.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardiovascular
Systems Reports Fiscal 2015 Third-Quarter Financial Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150916335380.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amgen
Announces FDA Advisory Committee Meeting To Review Repatha&#8482; (Evolocumab) As A
Treatment For High Cholesterol</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:16:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150801066550.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genomic
Health Announces Publication of Oncotype DX&reg; Prostate Cancer Test Decision
Impact Study in Urology Practice, Supporting Wider Adoption and Reimbursement</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150730316700.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celgene
Reports First Quarter 2015 Operating and Financial Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150702186445.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HeartWare
International Reports $70.0 Million In First Quarter 2015 Revenue</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150701166646.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>One
Call Care Management Leads RIMS Panel on Legalized Marijuana and Its Impact on
the Workplace</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150701186425.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>EnteroMedics
Reports First Quarter 2015 Financial Results and Provides Business Update</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150700316633.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dr.
Roy First Joins Transplant Genomics as Chief Medical Officer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150600306555.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Acorda
Reports First Quarter 2015 Financial Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150402046720.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>53%
packaged drinking water samples in Maharashtra fail FDA test</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 4:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123411079.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alere
Receives FDA CLIA Waiver for Alere&#8482; i Influenza A &amp; B Test</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123371075.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Grants Waiver for HIV Test</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123331062.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Clears Wider Use of Rapid Test for Influenza</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123204934.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>U.S.
Food and Drug Administration Grants CLIA Waiver for Alere Determine&#8482; HIV-1/2
Ag/Ab Combo Test</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123204940.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Grants CLIA Waiver for influenza A, B Test</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920152202112921.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Second
draft of 21st Century Cures released</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 10:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151831506140.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>QuickSplint
to Exhibit at Upcoming American Academy of Cosmetic Dentistry in San Francisco</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151700176398.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>U.S.
Food and Drug Administration Accepts Supplemental Biologics License Application
for Opdivo (nivolumab) in Patients with Previously Untreated Advanced Melanoma</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 5:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151630326357.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Charles
River Laboratories Announces First-Quarter 2015 Results from Continuing
Operations</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042920151619194162.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Preeclampsia
Test Developer Carmenta Bought For Undisclosed Sum</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:19:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151615296332.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Exact
Sciences to Participate in May Conferences</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151602495969.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hologic
Announces Financial Results for Second Quarter Fiscal 2015</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151556195951.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SHAREHOLDER
ALERT: Levi &amp; Korsinsky, LLP Notifies Shareholders of Accelerate
Diagnostics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff
Deadline of May 18, 2015 - AXDX</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 3:56:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151440146183.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novacyt
Full Year 2014 Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 2:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151410145877.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>America's
Next Top Technicians are: Pennsylvania High School Students, Who Take 1st Place
at National Automotive Technology Competition</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 2:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151405170979.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmacological
Advancements In Neuroscience Drug Discovery &amp; Pre-Clinical Studies For
Fragile X Syndrome To Identify Drug Candidates For Autism Therapies Lead
Biotech Sector Research</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 2:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042920151306193581.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
approves first generic versions of Abilify</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 1:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151100155995.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Partners
HealthCare Announces ¡°Disruptive Dozen¡± Technologies for 2015 at the World
Medical Innovation Forum</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042920150924024493.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We're Catching up on Gilead, Merck and Lots More!!</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150915315829.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Florida
Skateboarders ¡°Carve to Cure Duchenne¡± To Save Local Child¡¯s Life</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920150903048780.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pamlico
BioPharma Announces Financing Led by Accele Venture Partners</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150901055269.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Frost
&amp; Sullivan Names Toshiba America Medical Systems, Inc. Medical Imaging
Company of the Year, Recognizing Their Focus on Customer Partnerships</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150900195764.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>A
Phone with the Ultimate Macro Feature</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150856135757.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rosetta
Genomics¡¯ Patent on Therapeutic Use of miR-34a Upheld by European Patent Office
in Opposition Proceedings</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:56:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150846286836.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cambridge
Cognition: World Drug Safety Conference Hears Call for Wider Use of Cognitive
Safety Testing in Drug Development</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150830166821.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cytori
First Quarter Financial Results Update</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150813106634.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Microtransplantation
Less Aggressive Treatment for Elderly Patients with Acute Myleoid Leukemia</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:13:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150802076575.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Northwestern
Medicine Central DuPage Hospital's Advanced Comprehensive Stroke Center
Re-Certified</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150801056549.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Varian
Medical Systems and Sarah Cannon Cancer Network Expand Integrated Technology
for Radiation Oncology Program</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150800306729.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Myelin Repair Foundation and National Institutes of Health Initiate Clinical
Studies of Guanabenz for Treatment of Multiple Sclerosis</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150735286705.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celgene
and Acceleron Select Luspatercept to Advance to Phase 3 in Myelodysplastic
Syndromes</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150702316649.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerulean
to Present at the Deutsche Bank 40th Annual Health Care Conference</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150505197254.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Soon
all blood types could turn into universal donors</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 5:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150118396205.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TaiGen
Biotechnology Announces Initiation of Burixafor Chemosensitization Clinical
Trial in Acute Myeloid Leukemia in China</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920152203273037.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>One
more polio case surfaces</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 10:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920152202262935.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>USP38,
FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility
to Severe Malaria in Tanzania</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 10:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920152202112927.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celgene
strikes cancer deals with Agios, Northern Biologics</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 10:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920152102011964.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Uttarakhand
to send 1,241 units of blood to Nepal</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042920151617199182.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Saudi
Arabia elevates Aramco chief as it braces for more market uncertainty</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151556195951.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SHAREHOLDER
ALERT: Levi &amp; Korsinsky, LLP Notifies Shareholders of Accelerate
Diagnostics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff
Deadline of May 18, 2015 - AXDX</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 3:56:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151504005923.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Peninsula
Orthopaedic Associates Now Offers the Minimally Invasive Direct Anterior
Approach for Hip Replacement</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 3:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151414345595.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ruling
on French gay blood donor ban</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 2:14:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042920151401339338.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
therapy from naive cells attacks high-risk viruses in cord blood transplant
patients</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 2:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151214178387.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Boston
Scientific CEO Bullish on Atrial Fibrillation Device</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 12:14:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042920151211308472.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Golden
Meditech Proposes Open Offer to Eligible Shareholders to Subscribe One Offer
Share for Every Two Shares Held And to Acquire Outstanding Ordinary Shares of
China Cord Blood Corporation</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 12:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151152455726.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>April
Showers Bring May Flowers and Seasonal Allergies</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 11:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151100155995.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Partners
HealthCare Announces ¡°Disruptive Dozen¡± Technologies for 2015 at the World
Medical Innovation Forum</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042920151036267800.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>France
could ease ban on gay men giving blood after ECJ ruling</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 10:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151006135713.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Boston
Scientific Believes Atrial Fibrillation Device In Demand</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 10:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150930315849.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Peter
Davies, the 2015 Recipient of the Potamkin Award, Joins the Scientific Advisory
Board of QR Pharma</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042920150918055131.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ariad
Searches For New Leader As Berger Steps Down, Ending Proxy Battle</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150901125290.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CytRx
Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear
Medicine &amp; Radiation Therapy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150901055274.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Richard
N. Bergman, PhD, Receives American Diabetes Association's Albert Renold Award</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150900195780.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Trillion-Frame-Per-Second Camera</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150802076572.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abaxis
Reconfigures Executive Management Team</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150702316649.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerulean
to Present at the Deutsche Bank 40th Annual Health Care Conference</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150700316636.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AmerisourceBergen
Reports Second Quarter Fiscal Year 2015 Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042920152155382484.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
banks offering free platelets to go online</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042920152058422391.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>List
of blood banks offering free platelets to be uploaded on website</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042920152058452417.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>List
of blood banks offering free platelets</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:59:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042920150915336807.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>As
teachers¡¯ strikes loom over Ontario, the fight isn¡¯t about salaries, though it
is about the bottom line</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150124281153.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novacyt
Full Year 2014 Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123411080.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Role of Rapid Diagnostics in Antimicrobial Stewardship</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123331065.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alere
Awarded U.S. Government Contract to Advance Development of Point-of-Care
Molecular Diagnostic for Pandemic Influenza</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151700176398.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>U.S.
Food and Drug Administration Accepts Supplemental Biologics License Application
for Opdivo (nivolumab) in Patients with Previously Untreated Advanced Melanoma</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 5:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150901125290.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CytRx
Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear
Medicine &amp; Radiation Therapy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150802096595.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cypher
Genomics and University of Pennsylvania Collaborate on CurePSP-Funded Study to
Identify Genetic Factors in Progressive Supranuclear Palsy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151440146183.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novacyt
Full Year 2014 Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 2:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150841286725.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Health
Care Sector in Focus: Complementary Research on Great Basin, PhotoMedex,
Intellipharmaceutics, Transenterix, and Medovex</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:41:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150802346782.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Courtagen
Life Sciences Announced Today the Launch of rxSEEK&#8482; Epilepsy Drug Metabolism
Test for Epilepsy and Seizure Disorders</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150802096595.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cypher
Genomics and University of Pennsylvania Collaborate on CurePSP-Funded Study to
Identify Genetic Factors in Progressive Supranuclear Palsy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150801066567.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aptose
Biosciences To Host First Quarter Ended March 31, 2015 Financial Results
Conference Call and Webcast</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw043020150801056549.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Varian
Medical Systems and Sarah Cannon Cancer Network Expand Integrated Technology
for Radiation Oncology Program</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz043020150700316633.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dr.
Roy First Joins Transplant Genomics as Chief Medical Officer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss043020150123331065.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alere
Awarded U.S. Government Contract to Advance Development of Point-of-Care
Molecular Diagnostic for Pandemic Influenza</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 30, 2015 1:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042920152155467593.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics Prices IPO at $13.00-$15.00 Per Share (HTGM)</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151909446811.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Quidel
to Present at the Bank of America Merrill Lynch 2015 Health Care Conference</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 7:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151730496106.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Internationally
Renowned Researcher From NYU Langone Medical Center Elected To The National
Academy Of Sciences</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 5:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151615296332.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Exact
Sciences to Participate in May Conferences</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151605296275.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>GenMark
Diagnostics to Present at Bank of America Merrill Lynch 2015 Health Care
Conference</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920151602495969.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hologic
Announces Financial Results for Second Quarter Fiscal 2015</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151440146183.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Novacyt
Full Year 2014 Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 2:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151106191291.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics Sets Terms for $50 Million IPO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 11:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151104001136.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Centogene
Expands Rare Disease MDx Business with Clinical Variant, Exome Sequencing
Offerings</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 11:04:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920151100155995.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Partners
HealthCare Announces ¡°Disruptive Dozen¡± Technologies for 2015 at the World
Medical Innovation Forum</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920151006135717.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics, Inc. (Formerly Known as High Throughput Genomics, Inc.)
Sets Terms for $50 Million IPO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 10:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042920150930215861.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biocartis
unleashes $109M IPO to fuel product development</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150901125288.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sen.
Ed Markey Delivers Keynote Address At Cancer Prize Dinner For Harvard's Dr.
Frederick Alt</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150901055269.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Frost
&amp; Sullivan Names Toshiba America Medical Systems, Inc. Medical Imaging
Company of the Year, Recognizing Their Focus on Customer Partnerships</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150900195764.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>A
Phone with the Ultimate Macro Feature</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150856135757.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rosetta
Genomics¡¯ Patent on Therapeutic Use of miR-34a Upheld by European Patent Office
in Opposition Proceedings</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:56:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150700305552.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>US
FDA Grants Priority Review for Potential New Indication for BRILINTA</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151255534314.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WomenHeart
Announces Findings of Patient Research on Heart Failure and Women</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150846125240.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Orphan
Drug Designations Lead to New Therapeutic Breakthroughs for Rare Disorders and
Diseases</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150831025172.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cryoport
Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150805285692.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Guided
Therapeutics to Report First Quarter 2015 Results and Hold Conference Call;
Provide Update on LuViva FDA Timing</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920150802397770.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Creative
Biomart Launches an Intuitive New Website Design to Enhance User Experience</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150800255683.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Progenity
Acquires Carmenta Bioscience for Proprietary Preeclampsia Technology; Appoints
Matthew Cooper Chief Scientific Officer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150800505092.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pamlico
BioPharma Announces Financing Led by Accele Venture Partners</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150730315611.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield
Process) For Treatment of MS</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150701165562.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Align
Networks Presents PT Best Practices during RIMS Aging Workforce Panel</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150636274942.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Crowdfunding
an Ebola drug targeting the host, not the virus</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150631174937.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Oncolytics
Biotech Inc. Announces Receipt of Orphan Drug Status from the EMA for
Pancreatic Cancer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150600195468.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Humana
Reports First Quarter Financial Results; Reaffirms 2015 Financial Guidance</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150531124885.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Chinese Medical Devices Market to 2025</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 5:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920150505195716.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>cytena,
a University of Freiburg Spin-Off, Received EUR 1. ...</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 5:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820152103210564.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Merck's
Januvia meets in CV outcomes trial</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820152103210559.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Keytruda
tops Opdivo in 1Q15 sales</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820151858275386.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Meyers
&amp; Flowers Law Firm Announces $2.4 Billion Settlement for Plaintiffs in Suit
Against Takeda Co., Maker of Actos Diabetes Drug</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 6:58:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820151742135370.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fitch
Affirms Province of British Columbia, Canada's Rating at 'AAA'; Outlook Stable</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 5:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042820151711501282.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IGI
Laboratories, Inc. Announces Second ANDA Submission Of 2015</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 5:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151657454624.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
Culture Test Market Growing at 6.8% CAGR to 2019 - An In Depth Anaylsis Covered
By The Experts</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:57:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151642564614.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Human
Longevity, Inc. Receives CLIA Certification</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151616304584.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Merrimack
Pharmaceuticals Announces Timing of First Quarter 2015 Investor Conference Call
and Presentation at Credit Suisse 2015 Antibody Conference</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151605484564.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IGI
Laboratories Announces First Quarter 2015 Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820151414022956.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Meridian
Bioscience Earnings in Line; Revenues Top in Q2 - Analyst Blog</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 2:14:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820151218155076.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SuperSonic
Imagine Announces Clinical Data From Its Retrospective Multicenter Trial
Evaluating ShearWave&#8482; Elastography For The Non-invasive Staging Of Patients
With Chronic Liver Disease</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151200504228.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Exagen
Sees Growing Adoption of Avise Diagnostic for Connective Tissue Disease with
New Milestone</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151131074195.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>VA
Presentation at Wound Symposium to Show New Wireless Patient Monitoring System
Improves Pressure Ulcer Turn Compliance</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 11:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151010454032.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Report:
Retail Clinics Might Reduce Doctor Visits, But Not Replace Doctors</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 10:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150926163918.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Oramed
Pharmaceuticals Inc. Issues Phase IIb Study Update Letter</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042820150926146009.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We're Catching up on Takeda, Glaxo and Much More!!</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150918124764.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NavigAID
SLE - Protagen Zooms into the Micro Cosmos of Autoimmune Disease</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150901163794.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies and Researchers from MD Anderson Cancer Center Demonstrate
Ability to Detect Hodgkin's Lymphoma in Blood</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150846125242.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Berks
Plastic Surgery Offers Venus Legacy&#8482; to Reduce Cellulite and Improve Visible
Signs of Aging</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150800225678.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tyrogenex
Initiates the APEX study, a Phase 2 Trial of Oral Treatment with X-82 for Wet
AMD</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150800455059.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Corporation Announces Formation of a Special Committee to Evaluate
Non-Binding Proposal</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150702315566.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerulean
to Host First-Quarter 2015 Conference Call on May 6</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150700305540.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Intact
Vascular¡¯s First-In-Man Clinical Study Results Published in the Journal of the
American College Of Cardiology: Cardiovascular Interventions</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150649135523.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ARIAD
Founder, Harvey J. Berger, M.D., to Retire as Chairman and Chief Executive
Officer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150600195469.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Significant
Reduction of HBsAg and HDV RNA by REP 2139-Ca in Caucasian Patients with HBV /
HDV Co-Infection</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042920150319226521.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Early
Detection for Arthritis: The Nation's Most Common Cause of Disability Likely to
be Detectable Via a Blood Test Soon</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 3:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920150123243143.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
Culture Test Market Growing at 6.8% CAGR to 2019 - An In Depth Anaylsis Covered
By The Experts</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 1:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820152355406749.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Critical
Roles of Two Hydrophobic Residues within Human Glucose Transporter 9 (hSLC2A9)
in Substrate Selectivity and Urate Transport [Protein Structure and Folding]</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 11:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820152059350039.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Organ
donation saves many lives: official</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820152059390123.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Students
from Nepal plan blood donation camp</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151616304589.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Actavis
and Medicines360 Announce Publication of ACCESS IUS Efficacy and Safety Study
of LILETTA&#8482; (Levonorgestrel-Releasing Intrauterine System) 52 mg in
Contraception</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151602314549.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Biologic Products to Report First Quarter 2015 Financial Results</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820151414022991.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hydroxyurea
may be underused for patients with sickle cell anemia</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 2:14:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820151306275132.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>mHealth
Market in the US at a Glance</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820151306041618.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies and Researchers from MD Anderson Cancer Center Demonstrate
Ability to Detect Hodgkin's Lymphoma in Blood</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042820151217402407.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adults
With Sickle Cell Anemia and Pain Crises Receiving Hydroxyurea</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>JAMA</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151200524231.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
from Boston Children's Hospital reveals the first six months of life are best
for stimulating children's heart growth</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820151126154972.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Transplant
Recipient Gets Rare Chance to Meet Stem Cell Donor Who Saved Her Life at City
of Hope</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 11:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820151107483736.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
Health Gains European Patent for Novel Receptor</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 11:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151051104120.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Innovative
Blood Resources Announces New COO/CFO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 10:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150903276610.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Daxor
Announces the Receipt of a Contract for the Placement of a BVA-100 Blood Volume
Analyzer at Lankenau Medical Center</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150901163808.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>DanDrit
Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD
Foundation</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150901173840.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MSPA
North America announces dates for 2015 ShopperFest</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150901153780.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Webcast
Alert: Heska Corporation's Annual Meeting of Stockholders Webcast</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150800455059.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Corporation Announces Formation of a Special Committee to Evaluate
Non-Binding Proposal</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042820151416079507.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>As
teachers¡¯ strikes loom over Ontario, the fight isn¡¯t about salaries, though it
is about the bottom line</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 2:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042820151318113733.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BRIEF-Oncodesign
supports Nanocyclix based RIP2 program with new data</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151051104120.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Innovative
Blood Resources Announces New COO/CFO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 10:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150802055105.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amgen
To Discuss Details Of The Biologics License Application For Talimogene
Laherparepvec For Patients With Metastatic Melanoma</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150800505092.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pamlico
BioPharma Announces Financing Led by Accele Venture Partners</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920150607250435.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Acting Commissioner Ostroff Addresses the &quot;State of the FDA&quot;</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042820152155380919.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
Diagnostics in Infectious Disease Testing Market - Global Industry Analysis and
Forecast ...</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820151218155076.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SuperSonic
Imagine Announces Clinical Data From Its Retrospective Multicenter Trial
Evaluating ShearWave&#8482; Elastography For The Non-invasive Staging Of Patients
With Chronic Liver Disease</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820151200185036.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Seattle
BioMed Rebrands as Center for Infectious Disease Research</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151131074193.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ocean
Bio-Chem, Inc. Releases Update On Use Of PERFORMACIDE To Control Bird Flu
Infections</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 11:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150911183888.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ISS
Recommends Shareholders Vote For Specialty Drug Pricing Risk Assessment
Proposal At Gilead Sciences</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150800165653.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amniox
Medical Announces Expanded Health Plan Coverage</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151642564614.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Human
Longevity, Inc. Receives CLIA Certification</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:42:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820151051104120.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Innovative
Blood Resources Announces New COO/CFO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 10:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150900244701.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Florida
Outreach Lab Selects McKesson</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042920150846125240.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Orphan
Drug Designations Lead to New Therapeutic Breakthroughs for Rare Disorders and
Diseases</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042920150800255683.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Progenity
Acquires Carmenta Bioscience for Proprietary Preeclampsia Technology; Appoints
Matthew Cooper Chief Scientific Officer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042920150607250435.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Acting Commissioner Ostroff Addresses the &quot;State of the FDA&quot;</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 29, 2015 6:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820152355366739.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Flap
endonuclease 1 limits telomere fragility on the leading strand [Cell Biology]</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 11:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042820152155380919.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
Diagnostics in Infectious Disease Testing Market - Global Industry Analysis and
Forecast ...</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042820152155370918.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HTG
Molecular Diagnostics Sets Share Price Range on Planned IPO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042820152155366034.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tumor
profiling goes public: HTG Molecular Diagnostics sets terms for $50 million IPO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042820152155366042.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Trovagene
Schedules Release of First Quarter 2015 Financial Results and Investor
Conference Call</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:55:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820151611265234.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biocartis
charges ahead with $109M IPO to fuel product development</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042820151106528490.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Belgian
molecular Dx player Biocartis raises 100M to advance recent launch of Idylla
system</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 11:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042820151001537988.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Scientists
confirm the impact of submicroscopic malarial infections during pregnancy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 10:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150918124764.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NavigAID
SLE - Protagen Zooms into the Micro Cosmos of Autoimmune Disease</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150903161191.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rapid
Genome Sequencing of Infants in ICU Has High Diagnostic Yield, Changes
Management for Many</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150901163794.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies and Researchers from MD Anderson Cancer Center Demonstrate
Ability to Detect Hodgkin's Lymphoma in Blood</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720152126168233.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celladon
Anticipates Layoffs After Its Gene Therapy Trial Fails</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:26:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150801153571.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Janssen
Launches U.S. Hispanic Community Initiative to Help Improve Type 2 Diabetes
Care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150701033460.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Boston
Scientific Announces Results for First Quarter 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150700174384.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NEJM
Publishes Study Showing GSK¡¯s Shingles Vaccine Containing Agenus¡¯ QS-21
Stimulon&reg; Adjuvant Provides over 97% Protection in People Over the Age of 50</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150100204222.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Grants Fast Track Designation to Genzyme¡¯s Investigational Substrate Reduction
Therapy for the Treatment of Fabry Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042720151135593018.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Colesterol
alto aumenta&nbsp;risco de c&acirc;ncer de mama </span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150831163668.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pfenex
Announces Election of John Taylor to its Board of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150830324628.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Simulations
Plus Augments Marketing and Sales Organization with Addition of Seasoned
Scientist</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042820150819418024.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Intarcia,
Still Private, Nabs $225M More For Diabetes Device</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150801153602.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genomic
Health to Announce First Quarter 2015 Financial Results and Host Conference
Call on Tuesday, May 5, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150801153552.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>dorsaVi
Introduces ViSafe to U.S. to Help Companies Prevent Workplace Injuries</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042820150710430647.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Paradigm
Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by
Side Clinical Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150709008707.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Miraculins
Receives Guidance from U.S. FDA Related to Its Scout&reg; Device as an Aid in the
Identification of Pre-Diabetes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150601053413.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Unfors
RaySafe, a Fluke Biomedical company, unveils a new Survey sensor for the
RaySafe X2</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150600154319.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kamada
Announces Executive Management Changes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150429303362.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Faster
Detection of Disease: Anteo is Transforming The Way Scientists Work with
Luminex(R) xMAP(R)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:29:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150001503994.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Evidence-Based
Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel
Review and Molecular Parameters of EORTC 26951 and 26882 Trials [Neurooncology]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Prognostic Studies, Brain Tumors, Diagnosis &amp;amp; Staging,
Translational Oncology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042720152203494624.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Noninvasive
Cancer Diagnostics and Technologies Market - Global Industry Analysis and
Forecast ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 10:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042720151902047445.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
demonstrates potential of rapid whole-genome sequencing in critically ill
infants</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151900473195.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
Demonstrates Potential Of Rapid Whole-Genome Sequencing In Critically Ill
Infants</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042720151810334370.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Efficacy
and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells
and ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151636073098.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vermillion
Announces Expanded Medical Policy Coverage for OVA1&reg; Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 4:36:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151616343068.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Boston
Scientific Announces Strategic Collaboration With Brainlab AG</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 4:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151403252928.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Westchester
Health Orthopedics &amp; Sports Medicine to Kick Off First Annual &quot;Hot
Topics in Youth Sports Medicine&quot; Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 2:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151343162912.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Emirates
Pathology Society Hosts the 27th Annual Meeting of the Arab Division of The
International Academy of Pathology (IAP-AD)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 1:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151323032884.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>American
Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook
&quot;Understanding Mental Disorders&quot;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 1:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151322012883.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PAML
and Axela Collaborate on Immune Status for Vaccine Preventable Diseases</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 1:22:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720151205368668.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Oxford
Immunotec Limited Announces CE Mark Approval for T-SPOT.CMV Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 12:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151154163930.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CORRECTING
and REPLACING CureDuchenne Celebrates Submission of First-Ever New Drug
Application for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping;
CureDuchenne Was Early Funder of Drisapersen¡¯s Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:54:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151131422750.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Psychemedics
Corporation Announces First Quarter Earnings</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151113163890.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CureDuchenne
Celebrates Submission of First-Ever New Drug Application for Duchenne Muscular
Dystrophy Amenable to Exon 51 Skipping; CureDuchenne Was Early Funder of
Drisapersen¡¯s Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:13:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151100303865.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>First
FDA Cleared Ophthalmic App for Monitoring AMD and DR</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720151022578628.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
clears blood-glucose testing device from Nipro Diagnostics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 10:27:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720151020041346.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nipro¡¯s
TRUE METRIX AIR Consumer Glucometer FDA Cleared</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 10:20:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150942122582.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Eiger
Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or
Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720150924536201.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We're Catching up on Mylan, Teva, Rx Prices and
Lots More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150911302513.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Be
on Top of the Latest Happenings: Complementary Research on Wells Fargo, Mylan,
Great Basin, Pfizer, and AbbVie</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720150911014826.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BRH
Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and
Drug Administration (FDA) for the BRH-A2 Tissue Management System</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150901052422.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agena
Bioscience Names Bioyong Technology as Fifth Certified Service Provider in
China</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150900253713.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Invitae
Appoints Robert Nussbaum, M.D., as Chief Medical Officer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150900193684.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioTime¡¯s
Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in
Planned CIRM-Funded Preclinical Studies of Huntington¡¯s Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clinical Chemistry</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150841123732.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SomaGenics
Awarded 2-Year NIH Grant to Develop NGS microRNA Library Technology</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:41:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150830324616.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Constellation
Pharmaceuticals Initiates Clinical Development of CPI-1205, a Novel Inhibitor
of EZH2, in Patients with Lymphoma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150801153554.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Gartner
Names CafeX &quot;Cool Vendor in Unified Communications&quot;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150734453520.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CryoLife
Announces Enrollment of First Patient in PerClot&reg; IDE Clinical Trial</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:34:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150701043479.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Survey
Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet
Medication As Prescribed</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150600154321.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TriggerPoint&#8482;
Performance Therapy Issued U.S. Patent Covering GRID&reg; Foam Rollers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150410563348.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Data Evaluating The Boston Scientific Eluvia&#8482; Drug-Eluting Vascular Stent
System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 4:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150200304234.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ERYTECH&nbsp;Receives
the EnterNext Tech 40 Label</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117514666.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Progenika
Biopharma grants Grifols Worldwide distribution of its Bloodchip&reg; genotyping
test for blood donors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117474620.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Araclon
Biotech has identified a new blood protein with diagnostic value for
Alzheimer's disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117470131.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Plasmapheresis
reduces blood cholesterol levels according to a study by Grifols</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117460102.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Japanese
Red Cross selects Grifols as partner for nucleic acid screening of nation's
blood supply</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117470144.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
highly sensitive test to screen donors of blood, tissues, and organs for
Hepatitis E virus receives CE mark</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117434606.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Grifols
is to construct a plant in Brazil to manufacture bags for the extraction and
conservation of blood components</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720152259543331.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Expression
of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by
IFN-{beta} Therapy [AUTOIMMUNITY]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 10:59:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720152058052129.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Students
from Nepal plan to organise blood donation camp</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720152102447927.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Antimicrobial
and antioxidant flavonoids from the leaves of Oncoba spinosa Forssk.
(Salicaceae)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Complementary and Alternative Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720151922193136.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Diagnostic-Maker
Scanadu Lands $35M As FDA Submission Nears</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:22:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151729164178.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardiothoracic
Clinicians to Examine Benefits of Reducing On-X Aortic Valve Patients¡¯ Warfarin
Regimen at AATS</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 5:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rec042720151720041268.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Connecticut
teen to go home after forced chemo treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>USA-CONNECTICUT/CHEMOTHERAPY:Connecticut teen to go home after
forced chemo treatment</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 5:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151528274083.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Surgeons
Discuss High Readmission Rates for Patients with Retained Blood Syndrome After
Cardiac Surgery</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 3:28:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151515274077.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ortho
Clinical Diagnostics Appoints Industry Veterans to Board of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 3:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151421472947.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Global
Biobanking Market to See 7% CAGR to 2019</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 2:21:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151407284032.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Retractable
Technologies, Inc. Announces Amended Final Judgment and Notice of Appeal</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 2:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151143272762.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AMC
Health to Showcase Advances in Monitored Care at ATA 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720151122537912.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Scientists
Skeptical About Secret Blood Test That Has Made A Billionaire </span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720151113071962.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BiosureLaunches
World's First HIV Self-Testing Kit</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:13:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720151106387439.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NIH
launches clinical trial on statin therapy for HIV patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720150907469606.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerus
to Present at AABB Symposium on Pathogen-Reduced Components</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150901162490.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CytoSorbents
Appoints Dr. Joerg Scheier as European Medical Director</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117474642.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Grifols
Signs Cooperative Agreement for Commercialization of Immunohematology
Diagnostic Products in the US</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720152053451952.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Receives $512 Million Take-Private Offer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151712164171.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CORRECTING
and REPLACING Keller Rohrback L.L.P. and Legal Voice Announce Lawsuit
Challenging Transgender Discrimination by Major, for-Profit Plasma Donation
Company</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 5:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151456274064.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Keller
Rohrback L.L.P. and Legal Voice Announce Lawsuit Challenging Transgender
Discrimination by Major, for-Profit Plasma Donation Company</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 2:56:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151129272743.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>&quot;Top
Chef&quot; Star Sam Talbot and Some of Miami's Hottest Chefs to Turn Up the
Heat on Diabetes at &quot;Out of the Kitchen&quot; Event</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:29:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150901112479.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Stempeutics
Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for
its Novel Stem Cell Drug 'Stempeucel'</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150801153564.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Trovagene
Schedules Release of First Quarter 2015 Financial Results and Investor
Conference Call</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720151100303869.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>California
Patient Advocates Call on Congress to Reform 340B Drug Discount Program</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150119000281.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ortho-Clinical
Diagnostics Inc. Receives Health Canada Approval for ORTHO VISION&#8482; Analyzer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117470171.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Grifols
establishes Expert Advisory Council in Transfusion Medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117470176.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Grifols
launches a continuing education program for transfusion medicine professionals
in the United States</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117470165.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Grifols
extends its commitment to scientific dissemination with a new publication,
Perspectives in Transfusion Medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117474644.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Grifols
contributes to transfusion medicine education with the third edition of the Transfusion
Science Educational Course</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150117460123.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Grifols
continues to contribute to transfusion medicine training with its second
European edition of the Transfusion Science Education Course</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 1:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150801153555.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PTC
Therapeutics' Cancer Stem Cell Program Targeting BMI1 Enters Phase 1</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150745294473.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Courtagen
Life Sciences Appoints Helio Pedro, MD to the Company¡¯s Clinical And Strategic
Advisory Board.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:45:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042820150701043466.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NeoGenomics
Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic
Acquisition</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150700174382.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Critical
Path Institute Secures Regulatory Support for Parkinson¡¯s and Alzheimer¡¯s
Disease Biomarkers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042820150700174393.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Voyager
Therapeutics Promotes Jeff Goater to Senior Vice President, Finance and
Business Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150001514012.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Personalizing
Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual
Patients [Review Articles]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Diagnosis &amp;amp; Staging</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042820150001513997.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Controversies
in the Treatment of Local and Locally Advanced Gastric and Esophageal Cancers
[Review Articles]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Surgery, Radiation, Chemotherapy, Combined Modality,
Translational Oncology, Epidemiology, Diagnosis &amp;amp; Staging, Surgery,
Chemotherapy, Combined Modality, Translational Oncology, Epidemiology,
Diagnosis &amp;amp; Staging</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 28, 2015 12:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720152300003338.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Processed Amino-Terminal Fragment of Human TLR7 Acts as a Chaperone To Direct
Human TLR7 into Endosomes [INNATE IMMUNITY AND INFLAMMATION]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 11:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720152211222913.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biocartis
gains in first trading day after IPO</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 10:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720152211158407.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Management
tracks</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 10:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720151606043042.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Luminex
Corporation Provides Updates on ARIES&reg; Clinical Trials</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 4:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720151510551834.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Survey
Shows More NSCLC Patients Getting EGFR Testing, but Results Often Don't Inform
Care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 3:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720151011566232.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Amarantus
Bio Raises $5M</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 10:12:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150800163569.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>One
of the Most Important Global Healthcare Studies of this Generation Reaches
Significant Patient Enrollment Milestone</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150800163572.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Single
Use LED Specula Designed to Eliminate the Time and Expense of Reprocessing
Metal Specula, Reduce Cross-Contamination Risk</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150800253604.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Partnership Between St. Jude Medical and Mended Little Hearts Benefits Families
of Kids with Congenital Heart Defects</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150705153539.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Experts
in Pharma, Clinical Research, Omics, Environmental and Food Testing Meet for
SCIEX¡¯s 6th LC-MS/MS Symposium in Berlin</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150836252380.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vermillion
to Report First Quarter 2015 Financial Results and Host Investor Conference
Call on May 11</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150831142358.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Mesothelioma Victims Center Urges Victims to Call for Their Customized
Treatment Options Report and Calls Attention to Emerging Science</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150814592329.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BRH
Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and
Drug Administration (FDA) for the BRH-A2 Tissue Management System</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:14:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150802002290.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Varian
Unveils VitalBeam&#8482; for Affordable Advanced Radiotherapy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150800163569.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>One
of the Most Important Global Healthcare Studies of this Generation Reaches
Significant Patient Enrollment Milestone</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150800163580.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Avioq,
Inc. Expands FDA and CE-IVD Claims for Testing Organ and Tissue Donors with the
Avioq&reg; HTLV-I/II Microelisa System</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150730163556.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Navidea
Divests NAV5001, a Non-Core, Development-Stage Imaging Agent for Parkinson's
Disease</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150701372181.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Can-Fite
Reports Positive Results from Further Analysis of Phase II/III Psoriasis Trial</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150701342173.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Check-Cap
Receives Notice of U.S. Patent Allowance for Proprietary Non-Invasive,
Preparation-Free Capsule Endoscopy Technology</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150601302109.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Haemonetics
Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of
$0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides
Fiscal 2016 Guidance</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042620152107401951.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Capps
Wins All-Mopar Final on HEMI&reg; Day at NHRA SpringNationals</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 26, 2015 9:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150846142402.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Stem
Cell Therapy Network's Summer Workshops Help Physicians Build Regenerative
Medicine Practices</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150836252380.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vermillion
to Report First Quarter 2015 Financial Results and Host Investor Conference
Call on May 11</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150830273632.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerus
to Present at AABB Symposium on Pathogen-Reduced Components</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150814273622.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ALLY-1
Trial Results Show Investigational Daclatasvir-Based Regimen Cures 94% of
Post-Liver Transplant Patients with Hepatitis C and Up to 94% of Hepatitis C
Patients with Cirrhosis (Child-Pugh Class A or B)</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:14:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720150810455055.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Corporation Announces Receipt of &quot;Going Private&quot; Proposal</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720150809398541.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Haemonetics
Expands Executive Management Roles To Complement Global Growth Strategy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150802002308.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dr.
Rath Research Institute: Revolutionary new concept of heart disease threatens
end of global statin market</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150801002251.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Spring
Bank Pharmaceuticals Presents Preclinical and Clinical Data on Immunomodulatory
Agent SB 9200 at the 2015 Annual Meeting of the European Association for the
Study of the Liver</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150800163580.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Avioq,
Inc. Expands FDA and CE-IVD Claims for Testing Organ and Tissue Donors with the
Avioq&reg; HTLV-I/II Microelisa System</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150608002138.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
Health Gains Patent for Novel Receptor Utilizing Computational Biomarker
Discovery Technology</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150600303483.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Replicor
Announces Four Appointments to Scientific Advisory Board</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720150303260504.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>World
: Nepal Prime Minister Calls For Blood Donation In Wake Of Quake</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 3:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150247263447.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Neurovive
Pharmaceutical: FIrst Patient Enrolled in Clinical Phase II Study for Kidney
Protection During Heart Surgery</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 2:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720150810455055.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>China
Cord Blood Corporation Announces Receipt of &quot;Going Private&quot; Proposal</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150801002251.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Spring
Bank Pharmaceuticals Presents Preclinical and Clinical Data on Immunomodulatory
Agent SB 9200 at the 2015 Annual Meeting of the European Association for the
Study of the Liver</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150601302125.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SynGen
Inc. Expands Its Management Team</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042720150459456379.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Missing
genetic link found in a challenging immune disease</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 4:59:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042620150936505534.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nepal
earthquake: rescue continues as death toll exceeds 2,000 - live updates</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 26, 2015 9:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150700303525.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bruker
Launches High-Throughput MALDI Biotypersmart System with Lifetime Laser</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150600303483.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Replicor
Announces Four Appointments to Scientific Advisory Board</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150731402225.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Haemonetics
Expands Executive Management Roles To Complement Global Growth Strategy</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042720150601302109.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Haemonetics
Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of
$0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides
Fiscal 2016 Guidance</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042720150710566007.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
Health Gains Patent for Novel Receptor Utilizing Computational Biomarker
Discovery Technology</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150700303538.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bruker
Introduces CE-marked IVD MALDI Sepsityper Solution for Rapid Identification of
over 2,200 Microorganisms Directly from Positive Blood Culture</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150700303525.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bruker
Launches High-Throughput MALDI Biotypersmart System with Lifetime Laser</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042720150630273506.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vic
Myer, Ph.D. Joins Editas Medicine as Chief Technology Officer</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 27, 2015 6:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042620152110242715.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Functional
signatures of oral dysbiosis during periodontitis progression revealed by
microbial metatranscriptome analysis</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Genome Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 26, 2015 9:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042620150318234781.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Trivedi
Science&#8482; Has Started Scientific Research to Create More Effective
Pharmaceuticals and Nutraceuticals</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 26, 2015 3:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042520152209320292.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Immunolocalization
of the 29 kDa Schistosoma haematobium species-specific antigen: a potential
diagnostic marker for urinary schistosomiasis</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Infectious Diseases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 25, 2015 10:09:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042520152057574033.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>¡®Need
to organise more blood donation camps¡¯</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 25, 2015 8:59:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420151628221709.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lilly's
CYRAMZA&reg; (ramucirumab) Receives Fourth FDA Approval</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 4:28:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042520150009416650.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Epistem¡¯s
TB diagnostic test receives import license</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 25, 2015 12:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042420152016570830.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>U.S.
drug regulators approve first pill to treat binge eating, let the debate begin</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:09:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042420151839263402.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Jubilant
DraxImage Files Citizen Petition with the Food and Drug Administration (FDA)</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 6:39:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042420151217255354.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mobidiag
Presents Two New Diagnostic Platforms at ECCMID 2015</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 12:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420151009493671.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Recalls LuSys Laboratories Ebola Virus One-Step Test Kits</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 10:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420152307226104.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>A
single mutation in K13 predominates in Southern China and is associated with
delayed clearance of Plasmodium falciparum following artemisinin treatment</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 11:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420152104521118.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Intravenous
Solutions in the Care of Patients With Volume Depletion and Electrolyte Abnormalities</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>American Journal of Kidney Diseases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:08:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042420151711266767.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HIV
outbreak in Indiana grows</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 5:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042420151701153381.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tolero
Pharmaceuticals Presents Data Demonstrating Profound Synergy of Alvocidib and
Bromodomain Protein Inhibitors in Nonclinical Models of Acute Myeloid Leukemia</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 5:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420151002321429.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Australia,
Along With Other Nations Around The World, Celebrates Its Most Important And
Most Solemn National Day The Centenary Of Anzac Day: April 25th 1915 -- April
25th 2015 100th Anniversary Of The First Major Military Action Fought By Anzac
Force</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 10:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150903452558.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Jobs
at the Center for Biologics Evaluation and Research (CBER)</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042420150903263040.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MDS
Foundation 13Th International Symposium to Present New Treatment Options for
Myelodysplastic Syndromes and Related Acute Myelogenous Leukemia</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042420151915286135.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Researchers
alter embryo in such a way it could one day permanently change human DNA</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 7:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042420151532293344.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Thousands
of Comcast Colorado Employees, Families to Give Back to Nonprofits for 14th
Annual Comcast Cares Day</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 3:32:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042420151502535985.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fighting
rare blood disorder by raising public awareness</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 3:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042420150936587429.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Election
2015 live: HSBC threat to leave UK shows danger of Tory re-election, says
Labour</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042420150924217157.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. As the Weekend Nears, We're Catching up on AstraZeneca, Glaxo
and More!!</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042520150601238661.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hepatitis
C screening essential to help catch patients with advanced liver fibrosis</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 25, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042420152002101978.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HIV
cases skyrocket among US painkiller abusers (Update)</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042420151602053010.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>HIV
cases skyrocket among US painkiller drug abusers</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042420151217255354.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mobidiag
Presents Two New Diagnostic Platforms at ECCMID 2015</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 12:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042520150000436305.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Odontogenic
ameloblast-associated protein (ODAM) Mediates Junctional Epithelium Attachment
to Tooth via Integrin-ODAM-Rho guanine nucleotide exchange factor 5
(ARHGEF5)-Ras homolog gene family member A (RhoA) Signaling [Signal
Transduction]</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 25, 2015 12:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420152207435591.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biocartis
prices EUR 100M IPO</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 10:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042420151531316537.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Veracyte
unveils $40M private placement to generate cash for R&amp;D</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 3:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042420151217255354.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mobidiag
Presents Two New Diagnostic Platforms at ECCMID 2015</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 12:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150904409470.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mayo
Clinic, Exact Sciences Team IDs Methylated DNA Markers to Differentiate GI
Cancers</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:04:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042420150903263040.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MDS
Foundation 13Th International Symposium to Present New Treatment Options for
Myelodysplastic Syndromes and Related Acute Myelogenous Leukemia</span></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151658262781.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Grants Orphan Drug Designation for DCR-PH1, Dicerna¡¯s Investigational Therapy
for the Treatment of Primary Hyperoxaluria Type 1 (PH1)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 4:58:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151005282366.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Technavio
Says High Prevalence of Autoimmune Disorders Will Drive Growth in the Global
SLE Drugs Market Through 2019</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150557339289.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Health
Diagnostics Lab Settles With DOJ; Enters Corporate Integrity Agreement With New
Provisions Aimed At Referral Transparency</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 5:57:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150045550995.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>U.S.
FDA Grants Priority Review to AbbVie for Investigational, All-Oral,
Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 12:45:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151320162573.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PierianDx
Builds Leadership Team to Accommodate Fast Growth</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320151310513167.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Data Shows iRhythm's ZIO&reg; Service Increases Detection And Diagnosis Of Silent
Atrial Fibrillation In High-Risk Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151100162412.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agilent
Technologies to Collaborate with National University of Singapore on
Bioanalytical Studies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150808168308.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>How
to Develop Fit-for-Purpose Quantitative IHC Assays to Enable Clinical Trial
Patient Stratification, New Webinar Hosted by Xtalks</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 8:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150801181193.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alere
Recognizes 2015 World Malaria Day with New Video</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042420150746152945.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bristol-Myers
Squibb Receives Positive CHMP Opinion in the European Union for Opdivo
(nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and
Previously Treated Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 7:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150742101152.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hospira
Leadership Presents at Preeminent European Biosimilars Forum, Announces New
White Paper on Extrapolation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 7:42:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150701281129.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cipher
Pharmaceuticals announces outcome of Markman hearing in patent infringement
suit for Absorica</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042420150700302920.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>GSK¡¯s
Malaria Vaccine Phase 3 Study Containing Agenus¡¯ QS-21 Published in The Lancet</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150617281102.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kalorama:
NIAID Rewards HAI Innovators with Grants</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 6:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042320152316584686.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ebola
Virus One-Step Test Kits by LuSys Laboratories: Class I Recall - Not Cleared
for Marketing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 11:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320152109262843.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ADDING
and REPLACING Studies Presented at American Transplant Congress Describe
Validation of Noninvasive Tests for Post-Transplant Management of Kidney Graft
Recipients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042320151916135368.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>U.S.
drug regulators approve first pill to treat binge eating, let the debate begin</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151701200899.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roka
Bioscience to Exhibit and Present at the 2015 Food Safety Summit</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 5:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151600172691.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Acacia
Research Reports First Quarter Financial Results and Announces Payment of
Quarterly Dividend</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320151417157712.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Juniper
Pharmaceuticals Announces Formation of Scientific Advisory Board</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151313513554.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Green Lights Siemens' Breast Tomo Device</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:13:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151303500581.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Fluke
Biomedical launches online training center, bringing accessible training to the
biomedical engineering community</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151239200556.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ANSI
and ANSI-ASQ National Accreditation Board to Host Free Webinar in Celebration
of World Accreditation Day 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:39:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151215282493.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Extension
Healthcare to Participate in Alarm Middleware Vendor Roundtable</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151212561747.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>RealAmp
Loop-Mediated Isothermal Amplification as a Point-of-Care Test for Diagnosis of
Malaria: Neither Too Close nor Too Far</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151207351503.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Evidence
Generation for Genomic Diagnostic Test Development: A Workshop</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151207351500.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Refining
Processes for the Co-Development of Genome-Based Therapeutics and Companion
Diagnostic Tests: A Workshop</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151105350761.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Green Lights Breast Tomosynthesis Option for Siemens' Mammography Platform</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 11:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151103442889.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Class
I Medical Device Recall: LuSys Laboratories, Inc., Ebola Virus One-Step Test
Kits - Not Cleared for Marketing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 11:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320151101088056.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Approves Breast Tomosynthesis Option for Siemens Mammography Platform</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 11:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151021262384.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Studies
Presented at American Transplant Congress Describe Validation of Noninvasive
Tests for Post-Transplant Management of Kidney Graft Recipients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:21:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151010589420.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Group
B strep test from Great Basin Scientific scores FDA clearance</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151000320332.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Clear
Guide Medical Receives CE Mark on the Clear Guide ONE</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151000320331.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Swedish
Cancer Institute Elevates Personalized Medicine Program with Innovative
Software Platform</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150958162332.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PPD
Honored for Patient-Centric Communications on Clinical Research</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:58:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150946320301.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>1st
U.S. Patient Discharged from the Hospital without a Human Heart Celebrates 5th
Anniversary of Going Home with the Freedom&reg; Portable Driver</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320150926408841.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We're Catching up on Mylan, Drug Prices and Lots
More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320150920530702.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Claudia
Black Center Introduces T.O.V.A to Screen for ADHD</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:20:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320150911054202.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Trovagene's
Urine-Based HPV Assay to Be Featured in Presentation at the 13th Annual
Cervical Cancer Conference and HPV Consortium in Beijing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150901490208.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Veracyte,
Inc. Announces $40 Million Private Placement</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150859409240.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Trovagene's
UrineBased HPV Assay to Be Featured in Presentation at the 13th Annual Cervical
Cancer Conference and HPV Consortium in Beijing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:59:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150835571264.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Soxxy
Unveils Stylish Compression Sox at Women's Health Expo, April 25-26, Stamford,
CT -- Booth #806</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 8:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150801181172.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CytoSorbents
Issues Letter to Shareholders</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150601399413.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mylan
launches generic Sofosbuvir tablets in India</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 6:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150153536986.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SALL4
Knockdown Enhances ATRA Therapeutic Activity [Gene Regulation]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 1:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320152207042004.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bass
keeps fishing for patent challenges</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320152105033937.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Association
between biomarkers of endothelial injury and hypocoagulability in patients with
severe sepsis: a prospective study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Critical Care</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151953332845.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Uni-Bio
Files for China Approval of Novel Osteoporosis Drug</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:13:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151808218832.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mosquitoes
Play Genetic Favorites</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 6:08:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042320151601498532.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>US
regulators recall 10-minute Ebola test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151527132664.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SHAREHOLDER
ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000
From Investment In Accelerate Diagnostics, Inc. To Contact Brower Piven Before
The Lead Plaintiff Deadline In Class Action Lawsuit</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 3:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320151514262648.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Managing
Erectile Dysfunction Can Improve Cardiovascular Health ¡ª and Sex Too!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 3:14:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042320151437495904.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>I
know who you Skyped last summer: how Hollywood plays on our darkest digital fears</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:37:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs2042320151401301658.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>[In
Depth] Clinical trials get practical</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Science</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151327140607.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>DanDrit
Biotech and Riyadh Pharma Sign Partnership Agreement</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:27:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320151310513170.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Additional
Data Confirms Reduction In Blood Loss With Misonix SonicOne&reg; O.R. In Burn
Patients At 2015 National American Burn Association Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151215073707.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
center affiliation unveils new name expanded offerings to healthcare systems</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151212561752.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Longevity
of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in
Children</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151212561757.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Human
Polyomavirus 7-Associated Pruritic Rash and Viremia in Transplant Recipients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151212561745.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Downregulation
of Cytokines and Chemokines by GB Virus C After Transmission Via Blood
Transfusion in HIV-Positive Blood Recipients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151212561765.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>IL1B
and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection
After Solid-Organ Transplantation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151207323252.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Challenges
and Opportunities in Using Newborn Screening Samples for Translational
Research: A Workshop</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151026050377.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>RegeneRx
Receives Notice of Allowance For U.S. Patent For Healing and Reversing Heart
and Coronary Vessel Damage After A Heart Attack with TB4</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:26:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150933162298.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
National University Hospital, Singapore Pilots New Clinical Study of the
Hemolung RAS Extracorporeal CO2 Removal System</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:33:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150930262288.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>US
Patent Granted for Batu Biologics Cancer Immunotherapeutic Product ImmXcyteTM</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320150911064220.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Blood
center affiliation unveils new name, expanded offerings to healthcare systems</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042320150902345446.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Research
on cancer blood test is overhyped in the media</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150900350169.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ViaCyte
to Present at GTCbio 2015 Diabetes Summit</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150900390199.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Casio
Encourages Playing Music To Help Unwind During Stress Awareness Month</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042420150836241563.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Election
2015 live: HSBC threat to leave UK shows danger of Tory re-election, says
Labour</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 8:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042420150636579828.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Election
2015 live: Miliband's Libya comments are ill-judged, says Cameron</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 6:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042420150536243958.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Election
2015 live: HSBC says it may move HQ from UK as it warns of EU uncertainty</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 5:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042420150118590829.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Broadway Extravaganza Raises Funds for Chronic Neuro-Immune Disease Awareness
Week</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 1:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151805201038.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Human
embryo ¡®editing¡¯ sparks international debate</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 6:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320151410523171.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Missing
Genetic Link Found in a Challenging Immune Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151018101574.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Critics
Lash Out At Chinese Scientists Who Edited DNA In Human Embryos</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 10:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150937500283.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>5
Million Euros for Medical Innovation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:37:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150505436086.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>European
Liver Patients Association (ELPA) Launches New Digital Guide for People
Diagnosed with Hepatitis C</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 5:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042420150113073646.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hospitalization
Rates and Reasons among HIV Elite Controllers and Persons With Medically
Controlled HIV Infection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 1:13:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320151605520807.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cepheid
Reports 2015 First Quarter Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 4:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151311363311.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Patients
feel stigma, discrimination when living with hepatitis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151212473485.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cellular
Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal
Meningitis and Immune Reconstitution Inflammatory Syndrome</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042420150701191112.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Small
Cap IR Issues Analyst Coverage of PositiveID Corporation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 24, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320152105033938.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Late
recurrence of a tumor of Ewing¡¯s sarcoma family of tumors: report of a case</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Surgical Case Reports</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151909542381.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Beckman
Coulter Diagnostics Revolutionises Molecular Diagnostics with ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:09:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151704248140.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Quidel
Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 5:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151621058791.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioM¨¦rieux
Q1 Revenues Grow 21 Percent on Currency Effects</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 4:21:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs2042320151401291648.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>[Perspective]
The delicate dance of translation and folding</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Science</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320151103282197.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Meridian
Bioscience Fiscal Q2 Revenues Rise 3 Percent</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 11:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150900350170.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Standard
Clinical Assays Can Obscure the Diversity of Breast Cancer Subtypes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150400479757.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Glide
Technologies Completes Successful Proof-of-Concept Study With Novel Solid Dose
Formulation of Teriparatide SDI&reg;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 4:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151001319017.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
National Osteoporosis Foundation Announces Dr. Helen Burstin, Chief Scientific
Officer of The National Quality Forum, as Keynote Speaker for the 2015
Interdisciplinary Symposium on Osteoporosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 10:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150704215869.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Intercept
Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis
Resolution ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:04:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150609161914.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Global
mHealth Monitoring and Diagnostic Medical Devices Market to Be Fuelled by High
Incidence of Chronic Diseases: Transparency Market Research</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 6:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150820170069.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Guideline on How to Treat the One in 10 Who Experience a First Seizure</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:20:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150803026735.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CORRECTION
FROM SOURCE: Indian Approval of Import Licence for Genedrive(R) TB Molecular
Diagnostic Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150802030030.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CorMedix
Presents Data from Neutrolin&reg; Post Marketing Surveillance Study At Two Medical
Conferences</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150800252123.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celebrating
First Anniversary, Brain Health Registry on Path to Find Cures Faster for
Alzheimer¡¯s Disease and All Brain Disorders</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150800192094.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>World
Medical Innovation Forum 2015 to Feature Panels on Alzheimer¡¯s Disease and
Multiple Sclerosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150749029965.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AbbVie
Reports First-Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:49:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150730162052.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Meridian
Bioscience Reports Second Quarter 2015 Operating Results, Declares Regular Cash
Dividend, and Reaffirms Fiscal 2015 Guidance</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150702369918.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Accuray
to Showcase New CyberKnife&reg; and TomoTherapy&reg; Technologies at ESTRO 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150700191975.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agenus
Reports First Quarter 2015 Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150630261924.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alexion
Reports First Quarter 2015 Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 6:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150612449840.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Wage
Hope In The Fight Against Pancreatic Cancer At PurpleStride Detroit On Ford
Field</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 6:12:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150501226311.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Indian
Approval of Import Licence for Genedrive(R) TB Molecular Diagnostic Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 5:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150200151855.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Transgene
Presents New Data with TG1050, an Immunotherapy Being Developed to Treat
Chronic Hepatitis B, at The International Liver Congress&#8482; 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150200151858.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Transgenomic
to Incorporate Horizon Discovery's Genomic Reference Standards into Multiplexed
ICE COLD-PCR&#8482; Kits</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042320150019341355.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Innovation
Grants and Unsung Life Sciences Startups of San Diego</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220152204300450.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Roche
gives timeline for its anti-PD-L1</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 10:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151605181721.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Agilent
Technologies Announces Resolution to U.S. FDA Warning Letter for Dako Denmark</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 4:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151552259466.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MiNDERA
announces R&amp;D collaboration with large corporate partner</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 3:52:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220151524191573.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Generic
Drug Prices Keep Rising, but is a Slowdown Coming?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 3:24:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151521181661.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Applied
BioCode to Present Poster at CVS on Multiplex Gastrointestinal Pathogen
Detection with a User Friendly, High Throughput Molecular Diagnostic System</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 3:21:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042220151517206223.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
small Texas town that¡¯s reeling after a deadly bacteria outbreak wiped out its
ice cream supply</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 3:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151509374830.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Scientific (GBSN) Stock Soars Today on FDA Clearance for Molecular
Diagnostic Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 3:09:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151415121609.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>VuCOMP
Files Industry¡¯s First PMA for Computer-Aided Detection for Digital Breast
Tomosynthesis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220151406324648.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Concerns
over data manipulation lands Chinese API maker with US FDA Warning</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151310409344.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Breakthrough
Development in Cancer Immunology Published in Nature</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 1:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151205100173.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Scientific Wins FDA 510(k) Approval for Group B Strep Molecular
Diagnostic Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 12:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151201499831.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Scientific Inc receives FDA 510(k) clearance for Group B Strep Molecular
Diagnostic Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 12:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151200181496.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ligand
Earns Milestone from SAGE Therapeutics for SAGE-547</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151122459156.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>TowerView
Health Named Venture+ Forum Pitch Competition Winner At HIMSS15</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151107099643.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Gets FDA OK for Strep B Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220151101347877.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Receives FDA 510(k) Clearance for Group B Strep Molecular Diagnostic Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151005377987.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Scientific, Inc. Wins FDA 510(k) Approval for Group B Strep Molecular
Diagnostic Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 10:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150931128954.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Twist
Bioscience Launches Alpha Manufacturing Program For Synthetic Genes</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220150930363670.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Color
Genomics unveils $249 spit test for breast and ovarian cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220150924292415.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We're Catching up on Merck, Vaccines and Lots
More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150916291296.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hemoglobin
A1c Testing Devices Market to Register Exponential Growth Owing to Increasing
Global Diabetic Population: Transparency Market Research</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:16:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150906338905.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LabStyle
Innovations to Deliver Poster Presentation at American Diabetes Association's
75th Scientific Sessions on June 5-9, 2015 in Boston</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042220150905287759.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Great
Basin Scientific's (GBSN) GBS Diagnostic Test Receives FDA Clearance</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150901158842.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>My
Eye Media Turns to Tektronix Waveform Rasterizers for 4K Video Content Quality
Control</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150901158852.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Adaptive
Biotechnologies' clonoSEQ Minimal Residual Disease Test Detects Relapse with
Higher Specificity than PET/CT in Diffuse Large B-Cell Lymphoma Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clinical Chemistry</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220151310244935.html?CU=ocd3258&amp;PROFILE=n1uh&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Americas
Clinical Chemistry Analyzer Market by Product (Semi-Automated Clinical
Chemistry and Fully-Automated Clinical Chemistry Analyzer), by End-Users
(Academics Research Institutes, Diagnostic Laboratories, Hospitals) - Forecast
to 2019</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 1:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150836170125.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Women
Discover an Ancient Secret for Preventing Menstrual Cramps</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:36:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150800222119.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cytori
Reports Preclinical and Mechanistic Data Supporting Use of Cytori Cell Therapy
in Wounds Combining Thermal Burn and Radiation Exposure</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150700191990.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Baxter
Reports First Quarter Financial Results That Exceed Guidance</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042320150637449540.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>EL
James's husband to write screenplay for Fifty Shades of Grey sequel</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 6:37:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150501009784.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mylan
Launches Generic Sofosbuvir Tablets, MyHep&#8482;, in India</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 5:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042320150452110486.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Safety of the Blood Supply ¡ª Time to Raise the Bar</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>New England Journal of Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 4:52:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs5042320150351230166.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Husband
of E.L. James to write screenplay for sequel to Fifty Shades</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 3:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042320150337472215.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alexander
Gronsky¡¯s best photograph: invaders on the edge of snowy St Petersburg</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 3:37:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042320150257383579.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Scientists
here discover important role of a type of white blood cell which can destroy
dengue cells</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 2:57:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150130599694.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>CTI
BioPharma to Report First Quarter 2015 Financial Results on May 6, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150005072737.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>A
dose-response study of consuming high-fructose corn syrup-sweetened beverages
on lipid/lipoprotein risk factors for cardiovascular disease in young adults
[Cardiovascular disease risk]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150000401279.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Platelet-Driven
Leukotriene C4-Mediated Airway Inflammation in Mice Is Aspirin-Sensitive and
Depends on T Prostanoid Receptors [ALLERGY AND OTHER HYPERSENSITIVITIES]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042220152235372128.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>E.L.
James escolhe marido como&nbsp;roteirista do pr¨®ximo 'Cinquenta Tons de Cinza¡¯ </span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 10:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220152204300446.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tecfidera
becomes latest Bass target</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 10:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151608524835.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Repurposed
Microfluidic CTC Purification Tech Enables Blood-based Antibiotic Resistance
Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 4:08:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151429529410.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Banner
- University Medical Center Phoenix named Center of Excellence
radioembolization for liver cancer treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:29:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151147339203.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Inspire
Therapy Approved for Sleep Apnea Patients at Military and VA Hospitals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151101189116.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Portage's
Biohaven to begin Phase 1 study in 3Q2015 and readying for Phase 3 study start
by 1Q2016</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220151017541263.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tim
McGraw, Merck and the American Diabetes Association Challenge Americans with
Type 2 Diabetes to Get to Their A1C Goal</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 10:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150913006805.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cerus
to Release First Quarter 2015 Results on May 5, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:13:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150911526615.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Image
of the Day: Merging Blood Vessels</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150900211262.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Strategia
Therapeutics Initiates a Phase 1/2a Clinical Trial of the Anti-cancer Agent
E6201 in Patients with Advanced Hematologic Malignancies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042220151357358204.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Missing
genetic link found in a challenging immune disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 1:57:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220151120309149.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Possible
Breakthrough May Save Thousands of Cats' and Dogs' Lives</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:20:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150818262168.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Enanta
Announces U.S. FDA Grants Priority Review for AbbVie¡¯s Investigational,
All-Oral, Interferon-Free Treatment Regimen for Genotype 4 Chronic Hepatitis C
Infection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 8:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150304433239.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Decrypting
Cryptosporidium In Rural China</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 3:04:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220152307350934.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Association
between educational level and risk of cancer in HIV-infected individuals and
the background population: Population-based cohort study 1995-2011</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151402151598.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
Finds That Microinjection Platform Enables Assessment of Multiple Cancer Drugs
Directly in Tumors, Predicts Systemic Response</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151322301575.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmaleads
Announces the Inclusion of the First Patient in Phase IIa Study of Oral PL37
for Pain in Diabetic Neuropathy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 1:22:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151100151418.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SynteractHCR
Announces Webinar Series for Clinical Research and Biopharma Professionals</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042220151002177195.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Why
are HIV survival rates lower in the Deep South than the rest of the US?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 10:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150743152064.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Courtagen
Initiates Partnership with Pronto Diagnostics and Medica Labs for Distribution
of Clinical Next Generation Sequencing Tests for Neurological and Metabolic
Disorders</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:43:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150731299950.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PDI,
Inc. to Report 2015 First Quarter Financial Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150701209869.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NeoGenomics
Announces Promotions</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042320150700191979.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Gen9
Launches New Customer Portal Powered by Benchling</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150114122194.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Applied
BioCode to Present Poster at CVS on Multiplex Gastrointestinal Pathogen
Detection with a User Friendly High Throughput Molecular Diagnostic System</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 1:14:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042320150002199682.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>From
a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who
Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz
Awards Honors Six Changemakers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042320150001012561.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Transcriptional
Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of
Autophagy [Molecular Bases of Disease]</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 23, 2015 12:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151718261792.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cold
Plasma Used in World's First Clinical Surgical Procedure Performed to
Selectively Kill Cancer Tumor Cells</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 5:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151405212373.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>WIN
Consortium Describes Development of SIMS Algorithm to Personalize NSCLC Triplet
Therapies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151254251907.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Gene
Expression by Mouse Inner Ear Hair Cells during Development</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 12:54:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220151219151517.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Garrett
Lindemann, Ph.D., Joins Kyield as Executive Vice President and Chief Scientific
Officer for Life Sciences</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 12:19:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151202539892.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
New Biohackers: How (And Where) They Work</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 12:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042220151202016303.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Team
compiles current research on liquid biopsy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 12:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220151106208720.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abbott
Q1 Diagnostic Revenues Drop 2 Percent Despite Slight Uptick in MDx Sales</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 11:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150903317528.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Upsher-Smith
Research on Qudexy&#8482; XR (topiramate) Extended-Release Capsules Highlighted at
the 2015 American Academy of Neurology Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150731308584.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Orexigen
Announces Receipt of Paragraph IV Certification Notice</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150408592721.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biomedica
Launches First CE Marked FGF23 ELISA Assay In Europe and Asia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 4:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150200331685.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Prediction
of survival for patients with pemphigus vulgaris and pemphigus foliaceus: a
retrospective cohort study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Orphanet Journal of Rare Diseases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042120151300356626.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Childhood
cancer survivors more likely to claim social security support as adults</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151125260523.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Molecular
Medicine Awards 3rd Annual Ross Prize to Dr. Lewis C. Cantley, Cancer
Researcher at Weill Cornell Medical College and NY Presbyterian Hospital</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 11:25:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120151107197437.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LeukoDx
Inc. Announces Appointment of Dr. Tobias Volker as Senior Vice President for
Commercial Operations</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 11:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151032237760.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Stroke
Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:32:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150951207666.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Study Shows Cleveland HeartLab Inflammation Testing can Prevent Thousands of
Heart Attacks and Strokes, Averting $187 Million in Healthcare Costs for
Cardiovascular Disease -- The Number One Killer of Men and Women in the U.S.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:51:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120150924034350.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We're Catching up on Teva, Pfizer and Much More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150909057546.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AbilTo
To Present at the 2015 American Diabetes Association Annual Meeting on Remote
Delivery of Behavioral Change Therapy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150901177493.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Banner
Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150900250272.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genzyme
Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150808585720.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Easton
Pharmaceuticals Announces Finalized Joint Partnership Agreement With BMV Medica
for Exclusive Rights to Distribute World Patented Women's Health Diagnostic
Test in Mexico From Israel-Based Common Sense Ltd.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150801218649.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Piramal
Imaging is Proud to Support Major New Research Study Assessing the Value of PET
Scans in Alzheimer's Disease and Dementia Diagnosis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150800231104.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Policy
Innovation Lab at the University of Utah Selects Governments to Participate in
National Pay for Success Initiative</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150800201097.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Navidea
Data for Manocept&#8482; CD206 Targeting Platform Demonstrate Potential to Impact
Tumor-Associated Macrophages and Kaposi¡¯s Sarcoma Tumor Cells</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150747418607.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Report:
Strong Demand for Automation Systems in Drug Discovery Laboratories</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:47:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150730261045.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Acorda
Presents Data on First Clinical Study of Remyelinating Antibody for Multiple
Sclerosis at American Academy of Neurology Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150701151011.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Acorda
Therapeutics Named One of the Best Places to Work For in New York 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150701158524.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pfizer
Partnership Ready to Flourish; Opko Health Brief Report Issued by BrokerBank
Securities, Inc.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150606173978.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Mobidiag
Presents Two New Diagnostic Platforms at ECCMID 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 6:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150200150886.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>3rd
Quarter Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150119570869.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ben
Goldacre: Pharma industry has destroyed its own reputation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 1:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042120152016539059.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Brain
research at Toronto health centre gets $100M funding boost in federal budget</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:20:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120151924024225.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>By
Purchasing Mylan, Teva Gets Bigger, but is it Really a Strategic Fit?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:24:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151605170780.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Illumina
Reports Strong Start to Fiscal Year 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 4:05:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151604438182.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Perrigo
Company plc Reports Record Fiscal Third Quarter Net Sales, Adjusted Net Income,
Adjusted Margins, And Operating Cash Flow</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 4:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042120151602062404.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Researchers
identify methylated DNA markers¡ªnoninvasive cancer screen</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151531258158.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>World
PI Week: Turning Hope into Action!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 3:31:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120151500572569.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BRCA
Breakthroughs?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 3:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120151423521926.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
PhRMA industry profile reports 7,000 medicines currently in development </span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 2:23:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120151324060454.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AAHP
underscores homeopathic safety profile before FDA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:24:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120151310528241.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kasraeian
Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection
Technology</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151300200653.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>MetaStat
Demonstrates MenaCalc Lung&#8482; Is Prognostic for Outcome in Non-Small Cell Lung
Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151243187955.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rock
Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement
of Derivative Litigation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 12:43:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120151124410974.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Reimbursement
pressures, product innovation threatens blood-glucose meter market</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 11:24:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151057280479.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OPKO
Announces Publication of ProtecT Study Using Kallikrein Biomarkers in 4Kscore
Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:57:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151032177757.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ADM
Tronics Launches Second Expansion of Medical Device Design and Engineering
Capabilities</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:32:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042120151017092106.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Your
IQ ¡ª and disability benefits ¡ª might change as you cross the border to the U.S.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151015260440.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SHAREHOLDER
ALERT: Levi &amp; Korsinsky, LLP Notifies Shareholders of Accelerate
Diagnostics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff
Deadline of May 18, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151010517719.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Point
of Care Decision Support to Showcase AC Software at the Anticoagulation Forum
National Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151000160418.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pfizer
Receives U.S. FDA Breakthrough Therapy Designation For XALKORI&reg; (crizotinib)
For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150915477561.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Decision
Diagnostics Shrugs Off New Attack As Johnson &amp; Johnson Panics In Patent
Case</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120150908435971.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Invivoscribe(R)
Launches Four CE-Marked NGS-Based LymphoTrack(R) Dx Assays</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150902317522.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vigilant
Biosciences Announces Two Poster Presentations at the 2015 AACR Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150900310297.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Baxter
Supports IPOPI Initiative to Improve Global Care of Primary Immunodeficiencies
During 5th Annual World PI Week</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clinical Chemistry</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150309131944.html?CU=ocd3258&amp;PROFILE=n1uh&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Anne
Daley Honored with AACC Outstanding Speaker Award</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 3:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150830291174.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Triphase
Accelerator Corporation Initiates Phase I Study of Marizomib and Bevacizumab in
Patients with Glioblastoma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150830291176.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bio-Path
Holdings¡¯ Drug Delivery Technology to be Featured in a Presentation at IBC¡¯s
17th Annual TIDES Oligonucleotide and Peptide Therapeutics Conference</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220150828103049.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Small
European study highlights promise of gene therapy for rare immune disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:28:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220150811037494.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sysmex
Inostics Announces Agreement With IndivuTest to Offer Sysmex Inostics Blood
Based Mutation Testing in Germany, Austria and Switzerland</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:11:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150802278684.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Noted
Journalist Alan Duke Interviews Innovative Cancer Scientist Dr. Craig Dionne</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150802278676.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Celator&reg;
Pharmaceuticals Presents Data at the American Association for Cancer Research
Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150801291136.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genocea
Completes Enrollment in Phase 2a Human Challenge Study of GEN-004 for the
Prevention of Infection by Pneumococcus</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042220150801307704.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sysmex
Inostics Announces Agreement With IndivuTest to Offer Sysmex Inostics Blood
Based ...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150800291127.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biothera¡¯s
Investigational Cancer Immunotherapy Alleviates Immune Suppression by
Regulatory T Cells, Enabling CD4 and CD8 T Cell Proliferation, Study Finds</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150800231111.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Acetylon
Presents Data on Synergistic Activity of Selective HDAC6 Inhibition in
Preclinical Models of Multiple Myeloma and Mantle Cell Lymphoma at the American
Association for Cancer Research Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150746308600.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abbott
Reports First-Quarter 2015 Results</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:46:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150731308575.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nuvo
Research Announces New WF10 Phase 2 Trial</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150702514687.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>'Liquid
biopsy' leads to earlier detection of NSCLC treatment resistance</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150700300996.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nephros
to Present at Upcoming Investor Conferences</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150504233261.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>McKeesport
Wise Walk participants make friends, get healthier</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 5:04:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150216130893.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bonvisi:
New Urology Pump Makes Operation Faster and Safer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:16:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150200331669.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Objective
assessment of health or pre-chronic disease state based on a health test index
derived from routinely measured clinical laboratory parameters</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Journal of Translational Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150200331668.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bilateral
synchronous carcinoma breast- a rare case presentation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>SpringerPlus</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150200331676.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Reversible
cerebral vasoconstriction syndrome following red blood cells transfusion: a
case series of 7 patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Orphanet Journal of Rare Diseases</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 2:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120152207489196.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Analysis
of Breath Specimens for Biomarkers of Plasmodium falciparum Infection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042120151658347075.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Former
patients of Santa Barbara doctor test positive for blood-borne viruses, health
officials say</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 4:58:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs8042120151336160362.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Thirty
years in jail for a single hair: the FBI's 'mass disaster' of false conviction</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:36:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120151312290659.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Wagner
family grateful after second twin gets liver transplant</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:12:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151300200655.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Data Demonstrate Potential of Biothera¡¯s Investigational Cancer Immunotherapy
to Re-Orient the Tumor Microenvironment to Facilitate Greater&nbsp;Anti-Tumor
Activity</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151300200662.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biothera¡¯s
Imprime PGG Investigational Immunotherapy Drug Modulates the Function of
Macrophages and Dendritic Cells to Drive Expansion of Anti-cancer T Cells</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151228337938.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief,
Without a Hysterectomy, to 1 Million Southern California Women</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 12:28:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042120151202213536.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Type
2 diabetes: Understanding regulation of sugar levels for better treatment</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 12:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042120151202223542.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Caring
for blindness: A new protein in sight?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 12:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151200300558.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ERYTECH&nbsp;Strengthens
Its Intellectual Property Position in the US</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120151159208316.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biologics
Safety Testing Market Worth $3130.85 Million by 2019</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 11:59:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151118260520.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Retractable
Technologies, Inc. Announces U.S. Supreme Court Decision ¨C Denial of Writ of
Certiorari</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 11:18:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120151019143156.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Gene
Therapy Upstart Dimension Nabs $65M From ¡°Crossover¡± Backers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:19:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042120150902069488.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Video
of mini hearts and livers for &quot;Body on a Chip&quot; project update</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150901177502.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Delete
Blood Cancer DKMS to Hold Second Annual Awards Breakfast Hosted by Kimberly
Chandler at Dallas Museum of Art</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150800231103.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>BioTime
Licenses&nbsp;Beckman Research Institute of City of Hope to Manufacture
Clinical Grade Stem Cells</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120151719140832.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Walgreens
Brings Well Beyond HIV&#8482; Campaign to San Francisco</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 5:19:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151440248110.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>DEP
Study Reveals Lyme Disease Risk In All 67 Counties of Pennsylvania</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 2:40:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120151401471383.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Acting Commissioner Ostroff Addresses the &quot;State of the FDA&quot;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 2:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120151031177756.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Seattle
Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts
91% Complete Remission Rate in Children with Relapsed Leukemia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 10:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120150908474787.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Invivoscribe(R)
lan&ccedil;a quatro Ensaios -Based LymphoTrack(R) Dx baseado em NGS com a Marca CE</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042220150830154812.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardinal
Health pays feds $26M to settle charges of monopolizing molecular imaging agent
market </span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042220150808445704.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cardinal
Health pays feds $26M to settle charges of monopolizing molecular imaging agent
market</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 8:08:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150730261046.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Intellia
Therapeutics Announces Dr. Jennifer Doudna and Dr. Derrick Rossi to Join
Company</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042220150701158538.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Sequenom
Announces 2015 First Quarter Results Conference Call</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042220150700300992.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OurCrowd
Marks Israel's 67th Anniversary with Addition of 67th Portfolio Company</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 22, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120150953395681.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>National
Access Project for Cancer Testing Gains Momentum</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 9:53:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Bone and Mineral</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042020151602058895.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>What's
the life expectancy of patients when they begin treatment for osteoporosis?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020150905336093.html?CU=ocd3258&amp;PROFILE=lmpr&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>National
Foundation for Celiac Awareness Urges At-Risk Families to Test for Celiac
Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Cardiac</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467184.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>VolitionRx
Initiates Study with Hvidovre Hospital, Denmark, Specifically to Target NuQ(R)
Biomarker Panel for Colorectal Polyps</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120150605570850.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Doctor's
Article Counters The &quot;Myths That Undermine Medical Research&quot;</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 6:05:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150600169939.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Alnylam
Reports 12-Month Clinical Data from Phase 2 Open Label Extension (OLE) Study of
Patisiran, an Investigational RNAi Therapeutic for Patients with Familial
Amyloidotic Polyneuropathy (FAP)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020152059545114.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Validation
of the Appropriate Use Criteria for Coronary Angiography A Cohort Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151601506688.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Merrimack
Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust
Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast
Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151521556627.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Educational
Webinar Teaches Improved Patient Management Through Broader Access to Cardiac
MRI</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 3:21:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151436279603.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Board
Approves Cross-Border Merger Terms Relating to the Merger of Sorin S.p.A. with
and into Sand HoldCo PLC</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 2:36:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151213538719.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lori
Rafield, Ph.D. Appointed Permanent CEO Of diaDexus</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 12:13:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151200159516.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kids
with Dangerous Heart Arrhythmias Receive Lifesaving Support from High-Tech,
Implantable Devices at Stanford Children¡¯s Health</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151117137477.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Doctors
Ousted as LabCorp to Allow Consumers to Order Their Own Tests</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 11:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151012264285.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Doctors
Ousted as Laboratory Corporation of America Holdings (LabCorp) to Allow
Consumers to Order Their Own Tests</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:12:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151010004090.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lori
Rafield, Ph.D. Appointed Permanent CEO of Diadexus</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020150901016082.html?CU=ocd3258&amp;PROFILE=gdo5&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ibrutinib
(IMBRUVICA&reg;) Improves Outcomes for Pancreatic Ductal Adenocarcinoma in Mouse
Models</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Clincal &amp; Regulatory</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467211.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Delcath
Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With
Intrahepatic Cholangiocarcinoma</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467198.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>First-in-Human
Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467248.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Excelsys
Introduces Extended Trim Range Power Modules Offering Unmatched Design
Flexibility</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150800310157.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pfizer
Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients
With Relapsed Or Refractory Acute Lymphoblastic Leukemia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150800300113.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Vantage
mHealthcare Board of Directors Votes to Develop Marijuana Detection Capability
for its Sensor</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150800300102.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SurModics
to Webcast Second Quarter 2015 Earnings Conference Call on April 30</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150800300103.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Metamark
Announces Partnership with Highmark Blue Shield to Provide Access to
Comprehensive Urology Diagnostics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150800310131.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ArQule
Announces Data Presentations with ARQ 087, Inhibitor of FGFR, at AACR</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150800300123.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Castle
Biosciences Hires Vice President of Marketing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150800310133.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nodality
Publishes Study Results Confirming the Company¡¯s Diagnostic Can Predict
Induction Therapy Response in Elderly Patients with Acute Myeloid Leukemia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150735260067.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ARIAD
Announces Results of Preclinical Studies on Brigatinib at the American
Association for Cancer Research Annual Meeting</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:35:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150730260055.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Medical
University of Vienna Research Demonstrates Value of ANGLE plc¡¯s ¡®Blood Biopsy¡¯
Technology</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120150703292154.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>DRL,
Promius Pharma files NDAs with US FDA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150702287116.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Advanced
Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical
Meetings</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150701237111.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SI-BONE,
Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin
Watson to Board of Directors</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150701197088.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Lyme
Patient Advocates Denounce Intellectual Conflicts of Interest for Seven IDSA
Guidelines Review Panelists</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150700300014.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NeuroMetrix
Reports Q1 2015 Financial Results and Highlights</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150639307057.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ANGLE
plc Updates Results on Ovarian Cancer Study</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 6:39:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150600457017.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Results
Of Decision Impact Study Of Guardant360 In Metastatic Colorectal Cancer To Be
Presented At AACR</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120150202578614.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>EPA
May Recommend Testing Food Products for Common Herbicide</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 2:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020152203358030.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Correction</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020152059555123.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Electronic
Health Record¨CBased Interventions for Improving Appropriate Diagnostic Imaging
A Systematic Review and Meta-analysis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151703386775.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>U.S.
Preventive Services Task Force Issues Draft Recommendation Statement on
Screening for Breast Cancer; Seeks Comments from the Public</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151630266728.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Contemporary
Results From Commercial HVAD&reg; System Registries Highlighted At ISHLT Meeting In
Nice, France</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151616386711.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Actavis
Announces Retirement of Charles M. Mayr</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151611116704.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>National
Council Honors 18 Individuals and Organizations for Contributions to Mental
Health and Addiction Care</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:11:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151608421186.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA,
CMS Form Task Force On Lab Developed Test (LDT) Regulation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:08:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151601339668.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tokai
Pharmaceuticals Announces Preclinical Results from the University of Maryland
Showing Galeterone and Analogs Inhibit Pancreatic Cancer Cell Growth</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042020151515255659.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ottawa
scientists may have figured out how to fight ¡®silent killer¡¯ of pancreatic
cancer with viruses</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 3:15:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151503201853.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Japan¡¯s
Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake | Reuters</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 3:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151425128830.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aurobindo
Pharma approved for generic cefixime</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 2:25:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042020151416221376.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Ottawa
scientists may have figured out how to destroy ¡®silent killer¡¯ of pancreatic
cancer with viruses</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 2:16:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151413300786.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bio-Rad
Grants Beckman Coulter Exclusive Distribution Rights for Acces...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 2:13:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151317380062.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abbott¡¯s
Freestyle Precision Neo Glucometer Cleared by FDA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 1:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151200159518.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Implanet
Announces Definitive Clinical Results in a Comparative Study of the JAZZ Band
in Idiopathic Scoliosis Surgery</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151200159514.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OncoCyte
Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a
Marker and Potential Diagnostic for Breast Cancer and Other Types of Human
Cancers</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 12:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151117137466.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>OTC
glucose monitor approved by FDA</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 11:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151022041842.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Chronic
disease, cost of care expected to drive use of home-health technology</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:22:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151009064059.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Ponders Putting Homeopathy To A Tougher Test</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:09:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151001196225.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>International
Isotopes Inc. Provides Shareholders With An Update On New Opportunities And
Positive Developments Within Its Existing Business Segments</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151001206231.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
SU2C-OCRF-OCNA-NOCC Ovarian Cancer Dream Team Announced; $6 Million Grant Over
3 Years Will Focus on DNA Repair Therapies</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/goo042020151001155084.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bio-Rad
Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and
Hepat...</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Google Alert</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020150925303174.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmalot..
Pharmalittle.. Good Morning: We're Catching up on Merck, Teva, Pfizer and Lots
More!!</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:25:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020150912142999.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Positive
Clinical Results of OncoCyte¡¯s PanC-Dx&#8482; Diagnostic Test Demonstrate High Level
of Sensitivity and Specificity in Non-Invasive Detection of Bladder Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:12:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020150912064973.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Bio-Rad
Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and
Hepatitis C Assays</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:12:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020150910394852.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Pharmacological
Advancements in Neuroscience Drug Discovery &amp; Pre-Clinical Studies for
Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead
Biotech Sector Research</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020150900249245.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>FDA
Accepts Supplemental BLA and Grants Priority Review for ADCETRIS&reg; (Brentuximab
Vedotin) in the AETHERA Setting for the Post-Transplant Consolidation Treatment
of Hodgkin Lymphoma Patients at High Risk of Relapse</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020150900219238.html?CU=ocd3258&amp;PROFILE=hw3t&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>St.
Jude Medical Announces Intent to Acquire Spinal Modulation, Inc.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Donor Screening</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150845477417.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Earth
Day Diamond: Scientific Breakthrough</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:45:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042120150807074490.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Human
tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in
a humanized mouse model</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Journal for Immunotherapy of Cancer</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:07:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467261.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Abaxis
To Report Fourth Quarter And Fiscal Year 2015 Financial Results Thursday, April
30, 2015</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467237.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Enrollment
In Mast Therapeutics' Phase 3 &quot;EPIC&quot; Study In Sickle Cell Disease
Surpasses Halfway Mark</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467241.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>ILUVIEN&reg;
Is Now Widely Available To Diabetic Macular Edema Patients Throughout The U.S.</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467196.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Who's
In Charge? Survey Shows Most Parents Rely on Kids to Say it's Time for an Eye
Exam</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467209.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Relmada
Therapeutics Commences Proof-of-Concept Clinical Study for Novel Oral
Formulations of Buprenorphine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150730260053.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nimbus
Therapeutics Announces Initiation of Clinical Studies for ACC Inhibitor</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150730260059.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>PLEGRIDY&reg;
(Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support
Long-Term Safety and Efficacy in Multiple Sclerosis Patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150500169897.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Kineta,
University of Groningen Present New, Positive Data for Dalazatide in ANCA
Vasculitis, an Orphan Disease</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 5:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042120150406129876.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Neurovive
Pharmaceutical: Clinical Phase II Study with NeuroSTAT&reg; for Traumatic Brain
Injury Passes Safety Evaluation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 4:06:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042120150120530221.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nanoparticles
That Control Internal Bleeding After Explosive Blasts</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 1:20:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020152259308477.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Serum
syndecan-4 as a possible biomarker in patients with acute pneumonia</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:59:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020152118499239.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Banks
Chevrolet Hosts a Third American Red Cross Blood Drive</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:18:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020152000324649.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Breath
test breakthrough could lead to earlier malaria detection</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 8:54:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151804484925.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hydrogen
improves neurological function through attenuation of blood¨Cbrain barrier
disruption in spontaneously hypertensive stroke-prone rats</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Neuroscience</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 6:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151735236786.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SVIN
President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New
England Journal Of Medicine</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:35:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151707163863.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hair
regrowth in alopecia areata patients following Stem Cell Educator therapy</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Medicine</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151706093763.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Reuters:
Britain¡¯s Prime Minster Apologizes For Infected Blood In 70s, 80s</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:06:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151704386777.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Study
shows new technology may improve management of leading causes of blindness</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:04:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042020151702263834.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>New
study unravels why common blood pressure medicine can fail</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151610454335.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>World
Blood Pressure Monitoring and Measurement Instruments Industry</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042020151602058903.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Providing
universal donor plasma to massively bleeding trauma patients</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151600189654.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>The
Hartford Names David Robinson General Counsel And Kathy Bromage Chief Marketing
And Communications Officer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 4:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151500456601.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>SillaJen
Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A
Collaboration with University of California, San Francisco</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 3:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151410355351.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>American
Red Cross and Dell Expand Partnership, Using the Power of Social Data to
Support Disaster Relief and Blood Donor Services</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 2:10:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151317380063.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hemostatic
Nanoparticles Packed with Steroids Help Control Internal Bleeding After
Explosive Blasts</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 1:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042020151302084537.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>One
test for all infections</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 1:02:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020151301156495.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>DelMar
Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to
Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 1:01:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151230159535.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dell
Services Provides Organizations New Levels of Social Media Insights and
Analytics</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 12:30:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151130224402.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>LabCorp
rides direct-to-consumer wave with online testing services</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 11:30:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151003430618.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Jobs
at the Center for Biologics Evaluation and Research (CBER)</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:03:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151000309342.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Using
RFID Technology to Ensure the Traceability of French Plasma for Fractionation</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020150910486111.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Is
Dr. Craig Dionne the Steve Jobs of Cancer Research?</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:10:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042020150902346518.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>A
common nerve protein elevated in aggressive neuroblastomas</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:02:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020150901036086.html?CU=ocd3258&amp;PROFILE=ssah&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Safe-T
Named 2015 'Cool Vendor in Mobile and Wireless' by Gartner</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Immunohematology</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042020151317126991.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Welcome
to the ¡®New Mediocre¡¯ of a world drowning in debt</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 1:17:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs4042020151117128626.html?CU=ocd3258&amp;PROFILE=mtex&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Welcome
to the ¡¯New Mediocre¡¯ of a world drowning in debt</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 11:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Infectious Disease</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150723157129.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Physician
Specialty, Gender and Self-Employment Critical Factors Impacting Pay, According
to Medscape Compensation Report</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:23:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/biz042020151700309739.html?CU=ocd3258&amp;PROFILE=kp3e&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Hormel
Foods Discusses Impact of Recent Avian Influenza Outbreaks</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Business Wire</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:00:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Market</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151803343238.html?CU=ocd3258&amp;PROFILE=dujz&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>@MIT:
Synergy needed to Supress Cancer Tumors: Activation of the Innate Immune System
AND Stimulation of T cells ¨C the Adaptive Immune System</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 6:03:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<div class=MsoNormal align=center style='text-align:center'><span lang=EN-US
style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black'>

<hr size=2 width=581 style='width:435.75pt' noshade style='color:#666666'
align=center>

</span></div>

<p class=MsoNormal><span lang=EN-US style='font-size:10.5pt;font-family:"Verdana","sans-serif";
color:black'>Molecular Diagnostics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150831347328.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Tute
Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints
Josh Forsythe as New VP of Marketing</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:31:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467213.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Push
Telecommunications for Tele-Medicine (PTT) and M-Health Market by 2021</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150801467249.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>NanoCellect
And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform
For Cell Sorting And Analysis</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 8:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs6042120150700428989.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Real-world
targeted treatment based on whole genome sequencing difficult in pancreatic
cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 7:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042120150600457018.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genetic
Variance Explains Poor Response to Common Asthma Medications</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 21, 2015 6:00:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151707163857.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Genome-wide
identification of SSR and SNP markers from the non-heading Chinese cabbage for
comparative genomic analyses</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>BMC Genomics</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 5:07:00 PM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rss042020151115077274.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>AACR
Study Shows PD-L1 Expression Can ID Best Responders to Merck's anti-PD-1
Immunotherapy in NSCLC</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 11:15:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/rs1042020151017372588.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Biocartis
fixes IPO price at top end of range</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>RSS</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 10:17:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>


<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US><a
href="https://iwidget.infodesk.com/infodisplay/story/prw042020150901016078.html?CU=ocd3258&amp;PROFILE=hujn&amp;APP=3"
target="_blank"><u><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Cantrixil
Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer</span></u></a></span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>PRNewswire US</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:#666666'>Apr 20, 2015 9:01:00 AM</span></p>

<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";
color:black'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>
